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ABSTRACT 
Alexithymia has been defined as a personality construct that involves difficulties identifying 
and describing feelings, as well as an externally oriented thinking style and impoverished 
fantasy life, which places individuals at risk for various psychopathologies. For psychiatric 
populations, it represents an obstacle to therapeutic success. Despite extensive research, there 
is no consensus on the prevalence rate of alexithymia in the general psychiatric population 
and no data on alexithymia prevalence in the Australian general psychiatric population. In 
addition, there is inconsistency in the literature regarding the role of alexithymia in 
therapeutic intervention and a lack of robust studies involving control or comparative 
therapeutic conditions. 
 
Two systematic literature reviews were conducted to evaluate the prevalence rate of 
alexithymia in the psychiatric and community populations and the role of alexithymia in the 
therapeutic process, respectively. The first review, comprising 124 studies, revealed that 
prevalence rates of alexithymia, although extremely varied, were much higher in psychiatric 
samples compared to community samples. While different psychiatric diagnoses were likely 
to have contributed to the variation in rates of alexithymia across psychiatric samples, it was 
unclear whether other sample characteristics may have contributed. The second review, 
involving 31 studies, identified a balance between studies that found a negative influence of 
alexithymia on some therapeutic outcomes and studies that found no influence of alexithymia 
on therapeutic outcomes. In addition, numerous types of therapeutic intervention reduced 
alexithymic features on average. All of the reviewed studies found a consistent degree of 
change between individual’s alexithymia scores from before to after treatment (relative 
stability). 
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Study 1 examined differences in alexithymia between 166 general psychiatric outpatients and 
216 community participants from Australia. Alexithymia was measured with the 20-item 
Toronto Alexithymia Scale. Analysis of variance indicated that the psychiatric sample, 
independent of demographic factors, had higher alexithymia scores than the community 
sample. Chi-Square analysis showed a greater proportion of alexithymic participants in the 
psychiatric sample compared to the community sample. The strength of the associations 
between alexithymia and psychological distress (measured with the Depression Anxiety 
Stress Scale) were found to be similar for both sample groups. 
 
Study 2 examined the role of alexithymia in the therapeutic process in a subset (n = 61) of the 
original psychiatric sample who were subject to one of two treatment conditions: emotion 
focused group therapy or cognitive-behavioural focused group therapy. Higher alexithymia 
scores before treatment were associated with less change in psychological distress severity 
during treatment. This association was not significant in either treatment condition when 
examined separately. Analysis of variance showed that mean-level change in alexithymia 
from before to after treatment was not dependent on treatment condition. Correlation and 
hierarchical regression analyses showed a high degree of relative stability in alexithymia 
despite moderate change in psychological distress severity. Regression analysis showed that 
change in alexithymia could not be directly accounted for by change in psychological 
distress. Regression analysis also showed that less change in alexithymia severity during 
treatment significantly predicted higher psychological distress scores after treatment, even 
after controlling for group therapy type and psychological distress severity before treatment. 
 
The theoretical, research, and clinical implications of these research findings are discussed. 
The importance of identifying alexithymic patients prior to conducting therapeutic 
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intervention was emphasised, as was the need to provide those patients, who were 
alexithymic after treatment, with further psychiatric care. 
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CHAPTER 1 
INTRODUCTION 
More than 25% of all people will develop a psychiatric disorder at some point in their 
lives (World Health Organization, 2001). Individuals diagnosed with a psychiatric disorder 
have high rates of socioeconomic disadvantage (e.g., unemployment, poor housing, less 
social support, and less access to health services), morbidity (physical and mental disability 
and non-fatal health outcomes) and premature mortality (AIHW et al., 2007). In fact, mental 
illness was the third leading contributor to total burden of disease and the leading cause of the 
disability burden in Australia in 2003 (AIHW et al.). The global burden of mental illness is 
likely to increase rapidly in the future (Murray & Lopez, 1996). For these reasons, there is a 
growing body of research investigating the prevention and treatment of psychopathology, as 
well as potential risk factors for developing psychiatric disorders. 
Alexithymia is considered an important risk factor in the development, maintenance, 
and recovery from a broad range of psychiatric disorders, symptom presentations, and 
maladaptive behaviours (Taylor, Bagby, & Parker, 1997). Alexithymia is a personality trait 
that reflects a comprehensive deficit in the cognitive processing of emotions, that is the way 
in which individuals experience and express emotion (Sifneos, 1994; Taylor et al., 1997). 
Although alexithymia represents a trait that is normally distributed in the general population 
(Mattila et al., 2010), rates of alexithymia are typically far greater in psychiatric populations 
than in general populations. A number of studies have noted greater rates of alexithymia 
amongst psychiatric patients, including those diagnosed with depression (Son et al., 2012), 
anxiety and trauma related disorders (Frewen, Lanius, et al., 2008), somatoform disorders 
(Müller & Bühner, 2006), eating disorders (Beales & Dolton, 2000), and substance misuse 
(Evren, Cagil, et al., 2012). 
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Alexithymia may pose a particular problem for psychiatric patients by contributing to 
the chronicity of their disorder and interfering with their recovery. Alexithymia has been 
associated with persistent high levels of psychological distress following treatment (Grabe et 
al., 2008; Leweke, Bausch, Leichsenring, Walter, & Stingl, 2009; Ogrodniczuk, Piper, & 
Joyce, 2004). Further, alexithymia has been associated with higher levels of psychiatric 
symptomatology over extended periods of time (Bach & Bach, 1995; Speranza, Loas, 
Wallier, & Corcos, 2007). Understandably, there is growing interest into the extent to which 
alexithymia can be mitigated and the most effective treatments to achieve this. 
Numerous studies have explored the extent to which alexithymia levels change over 
time (alexithymia stability) as a result of therapeutic treatment for psychiatric disorders. 
Conclusions from prospective studies as to whether alexithymia is stable or not largely 
depend on the types of analyses conducted. The most common analyses conducted in 
alexithymia studies assess mean-level stability (average alexithymia score in the overall 
sample is consistent over time) and relative stability (differences between individual’s 
alexithymia scores are consistent over time). Some studies have found mean-level stability in 
alexithymia following treatment with multimodal cognitive-behavioural therapy (Rufer et al., 
2004) and pharmacotherapy (Schmidt, Jiwany, & Treasure, 1993; Todarello, Porcelli, 
Grilletti, & Bellomo, 2005). However, many more studies have shown significant reductions 
in alexithymia following multimodal psychotherapy (Honkalampi, Hintikka, Laukkanen, 
Lehtonen, & Viinamäki, 2001), emotion regulation training (Clyne & Blampied, 2004), and 
cognitive-behavioural therapy (Spek, Nyklίček, Cuijpers, & Pop, 2008). 
The present thesis progressed in four stages: two systematic literature reviews and two 
empirical studies. The first literature review is presented in Chapter 2. This literature review 
evaluated the occurrence of alexithymia in psychiatric and community samples, prevalence 
rates of alexithymia according to psychiatric diagnosis (e.g., mood disorders and somatoform 
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disorders) and psychiatric setting (inpatient and outpatient settings), and the influence of 
demographic factors of the study sample (e.g., gender) on alexithymia scores. 
The second literature review is presented in Chapter 3. This literature review 
evaluated the influence of alexithymia on therapeutic outcome in psychiatric samples. The 
stability of alexithymia following different therapeutic interventions was also evaluated in 
this review. 
The two empirical studies conducted in the present research sought to address some of 
the gaps and limitations that were highlighted in the literature reviews. Study 1 (Chapter 4) 
established the prevalence of alexithymia in an Australian psychiatric outpatient sample and 
then compared this rate to an Australian general community sample. To the researcher’s 
knowledge, this is the first study to examine alexithymia rates in an Australian general 
psychiatric sample. Given some conflicting findings reported on in the literature review 
(Chapter 2) regarding the potential influence of demographic factors on alexithymia, Study 1 
considered whether alexithymia poses a greater risk for particular groups of people by 
examining the impact of participants’ gender, education level, and employment status on 
alexithymia scores. The relationship between alexithymia and psychological distress for both 
sample groups was also considered in this study in order to explore the role of alexithymia as 
a predisposing factor to the development and/or maintenance of psychopathology. 
Study 2 (Chapter 5) examined the role of alexithymia in the maintenance of 
psychiatric symptomatology after group intervention. As very few studies in this area have 
compared different therapeutic approaches, this study investigated the influence of 
alexithymia on psychological distress levels in a sample of psychiatric outpatients after they 
had completed one of two therapeutic groups. In addition, this study examined the 
effectiveness of these therapy groups in reducing alexithymia over time. 
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The final chapter (Chapter 6) of this thesis provided a general discussion of the 
combined research findings from each chapter. This discussion included a general overview 
of what has been covered in the present thesis and a synthesis of the main findings from each 
chapter. This chapter also highlighted the strengths and limitations of the present research, 
provided theoretical and practical implications of the findings, and offered recommendations 
for future research. 
The stress-diathesis model was applied as a theoretical framework to guide the design 
and interpretation of the present research. The stress-diathesis model is a widely accepted 
model of causation used to explain the interaction of multiple factors in the development and 
maintenance of psychopathology (Zuckerman, 1999). In simple terms, this model suggests 
that psychopathology is a result of environmental stressors (stress) in individuals who have a 
vulnerability or predisposition (diathesis) to a given psychiatric disorder. Stress and a 
combination of predisposing factors exceed a threshold through which the individual will 
develop a psychiatric disorder. Factors that predispose an individual to develop a psychiatric 
disorder may be inherited (genetic), biological stressors during the prenatal to postnatal 
periods (e.g., damage to the neurological system), and/or psychological (e.g., early learning 
experiences that influence cognitive and emotional aspects of personality). Psychological 
predisposing factors are generally considered relatively stable but not necessarily permanent. 
In the stress-diathesis model, alexithymia is considered a stable personality trait, or 
psychological predisposing factor, that interacts with stressors to increase general 
susceptibility to psychopathology. 
The remainder of the present chapter has been written as an introduction to the 
alexithymia construct. This section provides a brief history of alexithymia as well as how it 
was conceptualised and is currently described, a discussion of various measures that have 
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been designed to assess and validate alexithymia, and an outline of the prominent aetiological 
theories that have been proposed to explain the origins of alexithymia. 
History of Alexithymia 
Freud was interested in the origin and treatment of patients with hysteria who 
experienced a pattern of physical symptoms, such as blindness and paralysis, that had no 
definable organic cause (also known as psychoneurotic disorders) (Breuer & Freud, 1895). 
He theorised that many of the physical symptoms experienced by hysterical patients could be 
connected to distressing childhood experiences that could not be recalled by the patient. 
Freud attributed the manifestation of somatic symptoms to an attempt by the unconscious 
mind to protect the patient from psychological distress. That is, whereby the somatic 
symptoms function to relieve this distress directly (by redirecting attention toward the 
presenting symptoms) or indirectly (e.g., avoiding work or responsibility). 
Freud’s psychogenic explanation of somatic symptoms was central to the 
development of psychoanalysis and the conceptualisation of psychosomatic disease (Taylor, 
Bagby, & Parker, 1991). For instance, several psychoanalysts (e.g., Alexander, 1950) 
advanced the idea that unconscious psychological conflicts and the distress associated with 
them might play a role in the development, presentation, and maintenance of a definable 
physical illness. However, psychoanalytic therapy as a treatment for psychosomatic disorders 
(e.g., ulcerative colitis or essential hypertension) did not prove to be as effective as 
anticipated (Eysenck, 1952; Lipowski, 1968). Many patients benefited more from supportive 
psychotherapy and/or behavioural interventions (Kellner, 1975; Sifneos, 1983) than 
psychoanalytic therapy, and other patients reported aggravated psychosomatic symptoms in 
response to psychoanalysts’ attempts to identify and interpret unconscious psychological 
conflicts (Sifneos, 1975). These limitations led several researchers to reject Freud’s 
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conceptualisation and treatment of psychosomatic disorders (e.g., Macalpine, 1952; 
MacLean, 1949; Ruesch, 1948). 
Alternative hypotheses about somatic symptoms emerged after World War Two. 
These approaches emphasised the role of affective disturbance rather than unconscious 
psychological conflict in the development of psychosomatic disorders. For instance, Ruesch 
(1948) and MacLean (1949) noticed that many patients with psychosomatic disorders showed 
difficulties verbalising their emotions. Ruesch described these patients as having an infantile 
personality, who lacked the symbolic and verbal skills necessary for the self-expression of 
emotion. He also observed that these patients did not discharge tension by means of action or 
through verbal, gestural or creative symbolism like mature adults. Moreover, psychoanalysts 
Marty and de M'Uzan (1963) recognised a pattern of thinking in psychosomatic patients that 
was devoid of fantasy, symbolism, imagination and personal elements. They referred to this 
deficient form of thinking as pensee operatoire (operational thinking). 
It was the investigations of Nemiah and Sifneos (1970) that resulted in the formal 
classification of the alexithymia construct. These clinicians began systematic investigations 
into the cognitive and affective characteristics of patients with psychosomatic disorders. The 
results of their investigations indicated that, unlike psychoneurotic patients, many 
psychosomatic patients had noticeable difficulty describing subjective feelings and 
elaborating fantasies, and a style of thinking that was similar to operational thinking (Marty 
& de M'Uzan, 1963). Sifneos (1973) proposed the term alexithymia (from the Greek: a = 
lack, lexis = word, thymos = emotion) to categorise the set of characteristics he had observed 
in patients with psychosomatic disorders. 
The introduction of the alexithymia construct promoted great interest in the subject 
and was chosen to be one of the main themes of the 11
th
 European Conference on 
Psychosomatic Research ( r utigam & Rad, 1977), alongside psychosomatic disease and 
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operational thinking. Several key outcomes emerged from this conference, including a 
distinction between psychoneurotic and psychosomatic disorders, further clarification of a 
definition of alexithymia, a need to integrate different fields of research that would facilitate a 
holistic approach to investigating alexithymia, and the need for more extensive and detailed 
investigations into the treatment of alexithymia. 
Describing Alexithymia 
Before presenting a description of the alexithymia construct it is important to take into 
consideration that alexithymia is not an independent psychiatric diagnosis that is included in 
any diagnostic manual of mental disorders (Swiller, 1988). Rather, the term alexithymia 
describes a number of related psychological disturbances. Taxometric analyses have 
indicated that alexithymia is best conceptualised as a dimensional rather than a categorical 
construct (Mattila et al., 2010; Parker, Keefer, Taylor, & Bagby, 2008). That is, alexithymia 
is viewed as a characteristic that is normally distributed in the general population. While 
alexithymia may be a dimensional construct, research often requires the identification of high 
(alexithymic) or low (non-alexithymic) alexithymic participants. Throughout this thesis, and 
the literature cited herein, the terms alexithymia and alexithymic are used to identify 
individuals with more severe or problematic levels of alexithymia. 
Alexithymia is currently defined by a set of four characteristics: 1) difficulties 
identifying feelings and distinguishing feelings from bodily sensations of emotional arousal; 
2) difficulties describing and communicating feelings to others; 3) constricted imaginal 
processes, as indicated by a relative deficiency of affect-related fantasies; and 4) a style of 
thinking characterised by a fixation on external stimuli. Although these characteristics are 
conceptually different, it has been suggested that they are logically interrelated and 
commonly manifest together (Taylor et al., 1997). For example, the ability to describe 
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feelings to others is dependent on the ability to identify and distinguish feelings (Bagby, 
Parker, & Taylor, 1994). 
Alexithymic individuals have a greater tendency to experience negative emotions like 
anger, anxiety, depression, and feelings of shame and embarrassment, as well as a reduced 
capacity to experience positive emotions, such as happiness and affection (Bagby, Taylor, & 
Parker, 1994; Krystal, 1988). However, while these individuals may report episodes of 
emotional disturbance, they have difficulty identifying them as feelings and differentiating 
them from physiological responses to emotional arousal (e.g., increased heart rate, sweating, 
or dry mouth). For example, the experience of anxiety and hunger may be confused. The 
limited capacity of alexithymic individuals to identify and differentiate negative emotion, 
together with difficulties expressing these emotions in a sufficient or healthy way, leads them 
to intensify and misinterpret ordinary bodily sensations associated with emotional arousal as 
physical disease (Lane & Schwartz, 1987; Taylor et al., 1997). Consequently, individuals 
who present to doctors with persistent complaints about bodily symptoms may be incorrectly 
treated or diagnosed with a somatoform disorder (Taylor et al., 1997). 
In addition to difficulties identifying and differentiating feelings, individuals with 
alexithymia have difficulty describing and communicating their feelings to others, both 
verbally and nonverbally. They often describe their feelings as vague tension states of which 
they cannot interpret or elaborate any further (Taylor et al., 1997). Their communication style 
is characterised as flat and monotone, with an absence of nuance, metaphor, or the use of 
emotional language (Meganck, Vanheule, Inslegers, & Desmet, 2009; Taylor, 1984). These 
features generate conversation that has been described by therapists as dull, lifeless, and 
boring (Nemiah & Sifneos, 1970; Taylor, 1977). Furthermore, difficulties communicating 
feelings nonverbally can produce a stiff wooden posture and limited facial expressions in the 
individual (Taylor et al., 1997). 
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Since emotions are not adequately communicated, it is difficult for individuals with 
alexithymia to elicit support and comfort from others. Difficulty recognising emotions that 
are being experienced by another person also limits their empathy and support for others 
(Grynberg, Luminet, Corneille, Grèzes, & Berthoz, 2010; McNeill, 2014). Alexithymic 
individuals may appear cold, detached, and socially avoidant (Vanheule, Desmet, Meganck, 
& Bogaerts, 2007). This characteristic may limit their chances of developing a strong 
working relationship with a therapist, forming intimate relationships (Humphreys, Wood, & 
Parker, 2009), and from using social interactions in everyday life as a way of regulating and 
coping with negative affect (C. Spitzer, Siebel-Jürges, Barnow, Grabe, & Freyberger, 2005). 
Another feature of alexithymic individuals is a reduction or absence of fantasies, 
imagination, or other phenomena related to their inner, private mental life of attitudes, 
feelings, desires, and drives (Taylor et al., 1997). They lack the ability to self-reflect or 
examine their conscious thoughts and feelings (introspection, Taylor et al., 1997) and to form 
new images and sensations that are not perceived through their senses (imaginative ability, 
Campos, Chiva, & Moreau, 2000), including daydreaming and dream recollection. 
The externally-oriented cognitive style of alexithymic individuals is, to some extent, 
reflected by their impoverished inner fantasy life (Bagby, Parker, et al., 1994; Marty & de 
M'Uzan, 1963). The reduced fantasy and imaginal activity in alexithymic individuals are 
replaced by a primary focus on external stimuli in their immediate environment, such as 
physical sensations. Conversations often involve repetitive recitation of concrete facts in 
excessive detail (Krystal, 1988). This monotonous style of communication in alexithymic 
patients, as well as their inability to interact emotionally and to link physical symptoms to 
feelings, may generate boredom and frustration in their therapist, which may ultimately affect 
the outcome of psychotherapy (Ogrodniczuk, Piper, & Joyce, 2005). 
 10 
 
In addition to determining a definition of alexithymia, researchers have examined 
various aspects of emotion processing in order to substantiate clinical observations of 
individuals with alexithymia. Three interrelated sets of processes broadly define emotion: 
physiological processes (e.g., activation of the autonomic nervous system), behavioural 
processes (e.g., facial expression and tone of voice), and cognitive-experiential processes 
(subjective awareness and verbal reporting of feelings) (Gross, 2013; Mauss, Levenson, 
McCarter, Wilhelm, & Gross, 2005). The fundamental assumption underlying the 
alexithymia construct is that features of alexithymia reflect a deficit in the cognitive-
experiential or cognitive processing of emotion (Taylor et al., 1997). Since these processes 
are interrelated, a deficit in the cognitive processing of emotion disrupts emotional processing 
on a physiological level as well as on a behavioural level. 
Several studies have examined differences in autonomic activity between alexithymic 
and non-alexithymic individuals, both at rest and in response to stressors or emotion-eliciting 
slides. Findings across the literature are inconsistent. A number of studies have found that, 
compared to non-alexithymics, individuals with alexithymia exhibit higher resting heart rate 
(Fukunishi, Sei, Morita, & Rahe, 1999; Wehmer, Brejnak, Lumley, & Stettner, 1995) and 
electrodermal activity (Friedlander, Lumley, Farchione, & Doyal, 1997; Stone & Nielson, 
2001), as well as greater physiological reactivity during emotion provoking situations 
(Waldstein, Kauhanen, Neumann, & Katzel, 2002). In contrast, some studies have found that 
alexithymic individuals exhibit lower physiological reactivity when viewing emotion-
eliciting slides compared to non-alexithymic individuals, evidenced by fewer skin 
conductance responses (Pollatos, Schubo, Herbert, Matthias, & Schandry, 2008) and heart 
rate decelerations (Franz, Schaefer, & Schneider, 2003; Wehmer et al., 1995). Furthermore, 
other studies have not found any differences at baseline between alexithymic and non-
alexithymic individuals in heart rate or electrodermal activity (Franz et al., 2003; Neumann, 
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Sollers, Thayer, & Waldstein, 2004; Roedema & Simons, 1999) or in blood pressure during 
stressful tasks (Fukunishi et al., 1999; Newton & Contrada, 1994). Inconsistent findings 
across the literature regarding autonomic activity associated with alexithymia may reflect a 
number of differences in methodologies and indicators of autonomic activity, measures used 
to identify alexithymia, and tasks used to elicit emotion and induce stress (Freund, 2012). 
Evidence that is more consistent has been found for differences in brain activity 
between alexithymic and non-alexithymic individuals. Individuals with alexithymia display 
lower brain activity in response to emotional stimuli compared to non-alexithymics when 
studied using positron emission tomography (Kano et al., 2003; Karlsson, Näätänen, & 
Stenman, 2008). In particular, individuals with alexithymia have been found to exhibit low 
levels of brain activity in regions associated with empathic ability and perspective-taking 
ability (Moriguchi et al., 2007; Moriguchi et al., 2006). Difficulties with empathy and 
perspective-taking result in problems differentiating between emotional states of the self and 
others and may lead to the contagion of others distress (Moriguchi et al., 2007; Moriguchi et 
al., 2006). Moriguchi et al. (2006) have suggested that poor empathic ability and perspective-
taking partly explain the association between alexithymia and psychological distress, as well 
as difficulties reading emotion from facial expressions. A literature review of 24 studies that 
have investigated the association between alexithymia and the processing of emotional facial 
expressions showed that alexithymia was associated with global impairments in perceiving 
emotional facial expressions to such an extent that individuals with alexithymia had 
difficulties detecting, matching, and labelling negative, positive, and neutral emotions 
(Grynberg et al., 2012). 
Studies that have examined brain activation, using functional magnetic resonance 
imaging, have shown reduced blood flow and neural activity in the anterior cingulate cortex 
(ACC) of alexithymic individuals (Frewen, Pain, Dozois, & Lanius, 2006; Heinzel et al., 
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2010). Abnormal activity in the ACC is viewed as a neurobiological correlate of alexithymia 
since it has been linked to cognitive deficits in emotion awareness and appraisal of emotion 
(Berthoz et al., 2002; Gündel et al., 2002). In addition to abnormal activity in the ACC, 
individuals with alexithymia have shown greater activation in sensory and motor cortices of 
their brains during emotion-provoking situations compared to non-alexithymic individuals 
(Karlsson et al., 2008; Moriguchi et al., 2009). It has been suggested that the combination of 
diminished emotion awareness and intensified bodily awareness may explain the external 
focus or heightened awareness of physical sensations seen in those with alexithymia 
(Karlsson et al., 2008). 
Researchers that have examined the functioning of brain hemispheres have observed 
lower activation of the right hemisphere in alexithymic individuals compared to non-
alexithymic individuals (Hatin, 2011; Jessimer & Markham, 1997; Tabibnia & Zaidel, 2005). 
The right hemisphere of the brain is thought to be primarily involved with emotion 
processing; an idea known as the right hemisphere hypothesis (e.g., Smith & Bulman-
Fleming, 2005). It has been suggested that right hemisphere dysfunction is responsible for 
poor emotion recognition and relative dominance of the left hemisphere, which may lead to 
the externally oriented style of thinking seen in individuals with alexithymia (Aftanas & 
Varlamov, 2007). However, evidence for the right hemisphere hypothesis has been 
conflicting. In particular, many studies have shown that individuals with alexithymia display 
low activation of both the left and right hemispheres (Grabe et al., 2004; Parker, Keightley, 
Smith, & Taylor, 1999; Richter et al., 2006; Romei et al., 2008; Tabibnia & Zaidel, 2005). 
Some researchers have proposed that low activation of both brain hemispheres is linked to 
deficits in the ability to verbally articulate (left hemispheric function) emotions (right 
hemisphere function) in individuals with alexithymia (Berenbaum & Prince, 1994; Hariri, 
Bookheimer, & Mazziotta, 2000). 
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By examining different aspects of emotional processing in alexithymic individuals, 
researchers have provided evidence to support the idea that features of alexithymia reflect a 
deficit in the cognitive processing of emotion (Taylor & Bagby, 2004). While research into 
autonomic activity associated with alexithymia remains contentious, previous studies have 
found that alexithymic individuals show low brain activation in response to emotional stimuli 
(Kano et al., 2003) as well as comprehensive difficulties in the processing of emotional facial 
expressions (Lee et al., 2011). Studies finding reduced blood flow and neural activity of the 
ACC in alexithymic individuals (Frewen et al., 2006; Heinzel et al., 2010) have provided 
insight into the cognitive deficits in emotion awareness and appraisal of emotion present in 
these individuals. Findings of greater activation of sensory and motor cortices of the brain in 
response to emotional stimuli have helped to explain the externally-oriented focus or 
heightened somatic awareness in individuals with alexithymia (Karlsson et al., 2008). In 
addition, findings of low brain activation of the right (e.g., Aftanas & Varlamov, 2007) and 
left and right hemispheres (e.g., Berenbaum & Prince, 1994) have substantiated clinical 
observations of difficulties in emotion recognition and verbal expression of emotion in 
alexithymic individuals, respectively. 
The advancement of cognitive and physiological research on emotional processing in 
individuals with alexithymia could not have been achieved if not for previous research efforts 
to develop a uniform, valid, and reliable psychometric tool for measuring alexithymia. What 
follows is an evaluation of some of the most common measures of alexithymia. 
Measurement of Alexithymia 
Following the 11
th
 European Conference on Psychosomatic Research ( r utigam & 
Rad, 1977) several measures for assessing alexithymia were developed. However, many of 
these measures lacked empirical support. The Schalling-Sifneos Personality Scales (Apfel & 
Sifneos, 1979) and the Minnesota Multiphasic Personality Inventory alexithymia Scale 
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(Kleiger & Kinsman, 1980) for example, were found to show little evidence of scientific 
rigour in their construction, lacked validity and reliability as a result, and were eventually 
abandoned (Taylor, Bagby, & Luminet, 2000). 
Two main approaches for assessing alexithymia have been proposed, which most 
commonly include observer-rated measures and self-report measures. Observer-rated 
measures, such as the Beth Israel Hospital Psychosomatic Questionnaire (BIQ; Sifneos, 
1973), the Observer Alexithymia Scale (OAS; Haviland, Warren, & Riggs, 2000), and the 
Toronto Structured Interview for Alexithymia (TSIA; Bagby, Taylor, Parker, & Dickens, 
2006) are based on questionnaires that are completed by a clinician after interviewing the 
participant or by someone (such as a family member) who is familiar with the participant. 
Self-report measures, such as the Bermond-Vorst Alexithymia Questionnaire (BVAQ; Vorst 
& Bermond, 2001) and the 20-item Toronto Alexithymia Scale (TAS-20; Bagby, Parker, et 
al., 1994), are based on questionnaires that participants complete by themselves without 
interference from others. 
The following description of the psychometric properties and methodologies of a 
range of common assessment measures of alexithymia was provided to inform the most 
appropriate instrument to measure alexithymia in the present research samples. Only 
measures that have been normalised on adult samples were considered as the present research 
involved adult samples. This is not a major limitation, since few measures of alexithymia 
have specifically targeted children or adolescents; the majority of measures have been 
normalised using university student samples, which are comprised of adults. 
Beth Israel Hospital Psychosomatic Questionnaire 
The original BIQ (Sifneos, 1973) is a 17-item measure developed in the United States 
of America (USA) in order to identify differences in alexithymia between patients with 
psychosomatic disorders and patients with “neurotic complaints” (e.g., borderline personality, 
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depression, hysterical personality, and alcoholism, Sifneos, 1973, p. 257). From the 17 
questions, 8 key items were selected (Sifneos, 1973) that best assess alexithymia 
characteristics. All items are scored by an interviewer or observer as either present (score 1) 
or absent (score 0), whereby the more key items endorsed the higher the presence of 
alexithymia. The questionnaire involves a combination of unstructured conversation with the 
patient followed by semi-structured probing to determine the patient’s ability to verbalise 
feelings and to report fantasies and dreams. 
The use of dichotomous questioning has been criticised as being unstable in factor 
analysis (Taylor & Bagby, 1988). In addition, although some research has supported the 
validity of the BIQ (Gardos, Schniebolk, Mirin, Wolk, & Rosenthal, 1984) less support has 
been found for the inter-rater reliability of this measure (e.g., r = .30, Taylor, Doody, & 
Newman, 1981), which may be due to the fact that it does not include a set of standardised 
interview questions (Lumley, Neely, & Burger, 2007). In addition, as an observer-rated 
measure, the reliability of the BIQ may be affected by the observer’s previous experiences, 
biases, and/or interviewing style (Taylor & Bagby, 1988). Furthermore, the BIQ has received 
criticism for its lack of specificity in measuring the alexithymia construct, as only 8 items out 
of the 17 are related and used to obtain an alexithymia score (Taylor et al., 2000). 
Based on these criticisms, the BIQ was modified (Bagby, Taylor, et al., 1994) to 
enhance reliability: four new items were included, nine items less relevant to alexithymia 
were excluded, and the dichotomous questioning methodology was replaced with a 7-point 
Likert-type design. The resulting 12-item modified BIQ comprises a two-factor structure: six 
items relate to affect awareness
 
(the ability to identify and communicate feelings) and six 
items relate to operational
 
thinking (imaginal activity and externally oriented thinking). 
Therefore, the modified BIQ assesses both affective and cognitive traits of alexithymia. 
Support for the two-factor structure of the BIQ has been shown in clinical samples in the 
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USA (Haviland, Warren, Riggs, & Nitch, 2002) and university students and clinical samples 
in Japan (Fukunishi, Nakagawa, Nakamura, Kikuchi, & Takubo, 1997). 
The findings of several studies support the modified BIQ as a reliable and valid 
measure of alexithymia (Bagby, Taylor, et al., 1994; Taylor et al., 2000), with good internal 
consistency (α = .85, Haviland et al., 2002) and concurrent validity with the TAS-20 
(Lumley, Gustavson, Partridge, & Labouvie-Vief, 2005). However, the modified BIQ is not 
widely used amongst clinicians and researchers, possibly due to the demands of training, the 
time required for interviewing, and the lack of standardised interview (Lumley et al., 2007). 
Recommendations to obtain inter-rater reliability when using the modified BIQ (Taylor et al., 
2000) may have limited its use further. 
Observer Alexithymia Scale 
The OAS (Haviland et al., 2000) is another observer-rated measure of alexithymia. It 
relies on collateral information obtained from a clinician, family member, or friend of the 
patient being assessed and is therefore based on the idea that reliable observations of 
alexithymia can be made by those close to the patient. The OAS consists of 33 items that 
yield a total score of alexithymia as well as five factor scores that correspond to alexithymia 
characteristics: Distant, Uninsightful, Somatizing, Humourless, and Rigid. 
The psychometric properties of the OAS were originally assessed in university 
student samples in the USA. The OAS was shown to demonstrate good internal reliability (α 
= .90, Haviland, Warren, Riggs, & Gallacher, 2001) and two week test-retest reliability (r = 
.87, Haviland et al., 2000). The five-factor structure of the OAS has been supported in 
English and French-speaking university students (Berthoz, Haviland, Riggs, Perdereau, & 
Bungener, 2005), Chinese-speaking university students (Yao, Yi, Zhu, & Haviland, 2005), 
and a clinical sample (Haviland et al., 2001). However, concurrent validity of the OAS is not 
strongly supported, with some studies showing small correlations with the TAS-20 (r ≤ .27, 
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Lumley et al., 2005; Meganck, Vanheule, Desmet, & Inslegers, 2010). Furthermore, inter-
rater reliability of four out of five OAS factors has been shown to be insufficient (α ≤ .62, 
Meganck et al., 2010). 
Toronto Structured Interview for Alexithymia 
The TSIA (Bagby et al., 2006) is an interview-based observer-rated measure for 
assessing alexithymia. It consists of 24 interview items that yield a total score of alexithymia 
that ranges from 0 to 48, with higher scores indicating a greater degree of alexithymia. Each 
item is scored along a 3-point Likert scale from zero to two. For some items, the scoring is 
based on the frequency of the presence of a characteristic, and for other items, it is based on 
the degree of the presence of a characteristic. For example, a score of zero is given if the 
characteristic is never or rarely present, or is not a feature of the respondent; a score of one is 
given if the characteristic is present some of the time or is a partial feature of the respondent; 
and a score of two is given if the characteristic is present most of the time or is a strong 
feature of the respondent. For each item, there are standardised prompts and probes designed 
to elicit information to assist in the accurate scoring of the item. Administration of the TSIA 
takes between 30 and 45 minutes. 
The TSIA was developed and initially validated with Canadian psychiatric outpatients 
and community participants where it demonstrated adequate item characteristics, acceptable 
levels of inter-rater, internal, and test-retest reliability, as well as concurrent validity with the 
TAS-20 (Bagby et al., 2006). Factor analysis identified a hierarchical four-factor model with 
four lower-order factors nested within two higher-order factors consistent with the theoretical 
underpinnings of the construct. This four-factor model consists of 24 items, 6 items for each 
of the four lower-order facet scales: difficulty identifying feelings (DIF), difficulty describing 
feelings (DDF), externally oriented thinking (EOT), and imaginal processes (IMP). The two 
lower-order facet scales DIF and DDF formed a single higher-order domain scale labelled 
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Affect Awareness (AA) and the other two lower-order facet scales EOT and IMP formed a 
single higher-order domain scale labelled Operative Thinking (OT). Acceptable levels of 
internal and inter-rater reliability have been obtained with German, Italian, and Dutch 
language translations of the TSIA (Caretti et al., 2011; Grabe et al., 2009; Inslegers et al., 
2013). Confirmatory factor analyses with the German, Italian, and Dutch language versions 
also supported the four-factor structure of the TSIA obtained with the original English 
version. 
Bermond-Vorst Alexithymia Questionnaire 
The BVAQ (Vorst & Bermond, 2001) is a 40-item self-report scale designed to 
measure alexithymia. Items are scored using 5-point Likert scales. The BVAQ is an extension 
of the earlier 20-item Amsterdam Alexithymia Scale (AAS; Bermond, Vorst, Vingerhoets, & 
Gerritsen, 1999), both of which have the same five-factor structure: Identifying, Verbalising, 
Analysing, Fantasising, and Emotionalising. The goal of extending the AAS to the BVAQ 
was to have two paralleled versions (A and B), each consisting of 20 items, and an extended 
test (A+B) of 40 items (Vorst & Bermond, 2001). Each factor of the BVAQ comprises eight 
balanced indicative and contra-indicative items. 
The BVAQ has been translated into several languages. The BVAQ was shown to be a 
valid and reliable measure of alexithymia in English, Dutch, and French (Belgian) speaking 
university student samples, with good internal reliability between translations (α > .80) and 
concurrent validity with the TAS-20 (Vorst & Bermond, 2001). However, confirmatory 
factor analyses have provided contradictory findings, with some studies showing support for 
the five-factor model of the BVAQ (Müller, Bühner, & Ellgring, 2004) and other studies 
showing less support for the five-factor model (Zech, Luminet, Rimé, & Wagner, 1999). 
Using data collected from a clinical sample, Müller et al. (2004) found that the five-factor 
model of the BVAQ yielded a better global fit than the three-factor model of the TAS-20. On 
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the other hand, they found that the smallest item loadings occurred in the factors Analysing 
and Emotionalising, which yielded loadings below Chronbach’s alphas of .49. At a 
conceptual level, Taylor et al. (2000) have argued that since the concept of Emotionalising 
(the degree to which a person is emotionally aroused by emotion-inducing events, Vorst & 
Bermond, 2001) was not part of the original definition of alexithymia, this factor should only 
be considered a correlate of alexithymia. 
Toronto Alexithymia Scale 
Probably the most well-known and used self-report measure of alexithymia is the 
Toronto Alexithymia Scale (TAS). There have been three revisions of the TAS: the original 
TAS-26 scale (Taylor, Ryan, & Bagby, 1985), the revised TAS-R (Taylor, Bagby, & Parker, 
1992), and the current TAS-20 (Bagby, Parker, et al., 1994). Factor analysis of the TAS-26, 
conducted with Canadian university students, supported a four-factor structure that was 
theoretically congruent with the alexithymia construct. The scale was shown to have good 
internal reliability (α = .79) and test-retest reliability over five weeks (r = .75). However, 
several shortcomings of the scale have been noted, including a high correlation between two 
of the factors, low magnitude correlations between the items comprising the daydreaming 
factor and the full-scale score, and a lack of congruence between the overall compositional 
structure of the scale and features of alexithymia (Taylor et al., 1985). 
Through a revision of TAS-26, three items relating to imaginal activity were removed, 
which resulted in the 23-item TAS-R. Factor analysis of the TAS-R yielded a two-factor 
model: the first factor comprised items assessing the ability to describe feelings to others and 
the ability to distinguish between bodily sensations and feelings, and the second factor 
comprised items assessing externally-oriented thinking. However, subsequent confirmatory 
factor analyses found that the two-factor structure was not a good representation of the data 
and so the scale was revised again (Bagby, Parker, et al., 1994). 
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The TAS-20 is the most current revision of the scale. In constructing the TAS-20 
Bagby, Parker, et al. (1994) extracted a new set of items from the item pool used in the 
development of the TAS-R and included 17 newly written items relating to imaginal capacity 
and daydreaming. The TAS-20 was cross-validated using a Canadian university student 
sample and a psychiatric patient sample. Factor analysis supported a three-factor structure: 
Difficulty Identifying Feelings (DIF; seven items); Difficulty Describing Feelings (DDF; five 
items); and Externally-Oriented Thinking (EOT; eight items). Items relating to imaginal 
capacity from the TAS-26 were removed from the TAS-20 due to high correlations with 
measures of social desirability (Parker, Taylor, & Bagby, 2003). Some authors have criticised 
the removal of items that reflect the reduced fantasy dimension of alexithymia and argue that 
without this dimension, alexithymia is not being measured as was originally conceptualised 
(see Sifneos, 1996; Vorst & Bermond, 2001). However, Bagby, Parker, et al. (1994) suggest 
that reduced fantasy is measured indirectly because it correlates negatively with the EOT 
factor. 
Items of the TAS-20 are scored on a 5-point Likert type rating scale, from 1 (strongly 
disagree) to 5 (strongly agree). The negatively keyed items are reversed prior to scoring (i.e., 
items 4, 5, 10, 18, and 19). Confirmatory factor analyses have found that the TAS-20’s three-
factor structure is the best fitting model (Meganck, Vanheule, & Desmet, 2008; Parker, 
Bagby, Taylor, Endler, & Schmitz, 1993; Parker et al., 2003).The TAS-20 has demonstrated 
high internal reliability (α = .81), test-retest reliability over three weeks (r = .77, Bagby, 
Parker, et al., 1994), construct validity, and concurrent validity with observer-rated measures, 
such as the original BIQ (r = .53, Bagby, Parker, et al., 1994) and the Spanish version of the 
BIQ (r > .47, Martínez-Sánchez, 1996). The TAS-20 has been shown to be a valid and 
reliable measure of alexithymia for use in both psychiatric and community populations 
(Meganck et al., 2008; Parker et al., 2003). In addition, the TAS-20 has been translated into 
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several languages and has demonstrated cross-cultural validity in several countries (see 
Taylor, Bagby, & Parker, 2003). 
A total score measuring alexithymia as well as three factor scores can be calculated. 
Preliminary cut-off scores for the total TAS-20 were developed. Individuals scoring below 52 
are considered non-alexithymic and those scoring above 60 are considered alexithymic 
(Taylor et al., 1997). While the applicability of these cut-off scores has not been investigated 
in many countries they have been applied in numerous clinical and non-clinical samples 
worldwide. The TAS-20 cut-off scores have enabled comparative studies on alexithymia 
among diverse samples, including investigations into the prevalence of alexithymia across 
various populations. 
The main criticism of the TAS-20 has been that the EOT factor has shown low 
internal reliability (α = .56, Meganck et al., 2008), far lower than the DIF and DDF factors 
(Bressi et al., 1996; Kooiman, Spinhoven, & Trijsburg, 2002; Leising, Grande, & Faber, 
2009; Loas et al., 2001; Loiselle & Cossette, 2001; Thorberg et al., 2010). Several studies 
have also noted low factor loadings of some items on the EOT factor (Bressi et al., 1996; 
Meganck et al., 2008; Müller, Bühner, & Ellgring, 2003; Pandey, Mandal, Taylor, & Parker, 
1996). Gignac, Palmer, and Stough (2007) have interpreted the low internal reliability of the 
EOT factor as indicating possible problems with the content of the items loading onto that 
factor. 
Researchers have also suggested that having an imbalance of positively and 
negatively worded items between the three factors would result in response tendencies or bias 
(Vorst & Bermond, 2001), and that this issue is especially exaggerated in the EOT factor 
because four out of the five items are negatively phrased (Meganck et al., 2008). Revision of 
the EOT factor and the use of negatively worded items has been suggested (Besharat, 2008; 
Gignac et al., 2007; Meganck et al., 2008). Furthermore, Gignac et al. (2007) have 
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recommended that future researchers who observe low internal reliability of the EOT factor 
interpret the total TAS-20 score as a general measure of alexithymia rather than interpret the 
separate TAS-20 factor scores as specific measures of alexithymia characteristics. While 
limiting a more detailed assessment of alexithymia, interpreting the total TAS-20 score rather 
than the factor scores of the TAS-20 may reduce concerns regarding the EOT factor when 
comparing alexithymia results across studies. 
The present review of observer-rated (BIQ, OAS, and TSIA) and self-report (BVAQ 
and TAS-20) measures of alexithymia revealed methodological advantages and 
disadvantages for use in clinical and research settings. A major problem with observer-rated 
measures has been maintaining consistency between interviewers (Meganck et al., 2010) who 
are subject to bias, differences in interviewing style, and differences in interpretation of the 
construct being measured (McCrae, 1994). In addition, the increased time and complexity 
involved in administering observer-rated measures makes them more appropriate to clinical 
settings rather than research settings. In contrast, self-report measures are inexpensive, 
simple, and fast to administer compared to observer-rated measures, which make them more 
applicable to research settings. Self-report instruments have been used more frequently in 
research and thus more information is available on the psychometric properties of these 
measures. On the other hand, some authors have criticised the use of self-report measures to 
assess alexithymia, questioning the extent that they can be used to accurately assess a 
construct whose central characteristic involves inadequate self-awareness (Lundh, Johnsson, 
Sundqvist, & Olsson, 2002; Mayer, Caruso, & Salovey, 2000; Suslow & Junghanns, 2002). It 
has been recommended that in ideal situations, where time and resources allow, alexithymia 
should be assessed using a multiple method approach (Caretti et al., 2011; Eid & Diener, 
2006; Taylor & Bagby, 2004; Taylor et al., 2000), such as by using observer-rated and self-
report measures of alexithymia together. 
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Despite criticisms of self-report measures, the TAS-20 has remained the most widely 
used measure of alexithymia. The TAS-20 provides a sound assessment of alexithymia and 
appears to meet the standards of validity and reliability necessary for research purposes. 
Studies have found the TAS-20 to be suitable for use in both psychiatric and community 
populations (Meganck et al., 2008; Parker et al., 2003), as well as in several cultures (see 
Taylor et al., 2003). While some critics question the use of self-report scales to assess 
alexithymia, studies have shown agreement between TAS-20 scores and observer ratings of 
alexithymia (Bagby, Taylor, et al., 1994; Martínez-Sánchez, 1996). In addition, the TAS-20 
cut-off scores used to identify alexithymic and non-alexithymic individuals offers a unique 
advantage that is beneficial for research purposes by allowing for comparisons of rates of 
alexithymia across studies (Taylor et al., 1997). 
Aetiology of Alexithymia 
The development of valid and reliable psychometric tools for measuring alexithymia 
not only refined the definition and quantification of the construct, but also allowed for 
extensive empirical research on alexithymia to accumulate. For instance, a considerable body 
of empirical research has replaced much conjecture regarding the origin or aetiology of 
alexithymia. 
The aetiology of alexithymia has been considered and debated for over three decades 
(see  r utigam & Rad, 1977). Understanding the aetiology of alexithymia has theoretical and 
practical implications, particularly for the way it is described, assessed, and approached in the 
therapeutic setting. Early distinctions were made between primary alexithymia, which is 
considered a life-long disposition, derived from genetic factors and/or factors that impact on 
affect development during early childhood; and secondary alexithymia, which is considered 
to arise not during development, but as a consequence of psychological and/or medical-
surgical events occurring later in life (Freyberger, 1977; Sifneos, 1988). 
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Studies have found significant correlations between alexithymia scores obtained from 
individuals and their first-degree relatives (Grabe et al., 2006; Lumley, Mader, Gramzow, & 
Papineau, 1996). These findings of significant intrafamilial associations of alexithymia 
indicate that underlying familial or genetic factors might contribute to the development of 
alexithymia (Grabe et al., 2006). Heritability studies involving twin pairs have provided 
stronger evidence to support views suggesting genetic and environmental factors underlying 
alexithymia, yet only four investigations have been conducted concerning alexithymia. 
In an early study, Heiberg and Heiberg (1977) examined genetic influences on 
alexithymia in 33 twin pairs. The findings of their study showed less variation in alexithymic 
characteristics between monozygotic twins (identical twins with an extremely high degree of 
genetic similarity) than dizygotic twins (fraternal twins that are genetically like any other 
sibling, just born at the same time). 
Three studies have examined the influences of genetic factors as well as shared and 
non-shared environmental factors on alexithymia in twin pairs. Shared environmental factors 
include features that make siblings similar, such as the socioeconomic status of the family 
and parental strategies on child rearing. On the other hand, non-shared environmental factors 
include features that make siblings different, such as unpredictable events in the child’s life, 
peer relationships, and differential parental treatment. Valera and Berenbaum (2001) 
examined the influences of genetic, shared, and non-shared environmental factors on 
alexithymia in 45 monozygotic and 32 same-sex dizygotic twin pairs. Results showed that 
characteristics of alexithymia relating to an externally-oriented style of thinking were 
influenced more by genetic factors than by aspects of the shared family environment. 
However, characteristics relating to difficulties identifying and describing feelings were 
influenced more by aspects of the shared family environment than by genetic factors. These 
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results indicate that inheritance may contribute more strongly to the development of certain 
aspects of alexithymia. 
Jørgensen, Zachariae, Skytthe, and Kyvik (2007) conducted the first large-scale 
heritability study of alexithymia which involved 8,785 twin pairs (2,688 monozygotic, 3,248 
same-sexed dizygotic, and 2,849 opposite-sexed dizygotic twins). The authors demonstrated 
the heritability of alexithymia to range from 30 to 33%. The remaining similarities in 
alexithymia scores between the twin pairs were accounted for by shared family 
environmental factors (12–20%), whereas differences in alexithymia scores between the twin 
pairs were accounted for by non-shared environmental factors (50–56%). The authors 
concluded that the primary source of environmental influence on alexithymia scores was 
related to factors that created differences in sibling’s alexithymia scores rather than 
similarities in sibling’s alexithymia scores. This finding was in contrast to Valera and 
Berenbaum (2001), who found that the primary source of environmental influence was 
related to factors that created similarities in alexithymia scores (i.e., shared family 
environmental factors). 
Baughman et al. (2012) conducted a recent study to examine genetic and 
environmental contributions to alexithymia in 216 monozygotic and 45 dizygotic same-sex 
twin pairs. Consistent with the findings of Jørgensen et al. (2007), Baughman et al. (2012) 
demonstrated the heritability of alexithymia to range from 33 to 50%. In addition, they found 
that alexithymia was best accounted for by additive genetic and non-shared environmental 
influences. Together, these studies provide evidence for both genetic and environmental 
influences, particularly non-shared environmental influences, in the development of 
alexithymia. 
In addition to genetic factors and non-shared environmental influences, heritability 
studies found evidence for the shared family environment as a contributing factor in the 
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development of alexithymia (Jørgensen et al., 2007; Valera & Berenbaum, 2001). Some 
researchers have proposed that, to some extent, the aetiology of alexithymia is related to 
factors that impact on affect development during early childhood (McDougall, 1982; Taylor 
et al., 1997), including parental emotion socialisation, infant attachment, and trauma. 
Parental emotion socialisation refers to parental reactions to children’s emotions, 
discussion of emotion, and expression of emotion (Eisenberg, Cumberland, & Spinrad, 1998). 
There is strong empirical evidence to suggest that parental emotion socialisation has 
longstanding influence on the emotional experience and expression in children as well as 
social competence and emotion regulation strategies that will be employed in adulthood 
(Eisenberg, Spinrad, & Eggum, 2010; Le, Berenbaum, & Raghavan, 2002). Berenbaum and 
James (1994) have suggested that difficulties identifying and communicating emotion - an 
essential characteristic of alexithymia - may be a consequence of a childhood environment 
where parents fail to model nonthreatening expressions of emotion. Indeed, alexithymia has 
been shown to occur more frequently in adults who recall childhood family environments that 
did not encourage the expression of opinions and feelings within the family (Kench & Irwin, 
2000), and especially the expression of positive feelings and physical affection (Le et al.). 
Joukamaa et al. (2003) conducted a 31-year prospective study that examined the association 
between alexithymia in adulthood and the social situation of the child’s family 31 years 
earlier. They found that unwanted children or children born into families with many children 
(≥ 5) reported elevated levels of alexithymia in adulthood. The authors concluded that factors 
such as having unwanted or numerous children may limit the time and attention given to the 
child and disturb the development of normal early mother-infant intimacy. 
It has been suggested that the family environment influences a child’s affect 
development at even earlier stages in life.  owlby’s attachment theory (1969, 1973) provides 
an explanation for the effects of early attachment relationships on affect development. 
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According to this theory, emotional expression of the infant, particularly expression of 
negative affect such as distress and discomfort, alerts caregivers to regulate the infant’s 
biological and psychological needs. Insecurely attached infants have learned not to rely on 
the caregivers’ responsiveness to regulate their emotional states, and these infants are thought 
to have adapted their attachment strategies (i.e., insecure-avoidant and insecure-anxious) 
based on these expectations in an attempt to regulate emotional states on their own (Cassidy, 
1994; Mallinckrodt & Wei, 2005). Consequently, it has been suggested that insecure 
attachment might prevent the infant from experiencing a variety of affective states and from 
processing, communicating, and regulating these states effectively without resorting to a 
defensive strategy (Fonagy, Gergely, Jurist, & Target, 2002; Harris, 1999). 
Findings from a meta-analysis by Fraley (2002) have provided evidence that 
attachment style remains relatively stable across the life span. It is possible that problems 
with affect development arising from insecure attachment in childhood also remain stable 
across the life span. For example, numerous studies have found associations between 
alexithymia and insecure attachment style in adults (Mallinckrodt & Wei, 2005; 
Montebarocci, Codispoti, Baldaro, & Rossi, 2004; Oskis et al., 2013; Picardi, Toni, & 
Caroppo, 2005; Troisi, D'Argenio, Peracchio, & Petti, 2001; Wearden, Lamberton, Crook, & 
Walsh, 2005). 
Another framework for conceptualising affect development in childhood has been 
proposed by Lane and Schwartz (1987). Lane and Schwartz  proposed a model where 
emotional awareness progresses along five developmental levels: 1) awareness of bodily 
sensations or somatic responses to emotion arousal; 2) action tendencies associated with 
emotions, whereby the individual is only aware of how he or she would like to act as a result 
of an emotion; 3) awareness of unidimensional feelings, such as feeling good or bad but 
nothing more differentiated; 4)  awareness of  combinations of discrete and differentiated 
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feelings, such as joy, excitement, sadness, and fear; and 5) awareness of complex blends of 
differentiated feelings in self and others, where multiple, often contradictive, feelings may be 
present at one time. Taylor et al. (1997) claim that alexithymia and disorders of affect 
regulation represent lower level functioning within this model that have occurred as a result 
of developmental disturbances that prevent progress to higher levels or bring about regression 
to lower levels. 
One such disturbance that prevents affective development in early childhood is 
trauma. Krystal (1988) theorised that infantile or childhood psychic trauma, resulting from a 
lack of sufficient ego development (distinction between the inner self and the outer 
environment) and defences to regulate the impact of the trauma, prevents the child from 
progressing to more advanced affective developmental levels. This theory is supported by 
studies finding that alexithymic individuals are more likely to have experienced sexual (Hund 
& Espelage, 2005; McLean, Toner, Jackson, Desrocher, & Stuckless, 2006) and non-sexual 
childhood abuse (Mazzeo & Espelage, 2002; McCaslin et al., 2006). Krystal also suggested 
that trauma in adulthood would result in a regression in affective-cognitive function to an 
infantile level of affect development. He proposed that the consequence of this regression 
would result in an adult who lacks the ability to verbalise, tolerate, and modify their emotions 
and whose affects remain undifferentiated and somatised. 
Alexithymia that arises from traumatic events that occur in later life has been seen as 
a defence mechanism in an attempt to cope with the stress of trauma (Freyberger, 1977), 
whether it be psychic trauma or physical trauma (e.g., a life threatening illness or conditions 
requiring intensive care). That is, alexithymia that develops secondary to a psychologically or 
physiologically traumatic event has been considered a defence or protection against highly 
emotional events. This view is supported by findings from a meta-analysis showing large 
effect sizes associating Posttraumatic Stress Disorder with alexithymia (Frewen, Dozois, 
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Neufeld, & Lanius, 2008) as well as studies finding higher levels of alexithymia in holocaust 
survivors (Yehuda et al., 1997) and victims of sexual assault (Zeitlin, McNally, & Cassiday, 
1993). 
In summary, the present review of research into the aetiology of alexithymia has 
revealed extensive research efforts incorporating biological theories and environmental 
theories in particular. Heritability studies on twin pairs have found genetic factors to play a 
role in the development of alexithymia, in addition to shared and non-shared environmental 
factors. Environmental factors that influence affect development during early childhood, such 
as negative childhood family environments and insecure attachment in childhood, are also 
likely to play an important role in the development of alexithymia. Experiences of trauma at 
any stage in life, including psychic and physical trauma, may also contribute to the 
development of alexithymia. It has been suggested that the numerous yet interrelated 
biological and environmental explanations for the origins of alexithymia indicates that the 
aetiology of alexithymia is likely to involve multiple contributory factors (Taylor et al., 
1997). 
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CHAPTER 2 
ALEXITHYMIA AND PSYCHOPATHOLOGY 
Alexithymia reflects a deficit in the cognitive processing of emotions that has been 
shown to affect around 10% of the general population (Franz et al., 2008; Honkalampi, 
Hintikka, Tanskanen, Lehtonen, & Viinamäki, 2000; Mattila, Salminen, Nummi, & 
Joukamaa, 2006). Several researchers have argued that deficits in the cognitive processing 
and regulation of emotions, such as those observed in alexithymia, lead to dysfunctional 
emotional states, and it is dysfunctional emotional states that are a central feature to most 
psychopathology (Krystal, 1988; Lane & Schwartz, 1987; Taylor, 1987). This idea is 
consistent with several studies that have found greater rates of alexithymia in psychiatric 
samples compared to community samples (Müller et al., 2003; Todarello, Taylor, Parker, & 
Fanelli, 1995; Vanheule et al., 2007). In fact, studies have found rates of alexithymia at over 
40% in patients diagnosed with depression (Saarijärvi, Salminen, & Toikka, 2001), anxiety 
disorders (Fukunishi, Kikuchi, Wogan, & Takubo, 1997), somatoform disorders (Cox, Kuch, 
Parker, Shulman, & Evans, 1994), addictive disorders (Evren, Evren, Dalbudak, Ozcelik, & 
Oncu, 2009), schizophrenia (Todarello et al., 2005), and in general psychiatric samples with 
varied diagnoses (Lecours & Bouchard, 2011). 
However, the rates of alexithymia across studies of alexithymia in psychiatric samples 
appear to be highly variable. For example, rates of alexithymia have ranged between 6% 
(Karvonen et al., 2005) and 56.7% (Celikel & Saatcioglu, 2006) for patients diagnosed with 
somatoform disorders and between 11% (Grabe et al., 2006) and 56% (Fukunishi, Kikuchi, et 
al., 1997) for patients diagnosed with anxiety disorders. Several factors may affect the 
proportion of patients who are identified as alexithymic in such studies, including the method 
of assessing alexithymia as well as sample characteristics. Most studies that have reported 
rates of alexithymia have utilised the TAS-20 as cut-off scores are provided to identify 
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alexithymic and non-alexithymic individuals (Taylor et al., 1997). Therefore, variations in the 
prevalence rate of alexithymia in psychiatric studies may be better accounted for by sample 
characteristics, such as psychiatric diagnosis and illness severity. 
The issue of whether psychiatric diagnosis may affect the proportion of patients 
identified as alexithymic in psychiatric studies is unclear. Some researchers have questioned 
whether alexithymia occurs more frequently in specific diagnostic groups or psychiatric 
disorders, such as somatoform disorders or depression (Bankier, Aigner, & Bach, 2001; 
Leweke, Leichsenring, Kruse, & Hermes, 2012). The conceptualisation of the alexithymia 
construct originated from observations of patients with psychosomatic disorders (or 
somatoform disorders) and thus some have considered alexithymia a pathological process 
underpinning somatic distress (Sifneos, 1973; Taylor et al., 1997). It has been proposed 
( r utigam & Rad, 1977; Taylor et al., 1991) that alexithymia is a useful conceptual 
framework for explaining the interactions between emotions, personality, and bodily 
functions that contribute to the aetiology of disease. Some studies support the theoretical and 
clinical impression of a link between alexithymia and somatic symptoms (Burba et al., 2006; 
Landa, 2009; Taylor, Parker, Bagby, & Acklin, 1992). However, some researchers have 
questioned this association, finding that alexithymia scores were no higher for patients 
diagnosed with somatoform disorders than for patients diagnosed with other disorders 
(Bankier et al., 2001; Leweke et al., 2012). 
Some researchers have suggested that there is a conceptual overlap between 
alexithymia and depressive symptoms (e.g., Leising et al., 2009). Müller et al. (2004) has 
proposed that depressive symptomatology, such as reduced cognitive processing speed, 
distractibility, social withdrawal, and pessimistic views of one’s abilities, can lead to the over 
reporting of symptoms like difficulties identifying and verbalising feelings that are also 
common in alexithymia. Depressive symptoms may therefore increase the rate of alexithymia 
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observed in patients diagnosed with depression.  However, many studies have found no 
differences in alexithymia scores between two (Duddu, Isaac, & Chaturvedi, 2003) and three 
(Celikel & Saatcioglu, 2007; Onur, Alkin, Sheridan, & Wise, 2013) diagnostic groups, or in 
mean alexithymia scores between six diagnostic groups (Subic-Wrana, Bruder, Thomas, 
Lane, & Kohle, 2005). 
Another sample characteristic that may affect prevalence rates of alexithymia in 
psychiatric studies is the severity of psychopathology. Alexithymia has been shown to 
correlate positively with psychopathology severity (Bach, Bach, Bohmer, & Nutzinger, 1994; 
Leweke et al., 2009) and psychological distress (Liang & West, 2011; Mikolajczak & 
Luminet, 2006). The treatment setting for psychiatric patients may be a general indicator of 
psychopathology severity. Higher rates of alexithymia are likely to be identified in 
psychiatric inpatient samples because patients admitted for inpatient hospitalisation are in 
more acute phases of their illness and require more intensive intervention compared to 
patients attending outpatient clinics for treatment. Therefore, the treatment setting of sample 
populations needs to be taken into account when evaluating the prevalence of alexithymia in 
psychiatric populations. 
Further variation in the prevalence rate of alexithymia may arise from demographic 
differences in the population surveyed. Some researchers have proposed that alexithymia is 
likely to be more prevalent in certain demographic groups, such as males (Levant, 1992) and 
those with less education or socioeconomic status (Borens, Grosse-Schulte, Jaensch, & 
Kortemme, 1977). Few studies have explicitly reported differences in prevalence rates of 
alexithymia between different demographic groups. Rather, a large number of studies have 
examined differences in alexithymia scores between different demographic groups. While 
these studies vary in the way alexithymia and demographic factors have been assessed (e.g., 
using continuous or categorical variables), a broad evaluation of these studies may offer 
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insight into whether demographic differences in study samples are likely contributors to 
variation in the prevalence rate of alexithymia. 
It should be noted that Levant et al. (2006) included a narrative review of studies that 
examined the link between alexithymia and gender that was part of the background to their 
study. They found that the majority of studies in their review that involved clinical samples 
(psychiatric and medical patients) reported no gender differences in alexithymia, whereas the 
majority of studies that involved non-clinical samples reported significantly higher 
alexithymia scores in males compared to females. Levant et al. (2006) concluded that this 
finding provided support for Levant’s theory of a gender-linked, subclinical alexithymia 
syndrome (see Levant, 1992). Unlike systematic reviews, narrative reviews are more likely to 
involve bias as only research selected by the author is included. Hence, narrative reviews are 
also more likely to provide a summary of evidence that is outdated and contradictory to 
available evidence (Montori, Swiontkowski, & Cook, 2003). In contrast, systematic reviews 
apply scientific strategies that limit bias, such as addressing a specific question, conducting a 
comprehensive literature search, and providing explicit and objective criteria to identify 
relevant studies (Montori et al., 2003). The narrative review that was conducted by Levant et 
al. (2006) failed to include 10 studies that examined the link between alexithymia and gender 
prior to and including 2006, which is equivalent to approximately 26% of the literature. The 
present systematic review will extend the narrative review conducted by Levant et al. (2006) 
by including the 10 studies that were missed and any additional studies post 2006, making it a 
more comprehensive and current review of the literature in this area. 
Furthermore, no study to date has systematically compiled and examined studies that 
have reported rates of alexithymia in either the psychiatric or community populations. A 
greater understanding of the prevalence rates of alexithymia in psychiatric and community 
populations is desirable, particularly given the association between alexithymia and the 
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development of psychiatric symptomatology in community samples (Heinrichs et al., 2005; 
McCaslin et al., 2006; Tolmunen et al., 2011) and with the persistence of psychiatric 
symptomatology in psychiatric samples over time (Bach & Bach, 1995; Loas, Fremaux, 
Otmani, Lecercle, & Delahousse, 1997; Reese, 2008; Viinamäki et al., 2002). Confounding 
factors, such as psychiatric diagnosis, severity of illness, and demographic differences make 
it difficult to compare the prevalence data for alexithymia across the literature. It is therefore 
necessary to take these factors into account when comparing data from different studies. This 
improved theoretical understanding could, in turn, generate awareness of the alexithymia 
construct amongst clinicians (mental health practitioners, including psychologists and 
psychiatrists) and researchers who work with psychiatric populations, in an attempt to help 
improve clinical outcomes and research practices. 
The purpose of the present literature review was to compare rates of alexithymia in 
studies involving psychiatric samples while taking psychiatric diagnosis and 
psychopathology severity into consideration. In addition, a comparison of alexithymia rates 
in studies involving community samples was conducted, and studies that have examined 
alexithymia and demographic differences in psychiatric and/or community samples were 
evaluated in order to obtain a clearer understanding of the factors that may influence 
alexithymia rates. 
It is important to note that the present review exclusively evaluated studies that have 
utilised the TAS-20 as a measure of alexithymia. This decision was taken because the TAS-
20 provides cut-off scores, which have been applied to diverse samples. These cut-off scores 
allow for the comparison of alexithymia rates across numerous international studies. The 
TAS-20 is also been translated into more languages than any other measure, cross-culturally 
validated in several countries (Taylor et al., 2003), and since it is the most widely used 
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measure of alexithymia worldwide there is more information about alexithymia available 
using the TAS-20 than any other measure. 
Method 
Search 
A systematic search was conducted through Medline, ProQuest Psychology Journals, 
and Web of Science databases to obtain potentially relevant articles. The database searches 
were supplemented by searching Google Scholar for relevant articles and by crosschecking 
the articles that were included in the subsequent systematic review (Chapter 3). All databases 
were searched using combinations of the following keywords: alexithymia, prevalence, 
demographics, gender, and TAS-20. The title and abstract of the identified articles were then 
screened for relevance against the inclusion and exclusion criteria. If abstracts were not 
available or unable to provide sufficient information, the full-text article was retrieved and 
screened in the same manner. 
Inclusion and Exclusion Criteria 
For inclusion, studies were required to: (1) include adults (≥ 18 years old), (2) 
measure alexithymia using the total TAS-20 score, (3) include psychiatric participants 
(patients presenting for psychiatric treatment) and/or community participants, and (4) be 
published in the English language. Studies involving psychiatric participants diagnosed with 
organic mental disorders (e.g., dementia), mental retardation, developmental disorders, or 
physiological conditions as the primary diagnosis were excluded. Also excluded were studies 
involving community samples that had been screened for past or present psychiatric illness as 
they are not representative of the general population. The census data for inclusion ranged 
from 1994 to 2014. 
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Data Extraction 
Data from the included studies were independently extracted onto a standardised form 
developed for this review. The following data were extracted: author(s) and date, country of 
the study, characteristics of participants (sample size and psychiatric diagnosis for psychiatric 
patients), prevalence rate of alexithymia (percentage), and study findings concerning the link 
between alexithymia and demographic variables. 
Results 
The search effort resulted in 394 citations. Seventy-six duplicate citations were 
removed and 107 citations were excluded as irrelevant after they were screened for potential 
relevance. The remaining 211 full-text articles were assessed for eligibility. Eighty-six 
studies were excluded for the following reasons: 43 studies did not report rates of alexithymia 
(and rates could not be calculated from the data provided) or did not report demographic 
variables (e.g., De Panfilis et al., 2008; Lumley & Sielky, 2000), 30 studies were follow-up 
studies or studies that shared a participant sample with a larger study that was included in the 
present review (e.g., Honkalampi, Hintikka, Laukkanen, et al., 2001; Mattila et al., 2010), 7 
studies did not use the TAS-20 (e.g., Bermond et al., 1999; Sayar, Acar, & Ak, 2003), 2 
studies provided sample descriptions that lacked sufficient in detail for rates of alexithymia to 
be identified (Berthoz et al., 2002; Graugaard, Holgersen, & Finset, 2004), 1 study was a 
literature review (Kooiman et al., 2002), 1 study did not use the total TAS-20 score (Kiyotaki 
& Yokoyama, 2006), 1 study did not involve adults (Guttman & Laporte, 2002), and 1 study 
involved a community sample that was screened for mental illness (de Vente, Kamphuis, & 
Emmelkamp, 2006). As a result of the exclusion process, 125 studies were identified as being 
eligible for the present review. Of the 125 studies, 72 studies involved psychiatric samples, 
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62 studies involved community samples, and 9 studies involved both psychiatric and 
community samples. 
Table 1 presents the data from studies that reported prevalence rates of alexithymia in 
psychiatric samples and Table 2 presents the data from studies that reported prevalence rates 
of alexithymia in community samples. The studies that involved both psychiatric and 
community samples appear in both Tables 1 and 2. 
Characteristics of the Studies 
Across the 125 studies in the present review, 76 studies reported rates of alexithymia, 
84 studies examined demographic differences in alexithymia, and 35 studies reported both 
rates of alexithymia and demographic differences in alexithymia. 
Studies that reported prevalence rates of alexithymia. 
Fifty-five studies that involved psychiatric samples reported rates of alexithymia. The 
majority of these studies were undertaken in Europe (n = 40), followed by North America 
(Canada and the USA, n = 10), Asia (n = 3), Australia (n = 1), and Britain (n = 1). Most of 
the studies involved sample sizes greater than 100 (n = 26) that ranged from 20 to 1461 
patients. Patients were most commonly recruited from outpatient (n = 23) and inpatient 
settings (n = 14). The studies that involved inpatient settings generally involved larger sample 
sizes (≥ 100) compared to the studies that involved outpatient settings. Two studies recruited 
patients from both outpatient and inpatient settings, and the remaining studies recruited 
patients from hospitals, mental health clinics and associations, community advertisement, a 
social insurance office, or did not specify the setting. The studies involved patients diagnosed 
with addictive disorders (e.g., eating disorders and substance misuse disorders, n = 21), 
varied diagnoses (i.e., general psychiatric samples, n = 13), anxiety disorders (n = 10), 
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somatoform disorders (n = 5), depressive disorders (n = 5), and one study involved patients 
diagnosed with schizophrenia. 
Twenty-six studies that involved community samples reported rates of alexithymia. 
The majority of these studies were undertaken in Europe (n = 15), followed by North 
America (n = 6), Australia (n = 3), Asia (n = 1), and Britain (n = 1). Most of the studies 
involved sample sizes greater than 100 (n = 21). The size of the samples ranged from 67 to 
5028 participants, with five studies involving samples sizes greater than 1000. A greater 
proportion of the studies undertaken in Europe involved larger sample sizes (≥ 100) 
compared to the studies undertaken outside of Europe, with most of these European studies 
involving samples greater than or equal to 300. Participants were most commonly recruited 
from university campuses (n = 13) and the general community (n = 8). Three studies 
recruited employees from various places of employment (e.g., childcare centre) and two 
studies recruited participants from both university campuses and the general community. The 
studies that involved community and student participants often referred to these samples 
interchangeably. 
Studies that examined demographic differences in alexithymia. 
The majority of the studies that examined demographic differences in alexithymia 
were undertaken in Europe (n = 45), followed by North America (n = 27), Asia (n = 5), 
Australia (n = 3), Britain (n = 1), and North Africa (n = 1). One study was undertaken in three 
locations (Europe, Canada, and the USA) and another study was undertaken in two locations 
(the USA and South America). The majority of the studies involved sample sizes greater than 
100 (n = 65). The size of the samples ranged from 42 to 5028 participants, with 11 studies 
involving samples sizes greater than 1000. Psychiatric samples were involved in 41 studies, 
community participants were involved in 48 studies, and 5 studies involved both psychiatric 
and community samples. 
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Most of the studies examined multiple demographic factors, including gender (n = 
70), age (n = 56), education (n = 37), economic status (including SES and income, n = 27), 
marital status (n = 22), employment status (n = 8), and other factors (including ethnicity, 
church membership, and rural or urban residency, n = 4). Age and education were examined 
either as continuous variables (e.g., age and education in years) or as categorical variables 
(e.g., age categories and levels of education). Gender, employment status, economic status, 
SES, income, and marital status were only examined as categorical variables. 
Prevalence of Alexithymia in Psychiatric and Community Samples 
Overall, prevalence rates of alexithymia in the psychiatric samples ranged from 
11.0% to 76.6% (median = 37.5%). Most of the studies that involved smaller sample sizes (< 
100) reported rates of alexithymia that were greater than 37.5%, whereas most of the studies 
that involved larger samples (≥ 100) reported rates of alexithymia that were less than 37.5%. 
Approximately half of the studies undertaken in Europe reported rates of alexithymia 
that were greater than 37.5% and the other half reported rates that were less than 37.5%. The 
vast majority of the non-European studies (predominately studies in North America) reported 
rates of alexithymia that were greater than 37.5%. 
In regards to treatment setting, approximately half of the studies that recruited patients 
from outpatient settings reported rates of alexithymia that were greater than 37.5% and the 
other half reported rates that were less than 37.5%. The majority of the studies that recruited 
patients from inpatient settings reported prevalence rates of alexithymia that were less than 
37.5%. 
Prevalence rates of alexithymia in community samples ranged from 0.0% to 22.9% 
(median = 10.0%). Approximately half of the studies reported rates of alexithymia that were 
greater than 10.0% and the other half reported rates that were less than or equal to 10.0%. 
This distribution did not appear to change according to the sample size of the study (< 300 or 
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≥ 300), the location of the study (European countries or non-European countries), or whether 
the study recruited community or student participants.
 41 
 
Table 1 
Prevalence of Alexithymia
a
 in Psychiatric Samples, as well as Demographic Differences in Alexithymia  
Study Country Sample Prevalence (%) Results 
Akkerman (1996) USA 131 substance misuse inpatients  ≠ gender 
Bagby, Parker, et al. (1994) Canada 218 general psychiatric outpatients  ≠ gender; ≠ age 
Bankier et al. (2001) Austria 297 general psychiatric inpatients  ≠ gender; ≠ age; lower education > higher 
education (elementary school, junior high 
school, and high school) 
Beales and Dolton (2000) Britain 79 members of an eating disorder association 74.0  
Bonnaire, Bungener, and 
Varescon (2009) 
France 84 community sourced pathological 
gamblers 
53.6
b, c
 ≠ gender 
Carano et al. (2006) Italy 101 binge eating disorder patients  ≠ gender; older patients > younger patients 
(age in years; did not report correlation 
coefficient); lower education > higher 
education (< high school and ≥ high school); 
≠ employment status; ≠ marital status 
Celikel et al. (2010) Turkey 81 depressed outpatients 33.3 ≠ gender; ≠ age; ≠ education; ≠ profession; ≠ 
marital status 
Celikel and Saatcioglu (2007) Turkey 124 depressive, anxiety, and somatoform 
disorder outpatients 
 ≠ age; ≠ education; ≠ marital status 
Celikel and Saatcioglu (2006) Turkey 30 somatoform disorder (chronic pain) 
outpatients (female) 
56.7  
Coriale et al. (2012) Italy 110 alcohol dependent inpatients 34.5  
Cox et al. (1994) Canada 55 somatoform disorder outpatients (chronic 
pain) 
53.0 ≠ gender; ≠ age 
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Table 1 (continued) 
Study Country Sample Prevalence (%) Results 
Cox, Swinson, Shulman, and 
Bourdeau (1995) 
Canada 146 anxiety disorder patients from a clinic 31.1  
Cucchi et al. (2012) Italy 139 panic disorder outpatients 25.9  
De Berardis et al. (2005) Italy 112 obsessive-compulsive disorder 
outpatients 
35.7  
De Berardis et al. (2007) Italy 84 panic disorder outpatients 38.1 ≠ gender; ≠ age; lower education > higher 
education (< high school and ≥ high school); 
≠ employment status; ≠ marital status 
Deborde et al. (2008) France 45 eating disorder patients from unspecified 
setting 
53.2
b 
 
de Haan et al. (2013) Netherlands 187 substance dependent inpatients  ≠ gender; ≠ age; fewer years of education > 
greater years of education (r = -.19); ≠ 
employment status; ≠ marital status 
de Haan, Schellekens, et al. 
(2012) 
Netherlands 100 alcohol dependent inpatients (male) 45.0 ≠ age; fewer years of education > greater 
years of education (r = -.21); ≠ employment 
status; ≠ marital status 
de Haan, van der Palen, 
Wijdeveld, Buitelaar, and De 
Jong (2014) 
Netherlands 130 substance dependent inpatients  ≠ gender; ≠ age; ≠ education; ≠ employment 
status; ≠ marital status 
De Panfilis, Rabbaglio, Rossi, 
Zita, and Maggini (2003) 
Italy 64 eating disorder outpatients (female) 14.4  
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Table 1 (continued) 
Study Country Sample Prevalence (%) Results 
de Timary, Luts, Hers, and 
Luminet (2008) 
Belgium 70 alcohol dependent inpatients 32.4 ≠ gender 
Eizaguirre, de Cabezón, de 
Alda, Olariaga, and Juaniz 
(2004) 
Spain 151 eating disorder patients (female) 
referred from an eating disorder association 
57.0  
El Rasheed (2001) Egypt 200 substance misuse inpatients  ≠ gender; ≠ age; ≠ education; ≠ employment 
status; ≠ marital status 
Evren, Cagil, et al. (2012) Turkey 118 alcohol dependent inpatients (males)  ≠ age; fewer years of education > greater 
years of education (r = -.28) 
Evren, Cinar, and Evren 
(2012ᵈ) 
Turkey 200 substance dependent inpatients 34.0  
Evren, Dalbudak, and 
Çakmak (2008) 
Turkey 176 alcohol dependent inpatients 30.1 ≠ age; ≠ education; ≠  employment; ≠ marital 
status 
Evren, Dalbudak, Cetin, 
Durkaya, and Evren (2010) 
Turkey 156 alcohol dependent inpatients 30.1  
Evren et al. (2009) Turkey 159 alcohol and other drug dependent 
inpatients 
45.3 ≠ age; lower education > higher education 
(elementary school, 6-8 years high school, 9-
12 years high school, and university); 
unemployed > employed; ≠ marital status 
Frewen, Lanius, et al. (2008) Canada 105 post-traumatic stress disorder patients 
from unspecified setting 
47.0  
Fukunishi, Kikuchi, et al. 
(1997) 
Japan 50 anxiety disorder patients from a hospital 
and clinic 
56.0
c
  
Galderisi et al. (2008) Italy 32 panic disorder outpatients 29.0  
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Table 1 (continued) 
Study Country Sample Prevalence (%) Results 
Grabe et al. (2008) Germany 414 general psychiatric inpatients 27.0 Females > males; ≠ age; ≠ education; ≠ 
marital status 
Grabe et al. (2006) Germany 82 obsessive-compulsive disorder 
outpatients 
11.0  
Güleç et al. (2013) Turkey 100 depressive disorder patients  Males > females 
Haviland, Hendryx, Shaw, 
and Henry (1994) 
USA 204 substance dependent inpatients 41.7 Females > males 
Honkalampi, Hintikka, 
Saarinen, Lehtonen, and 
Viinamäki (2000ᵈ) 
Finland 169 depressive disorder outpatients 39.0 Males > females; ≠ age; lower education > 
higher education (≤ high school and > high 
school); ≠ economic status; ≠ marital status 
Joukamaa et al. (2008) Finland 161 general psychiatric outpatients 34.2
c
 ≠ gender 
Joyce, Fujiwara, Cristall, 
Ruddy, and Ogrodniczuk 
(2013) 
Canada 51 general psychiatric outpatients 51.0  
Kim et al. (2008) Korea 104 depressive disorder patients from a 
hospital 
50.0 ≠ gender; ≠ age; ≠ education 
Kubota et al. (2012) Japan 44 schizophrenia patients  ≠ gender; ≠ age 
Landa (2009) USA 20 somatoform disorder patients from 
several clinics 
40.0  
Lecours and Bouchard (2011) Canada 64 general psychiatric outpatients  ≠ gender; ≠ age; lower education > higher 
education (elementary school, high school, 
university preparation course, and university) 
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Table 1 (continued) 
Study Country Sample Prevalence (%) Results 
Leweke et al. (2012) Germany 1461 general psychiatric outpatients 21.4 Males > females; ≠ age; lower education > 
higher education (9 years, 10 years, and 13 
years of school, still in school, and other 
graduation) 
Loas et al. (2001) France 659 substance misuse and eating disorder 
inpatients and outpatients 
 ≠ gender 
Luminet, Bagby, and Taylor 
(2001) 
Canada 46 depressive outpatients  ≠ gender; ≠ age; ≠ education; ≠ SES; ≠ 
marital status 
Lundh and Broman (2006) Sweden 100 general psychiatric patients (with 
insomnia) from a sleep disorders unit 
20.4  
Marchesi, Fonto, Balista, 
Cimmino, and Maggini 
(2005) 
Italy 101 panic disorder patients from a clinic 44.2  
Melin, Thulesius, and 
Persson (2010) 
Sweden 54 somatoform disorder outpatients (chronic 
pain) 
36.0  
Müller and Bühner (2006) Germany 300 general psychiatric inpatients 35.0  
Müller et al. (2003) 
 
Germany 204 general psychiatric patients from 
inpatient and clinic settings
e
 
17.6  
Özsahin, Uzun, Cansever, 
and Gulcat (2003) 
Turkey 65 depressive disorder outpatients 49.2
c
 ≠ gender; ≠ age; ≠ education; ≠ SES; ≠ 
marital status 
Pinaquy, Chabrol, Simon, 
Louvet, and Barbe (2003) 
France 40 binge eating disorder outpatients (female) 62.5  
Pinard, Negrete, Annable, 
and Audet (1996) 
Canada 48 substance dependent patients  ≠ gender; ≠ age 
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Table 1 (continued) 
Study Country Sample Prevalence (%) Results 
Porcelli et al. (2004) Italy 52 general psychiatric outpatients 21.1  
Reese (2008) USA 84 somatoform disorder patients from clinics 
and community 
23.8 ≠ gender; ≠ age; ≠ employment status;  ≠ 
marital status; ≠ ethnicity 
Rufer et al. (2010) Germany 55 panic disorder outpatients  ≠ gender; ≠ age 
Rufer et al. (2004) Germany 42 obsessive-compulsive disorder inpatients 14.0 ≠ gender; ≠ age; ≠ employment status; ≠ 
marital status 
Saladin et al. (2012) USA 40 substance dependent patients from clinics 
and community 
15.0  
Saarijärvi et al. (2001) Finland 120 depressive disorder patients from social 
insurance offices
f
 
46.0  
Son et al. (2012ᵈ) Korea 388 general psychiatric inpatients and 
outpatients 
37.1
c
 Younger patients > higher patients (r = -.20); 
fewer years of education > greater years of 
education (r = -.12) 
Speranza et al. (2004) France, 
Switzerland, 
& Belgium 
564 addictive disorder inpatients and 
outpatients (anorexia, bulimia, and alcohol 
dependence) 
52.8
b ≠ gender 
C. Spitzer et al. (2005) Germany 149 general psychiatric inpatients 35.5 ≠ gender; ≠ age 
Taylor, Parker, Bagby, and 
Bourke (1996) 
Canada 48 eating disorder patients from private 
clinics 
68.8  
Thorberg et al. (2011) Australia 254 alcohol dependent outpatients 32.4  
Todarello et al. (2005) Italy 29 schizophrenic outpatients 65.5  
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Table 1 (continued) 
Study Country Sample Prevalence (%) Results 
Todarello et al. (1995) Italy 113 general psychiatric outpatients 32.7 ≠ gender; ≠ age; fewer years of education > 
greater years of education (r = -.37) 
Toneatto, Lecce, and Bagby 
(2009) 
Canada 143 pathological gamblers from community 76.6  
Tutkun et al. (2004) Turkey 154 general psychiatric outpatients 46.8 ≠ age; fewer years of education > greater 
years of education 
Uzun (2003) Turkey 56 alcohol dependent outpatients 48.2 ≠ age; fewer years of education > greater 
years of education; lower economic status > 
higher economic status (good and poor
g
); ≠ 
marital status 
Vanheule et al. (2007) Belgium 404 general psychiatric outpatients 38.0  
Verrocchio, Conti, and 
Fulcheri (2010) 
Italy 77 substance dependent inpatients 44.2  
Zhu et al. (2007) China 179 general psychiatric outpatients  ≠ gender; ≠ age; ≠ education 
Note. ≠ = no significant correlation between the demographic variable and alexithymia, or no significant differences between the categorical variables (e.g., male and female) 
in alexithymia scores; > and < = respectively higher or lower levels of the demographic variable correlated with alexithymia (e.g., older age in years) or significantly greater 
alexithymia scores in higher or lower levels of the categorical variable (e.g., older age group); SES = Socioeconomic status. 
a
Percentage of patients with TAS-20 scores ≥ 61. 
b
Alexithymia prevalence was determined using TAS-20 cut-off scores derived for French samples (see Loas et al., 1996). 
c
Percentage of Alexithymia was calculated by the author. 
d
The authors have published multiple articles using this participant sample. Therefore, either the original study was included or, if the sample was expanded in a subsequent 
study, the study with the largest sample was included. 
e
This sample was counted as a general psychiatric sample in present calculations as primary diagnoses were a mix of anxiety, somatoform, and alcohol dependence disorders. 
f
Employees paid > 2 months sickness allowance due to major depression were included (excluded inpatients). 
g
Author did not define economic status beyond categories ‘good’ and ‘poor’. 
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Table 2 
Prevalence of Alexithymia
a
 in Community Samples, as well as Demographic Differences in Alexithymia 
Study Country Sample Prevalence (%) Results 
Bagby, Parker, et al. (1994) Canada 965 university students; 401 university 
students 
 Males > females, younger participants > older 
participants (965 sample; r = -.13); ≠ gender, ≠ age 
(401 sample) 
Balaban et al. (2012) Turkey 246 university students 3.6  
Berenbaum, Davis, and 
McGrew (1998) 
USA 62 university students  Males > females 
Beyer (2008) USA 190 community participants  ≠ age 
Bogutyn, Kokoszka, 
Pałczyński, and Holas 
(1999) 
Poland 387 university students 10.1  
Bonnaire et al. (2009) France 100 community participants (gamblers)  ≠ gender 
Bonnet, Brejard, and 
Pedinielli (2013) 
France 256 university students  ≠ gender 
Bouchard (2009) Canada 270 university students and community 
professionals 
 ≠ gender 
Bressi et al. (1996) Italy 206 community participants and 
university students 
 ≠ gender; ≠ age; fewer years of education > greater 
years of education (r = -.33) 
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Table 2 (continued)     
Study Country Sample Prevalence (%) Results 
Byrne and Ditto (2005) Canada 610 community participants (blood 
donors) 
 ≠ age 
Carpenter and Addis (2000) USA 172 university staff  Males > females; lower education > higher 
education (some high school or graduate, some 
college, 4-year college graduate, graduate degree) 
Campos et al. (2000) France 1171 university students 10.7  
Chen, Xu, Jing, and Chan 
(2011) 
China 1788 university students  ≠ gender; older participants > younger participants (r 
= .05); ≠ education; ≠ income 
De Berardis et al. (2009) Italy 546 university students (female)  ≠ age; ≠ employment status; ≠ marital status 
Deborde et al. (2008) France 253 university students and university 
staff 
13.8
b 
 
Declercq, Vanheule, and 
Deheegher (2010) 
Belgium 136 nurses and ambulance staff  Males > females; ≠ age 
Dion (1996) Canada 950 university students  ≠ gender 
Franz et al. (2008) Germany 1859 community participants 10.0 Males > females; ≠ age; lower education > higher 
education (school degree and university degree); 
lower income > higher income (3 categories of 
income); unemployed > employed; divorced > 
married; church membership > no church 
membership 
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Table 2 (continued)     
Study Country Sample Prevalence (%) Results 
Honkalampi, Hintikka, 
Tanskanen, et al. (2000) 
Finland 2018 community participants 10.3 Males > females; older participants > younger 
participants (age in years); fewer years of education 
> greater years of education; lower economic status
 
> higher economic status (subjective rating of good 
and poor), ≠ marital status 
Jørgensen et al. (2007) Denmark 8785 community participants (twins)  Males > females; significant difference in age (did 
not report correlation coefficient or direction) 
Joukamaa et al. (2003ᶜ) Finland 5028 community participants 7.1 Males > females; lower social class > higher social 
class (high, low, and farmer); rural location > urban 
location 
Katz, Martin, Page, and 
Calleri (2009) 
Canada 67 university students 10.0  
Kench and Irwin (2000) Australia 92 university students 10.9 ≠ gender; older participants > younger participants (r 
= .07) 
Kojima, Senda, Nagaya, 
Tokudome, and Furukawa 
(2003) 
Japan 120 employees of a gas utility company 19.2  
Lane, Sechrest, and Riedel 
(1998) 
USA 380 community participants  Males > females; older participants > younger 
participants (five age categories); fewer years of 
education > greater years of education (r = -.30); 
lower SES > higher SES (working, middle, and 
upper classes) 
Levant et al. (2006) USA 407 university students  Males > females 
Levant et al. (2003) USA 1151 university students and community 
participants 
 ≠ age; ≠ SES; ≠ marital status; lower income > 
higher income (six categories) 
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Table 2 (continued)     
Study Country Sample Prevalence (%) Results 
Loas et al. (2001) France 769 community participants  ≠ gender 
Loiselle and Cossette 
(2001) 
USA; Peru 561 university students (USA and 
Peruvian campuses) 
 Males > females; ethnicity (Peruvian sample > USA 
sample) 
Lundh et al. (2002) Sweden 88 community participants and university 
students 
 Males > females; lower education > higher 
education (university students vs. community 
participants) 
Lundh and Simonsson-
Sarnecki (2001) 
Sweden 137 community participants 2.2 Males > females; ≠ age; ≠ education; ≠ SES 
Lyvers, Onuoha, Thorberg, 
and Samios (2012) 
Australia 314 community participants (drinkers)  Younger participants > older participants (r = -.14) 
Mason, Tyson, Jones, and 
Potts (2005) 
Britain 371 university students 17.9 Females > males 
Mattila et al. (2006) Finland 5418 community participants  Males > females; Older participants > younger 
participants (6 age categories); lower education > 
higher education (basic, secondary, and higher 
schooling); lower income > higher income (3 
categories); unmarried > married 
McCaslin et al. (2006) USA 166 urban police officers  Males > females 
McNeill (2014) Australia 171 community participants (couples) 8.2
d
 Males > females 
Messina, Fogliani, and 
Paradiso (2010) 
Italy  111 university students  ≠ gender 
Montebarocci et al. (2004) Italy 301 university students 8.3 ≠ gender 
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Table 2 (continued)     
Study Country Sample Prevalence (%) Results 
Müller et al. (2003) Germany 224 office workers and skilled workers 6.3  
Pandey et al. (1996) India 285 teachers, office workers, and 
university students 
 ≠ gender; ≠ age; fewer years of education > greater 
years of education (r = -.23) 
Paradiso, Vaidya, 
McCormick, Jones, and 
Robinson (2008) 
USA 24 volunteers from unspecified setting  Older participants > younger participants (r = .48) 
Parker, Bagby, et al. (1993) Canada; 
Germany; 
USA 
1003 university students (Canadian, 
German, and USA campuses) 
 Males > females in all samples; location (USA and 
Canadian sample > German sample) 
Parker, Shaughnessy, 
Wood, Majeski, and 
Eastabrook (2005) 
Canada 123 aboriginal community participants  ≠ gender; ≠ age 
Parker, Taylor, and Bagby 
(1993) 
Canada 70 university students 22.9  
Parker, Taylor, and Bagby 
(2001) 
Canada 734 community participants  Males > females 
Parker et al. (2003) Canada 1933 community participants  Males > females; fewer years of education > greater 
years of education (r = -.23) 
Parker, Wood, Bond, and 
Shaughnessy (2005) 
Canada 562 university students 12.0 ≠ gender 
Parry (2012) Australia 323 university students and general 
community 
9.0  
Peters (2006) USA 162 community participants (African 
American) 
8.0  
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Table 2 (continued)     
Study Country Sample Prevalence (%) Results 
Picardi et al. (2005) Italy 221 university students  ≠ gender; younger participants > older participants (r 
= -.17) 
Posse, Hallstrom, and 
Backenroth-Ohsako (2002) 
Finland 864 childcare employees (female) 7.9 ≠ age; lower education > higher education (< high 
school and ≥ high school) 
Salminen, Saarijärvi, 
Äärelä, Toikka, and 
Kauhanen (1999) 
Finland 1285 community participants 12.8 Males > females; older participants > younger 
participants (r = .15 in men and r = -.10 in women); 
lower education > higher education (secondary 
school graduate and non-graduate); lower SES > 
higher SES (private entrepreneur, white-collar 
workers, blue-collar workers, and others) 
Samson, Huber, and Gross 
(2012) 
USA 27 community participants 0.0  
Scimeca et al. (2013) Italy 300 university students 10.0  
Scott (2009) USA 150 university students  ≠ gender 
Taylor et al. (1996) Canada 234 university students 13.7 Males > females 
Tsaousis et al. (2010) Greece 340 university students  Males > females; ≠ age 
Vanheule et al. (2007) Belgium 157 university students 2.0  
Verrocchio et al. (2010) Italy 77 university students and community 
participants 
20.8  
Viinikangas et al. (2009) Finland 669 community participants  Males > females; ≠ age 
Yelsma, Hovestadt, 
Anderson, and Nilsson 
(2000) 
USA 295 university students  ≠ gender 
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Study Country Sample Prevalence (%) Results 
Zhu et al. (2007) China 870 university students  ≠ gender 
Note. ≠ = no significant correlation between the variable and alexithymia or no significant differences between the categorical variables (e.g., male and female) in alexithymia 
scores; > and < = respectively higher or lower levels of the variable correlated with alexithymia (e.g., older age in years) or significantly greater alexithymia scores in higher 
or lower levels of the categorical variable (e.g., older age group); SES = Socioeconomic status. 
a
Percentage of patients with TAS-20 scores ≥ 61. 
b
Alexithymia prevalence was determined using TAS-20 cut-off scores derived for French samples (see Loas et al., 1996) 
c
The authors have published multiple articles using this participant sample. Therefore, either the original study was included or, if the sample was expanded in a subsequent 
study, the study with the largest sample was included. 
d
Percentage of Alexithymia was calculated by the author.
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Prevalence of alexithymia according to psychiatric diagnosis. 
In order to evaluate whether psychiatric diagnosis impacted on the proportion of 
patients identified as alexithymic, each of the studies were categorised according to one of 
five broad diagnostic groups as follows: depressive disorders (n = 5), anxiety and stress 
related disorders (various anxiety disorders, panic disorder, obsessive-compulsive disorder, 
and post-traumatic stress disorder, n = 10), somatoform disorders (somatoform disorders, 
chronic pain disorder, somatoform disorder with chronic pain, and functional dyspepsia, n = 
5), addictive disorders (eating disorders, alcohol and/or substance-dependence, and 
pathological gambling, n = 21), or general psychiatric (various diagnoses, n = 13). The study 
that involved patients diagnosed with schizophrenia was not included because rates of 
alexithymia within this group could not be compared. 
The majority of the studies in the addictive, depressive, and somatoform disorders 
groups reported rates of alexithymia that were greater than 37.5%, whereas the majority of 
the studies in the anxiety and stress-related disorders, and the general psychiatric disorders 
groups reported rates of alexithymia that were less than 37.5%. Across all of the diagnostic 
groups, two studies in the anxiety and stress-related disorders group reported the lowest rates 
of alexithymia at 11.0% (Grabe et al., 2006) and 14% (Rufer et al., 2004) in patients 
diagnosed with obsessive-compulsive disorder. Five studies in the addictive disorders group 
reported the highest rates of alexithymia at 57% (Eizaguirre et al., 2004), 62.5% (Pinaquy et 
al., 2003), 68.8% (Taylor et al., 1996), and 74% (Beales & Dolton, 2000) in patients 
diagnosed with eating disorders, and 76.6% in community participants diagnosed as 
pathological gamblers (Toneatto et al., 2009). 
Two studies in the present review directly compared prevalence rates of alexithymia 
and alexithymia scores (as a continuous variable) between different diagnostic groups 
(Leweke et al., 2012; Son et al., 2012). Leweke et al. (2012) conducted a study with 1,461 
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German psychiatric outpatients and found that the proportion of alexithymic patients was 
significantly greater in the group of patients diagnosed with depressive disorders compared to 
four other diagnostic groups (adjustment disorders, psychological and behavioural factors 
associated with disorders or diseases, somatoform disorders, and eating disorders). In 
addition, after controlling for depression symptoms in the anxiety disorders group, 
alexithymia scores were only found to correlate significantly with depressive disorders 
compared to the other diagnostic groups. In contrast, Son et al. (2012) conducted a study with 
388 Korean psychiatric inpatients and outpatients and found no differences in alexithymia 
scores or in the proportion of alexithymic patients between four diagnostic groups (depressive 
disorders, somatoform disorders, anxiety disorders, and psychotic disorders). 
Alexithymia and demographic factors. 
Some studies recruited and examined demographic factors in multiple samples. 
Therefore, the following results refer to the number of samples rather than the number of 
studies. In addition, age and education were the only demographic variables to be examined 
as either continuous variables (e.g., age and education in years) or as categorical variables 
(e.g., age categories and levels of education). Results of correlational analyses will be 
reported on first, for each of these variables. All other demographic variables (e.g., gender 
and employment status) were examined as categorical variables only. 
 In 70.3% of the samples where age was examined as a continuous variable (n = 38), 
age was not found to be associated with alexithymia. Small correlations were found between 
younger age and higher alexithymia score in four samples (r ranged between -.13 and -.20) 
and small to moderate correlations were found between older age and higher alexithymia 
score in seven samples (r ranged between .05 and .48). One study reported a significant 
correlation between age and alexithymia in their sample but did not report the correlation 
coefficient or specify the direction of the association (Jørgensen et al., 2007) and another 
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study reported a significant correlation in their sample between older age and higher 
alexithymia score but did not report the correlation coefficient (Carano et al., 2006). 
In 90% of the samples that examined categorical differences between age and 
alexithymia (n = 18), no significant differences were found. In two samples, groups of older 
participants reported higher alexithymia scores compared to groups of younger participants. 
In 20% of the samples that examined education as a continuous variable (n = 3), no 
association was found between years of education and alexithymia score. Small to moderate 
correlations were found between fewer years of education and higher alexithymia score (r 
ranged between -.12 and -.37) in the remaining 12 samples. 
In 41% of the samples that examined categorical differences between education and 
alexithymia (n = 9), no significant differences were found. In 13 samples, participants with 
lower education levels reported higher alexithymia scores compared to participants with 
higher education levels. 
In 59.2% of the samples (n = 45), no differences in alexithymia scores were found 
between genders. Males reported higher alexithymia scores than females in 28 samples, 
whereas females reported higher alexithymia scores in three samples. 
In 66.7% of the samples (n = 18), there were no differences in alexithymia scores 
between various economic factors (including SES, employment status, and income). In nine 
samples, participants who identified as having a lower economic status or income rate 
reported higher alexithymia scores. There were no differences in alexithymia scores between 
married and unmarried participants in 91% of the samples (n = 20), whereas higher 
alexithymia scores were found in unmarried participants in 9% of the samples (n = 2).The 
studies that examined other demographic factors generally found significant differences in 
alexithymia scores between the factors under examination. One study found higher 
alexithymia scores in participants from Peru compared to participants from the USA (Loiselle 
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& Cossette, 2001). Another study found no differences in alexithymia scores between 
participants from the USA who were identified as Caucasian, African-American, and 
Hispanic (Reese, 2008). One study reported higher alexithymia scores in participants who 
were members of a church compared to non-members of a church (Franz et al., 2008), and 
another study reported higher alexithymia scores in participants residing in a rural location 
compared to an urban location (Joukamaa et al., 2003). 
Finally, differences were observed in the findings of the present studies based on 
whether the study involved a psychiatric sample or a community sample. In 70.5% of the 
psychiatric samples, alexithymia scores were not found to be related to demographic 
variables, such as gender, age, education, economic status, marital status, employment status, 
and other factors included in the present findings (demographic variables were measured as 
categorical or continuous variables). In contrast, alexithymia scores were related to 
demographic variables in 71.2% of the community samples. In addition, the studies 
conducted in psychiatric and community settings where greater prevalence rates of 
alexithymia were reported (above the median rate of alexithymia for each group of studies, 
respectively) generally found significant differences in alexithymia scores between 
demographic variables compared to the psychiatric and community studies that reported 
lower prevalence rates of alexithymia. Essentially, the effect of demographic variables on 
alexithymia was more salient in studies that involved community participants and in studies 
that identified high prevalence rates of alexithymia. 
Discussion 
A systematic literature review was carried out to obtain a clearer understanding of the 
factors that may influence alexithymia rates in order to generate awareness of the alexithymia 
construct amongst clinicians and researchers who work with psychiatric populations. This 
review examined rates of alexithymia in studies involving psychiatric samples while taking 
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psychiatric diagnosis and psychopathology severity into consideration. Rates of alexithymia 
in the psychiatric samples were compared to rates of alexithymia reported in studies 
involving community samples. This review also evaluated studies that have examined 
alexithymia and demographic differences in psychiatric and/or community samples to obtain 
a clearer understanding of the factors that may influence alexithymia rates. 
Findings from the studies that involved psychiatric samples indicated a high degree of 
variability in prevalence rates of alexithymia independent of the study location (Europe or 
elsewhere) or sample size (< 100 or ≥ 100 patients). In addition, greater rates of alexithymia 
were more frequently reported in psychiatric studies that were undertaken outside of Europe 
(predominately North America). The prevalence range of alexithymia in the community 
samples were similar across studies involving European samples, which tended to be larger, 
and studies involving non-European samples, which tended to be smaller. The similarity in 
prevalence range of alexithymia in the community samples, despite sample size or location, 
indicates that the differences in prevalence rates in the psychiatric samples for different 
countries is unlikely to be a result of sample size or cultural influences on alexithymia scores, 
but rather something to do with psychopathology in the different cultures. More specifically, 
the variety of psychiatric diagnoses did not differ according to the location that the studies 
were undertaken. Therefore, the differences in prevalence rates in the psychiatric samples for 
different countries are likely to be a result of diagnostic severity or other unknown factors 
that influence psychopathology in different cultures. 
It was expected that a greater proportion of studies involving patients with severe 
psychiatric illness that are commonly observed in inpatient settings would report higher rates 
of alexithymia compared to studies involving patients in outpatient settings. However, most 
of the studies that involved inpatient samples reported lower rates of alexithymia compared to 
the studies that involved outpatient samples. One explanation for this finding is that treatment 
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setting of a patient sample in the studies reviewed did not offer an ideal indication of 
psychopathology severity. For example, many studies that involved patients diagnosed with 
chronic and acute psychiatric disorders, such as somatoform disorder with chronic pain 
(Celikel & Saatcioglu, 2006; Cox et al., 1994) and schizophrenia (Todarello et al., 2005), 
recruited patients from outpatient settings. These studies in particular reported some of the 
highest rates of alexithymia across studies that involved outpatient samples. Therefore, 
speculation about whether psychopathology severity is a likely contributor to greater rates of 
alexithymia requires further examination. 
Type of psychiatric diagnosis was another sample characteristic considered to 
influence the prevalence rate of alexithymia. Most of the studies reviewed where patients 
were diagnosed with addictive disorders, depressive disorders, and somatoform disorders 
reported higher rates of alexithymia (that is, rates of alexithymia > 37.5%), whereas most of 
the studies reviewed where patients were diagnosed with anxiety and stress-related disorders 
and general psychiatric samples reported lower rates of alexithymia. These general trends in 
the literature were not consistent with a study in the present review (Son et al., 2012) that 
directly compared prevalence rates of alexithymia between various psychiatric diagnoses and 
found no significant differences. However, the present findings are partially consistent with 
the findings of Leweke et al. (2012) who found a significantly greater prevalence rate of 
alexithymia amongst patients diagnosed with a depressive disorder compared to other 
psychiatric diagnoses. The present findings are also partially consistent with early 
alexithymia researchers who considered alexithymia a pathological process underpinning 
somatic distress (Sifneos, 1973; Taylor et al., 1997). Moreover, and based on the present 
findings, a greater proportion of patients with addictive disorders, particularly eating 
disorders, may be identified as alexithymic given that some of the highest rates of 
alexithymia were reported in studies involving patients diagnosed with eating disorders. 
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The prevalence rates of alexithymia reported in studies that involved psychiatric 
patients were generally much higher than the rates reported in studies that involved 
community participants, with median rates of alexithymia at 37.5% and 10%, respectively. 
Comparing psychiatric and community samples has emphasised the link between alexithymia 
and psychopathology. In addition, the common practice across the alexithymia literature of 
employing and referring to community and student samples interchangeably was supported 
by the present finding that the distribution of alexithymia rates was similar in studies 
involving community and student samples. 
The relative number of studies that found no differences in alexithymia between 
various demographic groups, such as gender, age, employment status, SES, income, and 
marital status, indicate that prevalence rates of alexithymia are unlikely to be influence by 
demographic factors. In addition, there were a number of contradictory findings in the 
literature regarding age and gender. While most studies found non-significant correlations 
between age and alexithymia score, some studies found small to moderate negative or 
positive correlations between age and alexithymia, indicating that alexithymia was related to 
younger participants in some samples and older participants in other samples. Similarly, most 
studies reported no differences in alexithymia between genders, yet some studies reported 
higher alexithymia scores in males and other studies reported higher alexithymia scores in 
females. It may be premature to conclude that these demographic factors do not influence or 
relate to the alexithymia construct in some way. However, inconsistencies in the literature, 
particularly concerning differences in alexithymia by age and gender, further complicate the 
relationship between alexithymia and demographic factors.  
In contrast, there is more evidence to suggest that education level may influence 
alexithymia rates in psychiatric and/or community populations, as most studies found that 
higher alexithymia scores were related to fewer years or a lower level of education. The small 
 62 
 
to moderate correlations that were found between fewer years of education and higher 
alexithymia scores across the literature indicate that difficulties identifying, communicating, 
and examining ones feelings may have a small to moderate negative impact on the amount of 
time an individual spends at school. Perhaps alexithymia prevents individuals from 
continuing with higher education, or removes their desire to do so, due to the difficulties they 
experience in processing and regulating emotions. Alternatively, additional years of 
schooling, particularly at a tertiary level, may have enhanced individuals’ ability to 
communicate and verbally articulate their feelings. It would be interesting to assess whether 
additional years of schooling was linked to the Difficulty Describing Feelings subscale 
specifically, and whether this subscale was responsible for higher total TAS-20 scores in 
these studies. 
Over two thirds of the studies that found significant differences in alexithymia scores 
between demographic factors involved community samples. The exact opposite was true of 
the psychiatric studies, with over two thirds of these studies finding non-significant 
differences in alexithymia scores between demographic factors. This finding supports a 
previous observation by Levant et al. (2006), where significant differences in alexithymia 
scores between males and females were more frequently found in non-clinical studies 
compared to clinical studies that involved psychiatric and medical patients. Levant suggested 
that this observation provided support for his theory of a gender-linked subclinical 
alexithymia syndrome (Levant, 1992). However, the present findings dispute the specificity 
of a gender-linked subclinical alexithymia syndrome and rather indicate that this syndrome 
would be linked to numerous demographic variables and not just to gender. A more probable 
explanation for the finding that the effect of demographic factors on alexithymia was more 
salient in studies that involved community samples compared to psychiatric samples, is that 
the larger sample sizes employed in the community studies provided greater statistical power 
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to detect small effects between alexithymia and demographic factors. In addition, the 
relationships between alexithymia and different demographic factors may have been detected 
more easily in the community samples because variables related to psychopathology were not 
present to confound or dilute analyses. The finding that significant differences in alexithymia 
scores between demographic factors were more often reported in studies that reported higher 
rates of alexithymia could be explained in a similar way: a greater proportion of alexithymic 
participants may provide greater statistical power to detect relationships between alexithymia 
and different demographic factors. Overall, the findings from the present review indicate that 
the possible effect of demographic factors such as gender, age, employment status, SES, 
income, and marital status on prevalence rates of alexithymia is likely to be small. 
Limitations and Recommendations 
There are several limitations to the findings of the present review. The review focused 
on studies where the TAS-20 was used as the measure of alexithymia. Although a number of 
studies were not included in this review because they employed other measures of 
alexithymia, such as the TAS-26 or BVAQ, the populations they studied were represented in 
the selection of studies included in this review. Therefore, the decision to include only the 
studies employing the TAS-20 was unlikely to make the selected studies unrepresentative of 
the populations studied to date. In addition, while systematic reviews do have a number of 
advantages, findings from studies that vary in sample size are treated equally when evaluating 
the impact of the findings on the conclusions made. The samples sizes of individual studies 
identified for this review varied from 20 to 8785. Further empirical examination of these data 
is required to draw findings that are more conclusive (i.e., by conducting a meta-analysis) 
where issues such as sample size are accounted for in determining the size of effects. 
The main limitation observed across the literature was the underrepresentation of 
studies undertaken in countries outside of Europe and North America. This lack of 
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representation may affect the international applicability of the present findings to psychiatric 
and community populations. Previous researchers who have examined the international 
prevalence rates of attention-deficit/hyperactivity disorder (see Faraone, Sergeant, Gillberg, 
& Biederman, 2003; Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007) have also 
raised this issue. The examination of alexithymia rates in Australian psychiatric and 
community samples that is conducted in Chapter 4 of the present thesis will contribute to this 
gap in the alexithymia literature. There is also a need for more research to directly compare 
prevalence rates of alexithymia by psychiatric diagnosis in order to examine the role that 
psychiatric diagnosis has on the prevalence rate of alexithymia in the psychiatric population. 
The findings of this research need to be extended into clinical practice, with a better 
awareness of alexithymia and effective means of alleviating alexithymic features on the 
individual. The influence of alexithymia on therapeutic outcome and the impact of different 
treatment approaches will be the focus of Chapters 3 and 5 in the present thesis, whereby 
more detailed recommendations on these topics are provided. 
Conclusion 
The purpose of the present literature review was to evaluate prevalence rates of 
alexithymia in psychiatric and community samples. The data from studies using the TAS-20 
to assess the prevalence of alexithymia indicates that, despite some variability, alexithymia 
reflects a pervasive problem affecting a large proportion of psychiatric patients because the 
prevalence rates of alexithymia were far greater in the psychiatric population than in the 
community population. Trends across the literature indicate that variation in the prevalence 
rate of alexithymia in the psychiatric population might have been influenced by psychiatric 
diagnosis, with higher rates being reported more frequently in studies involving patients 
diagnosed with depressive and somatoform disorders, and especially in studies involving 
patients diagnosed with addictive (eating) disorders. This finding is consistent with some 
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previous research, yet more studies are needed to directly examine prevalence rates of 
alexithymia between different diagnostic groups. In addition, there are other unknown factors 
that may influence differences in psychopathology between European and non-European 
samples, which might have contributed to the variation in the prevalence rate of alexithymia 
in the psychiatric population. 
Findings in the literature revealed numerous inconsistencies regarding the influence of 
demographic factors on prevalence rates of alexithymia in psychiatric and community 
populations, and thus speculation about the impact of demographic differences in study 
samples on alexithymia rates remains valid. Future researchers should continue to account for 
the potential confounding influence of demographic factors on alexithymia, particularly the 
influence of gender, education level, and economic status. Further studies are needed to 
report prevalence rates of alexithymia, particularly studies involving large samples and 
samples recruited from populations outside of Europe and North America. Studies assessing 
the prevalence of alexithymia and directly comparing the prevalence of alexithymia in 
different countries are also required to provide a clearer picture of the affliction of 
alexithymia worldwide. 
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CHAPTER 3 
ALEXITHYMIA AND THERAPEUTIC INTERVENTION 
Since the early conception of alexithymia, it has been widely assumed that 
alexithymia would have an adverse role in the therapeutic process. In particular, alexithymic 
individuals were thought to produce poorer therapeutic outcomes compared to non-
alexithymic individuals and it has been suggested that alexithymic features are difficult to 
improve during therapy (Sifneos, 1972/1973, 1975; Taylor et al., 1997). 
There are several reasons for why alexithymia has been considered an obstacle for 
therapeutic success. The original clinical observations of patients with alexithymic features 
described them as having responded poorly to psychodynamic psychotherapy (Sifneos, 
1975). Many forms of psychotherapy regard a certain level of introspection or awareness of 
emotion as fundamental to achieving positive outcomes. It has been suggested that an 
externally-oriented thinking style predisposes patients to experience difficulties with insight-
oriented therapies, and a reduced capacity to examine ones thoughts and feelings and to think 
symbolically or imaginatively about inner experiences impedes client engagement (Taylor et 
al., 1997). Difficulties communicating feelings to others, particularly to healthcare providers, 
may hinder the detection and diagnosis of psychiatric disorders as well as the development of 
appropriate treatment approaches for individuals with alexithymia (Bamonti et al., 2010). 
Alexithymia may also interfere with the utilisation of emotion regulation skills such as 
modification and acceptance of emotions, which have been shown to significantly contribute 
to the prediction of mental health and treatment gains (Berking et al., 2008). In particular, an 
awareness and understanding of emotions are considered basic skills that are needed to 
facilitate the application of the emotion regulation skills of modification and/or acceptance 
(Berking et al., 2008; Lumley et al., 2005). Therefore, core characteristics of alexithymia, 
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namely difficulties identifying and differentiating emotions, may be counter to effective 
emotion regulation, thereby obstructing therapeutic success. 
Although alexithymia has been defined by deficits that are thought to interfere with 
therapeutic outcome, the empirical evidence to support this reasoning has not been consistent. 
Some studies have found higher baseline levels of alexithymia to be a predictor of poor 
therapeutic outcome (Bach & Bach, 1995; Leweke et al., 2009; Özsahin et al., 2003) while 
others have found no link between alexithymia and therapeutic outcome (de Haan, 
Schellekens, et al., 2012; Rufer et al., 2010; Rufer et al., 2004; C. Spitzer et al., 2005). 
Moreover, some authors have proposed that alexithymia may interfere less with behavioural-
based treatments, such as cognitive behavioural therapy (CBT, Rufer et al., 2010), because an 
external focus of alexithymic patients may enhance their adherence to structured exercises 
and behavioural recommendations (Lumley et al., 2007). In contrast, it has been proposed 
that alexithymic patients may respond unfavourably to treatments that focus on insight or 
emotional awareness because they have difficulties examining their problems from a 
psychological perspective (Lumley et al., 2007; Sifneos, 1973). 
In addition to the assumption that alexithymic individuals produce poor therapeutic 
outcomes, it has also been suggested that alexithymic features are difficult to improve during 
therapy (e.g., Sifneos, 1972/1973). One reason why alexithymia has been considered difficult 
to treat involves the view that alexithymia is a personality trait. The perception of alexithymia 
as a personality trait implicates the construct as a vulnerability factor for psychological 
distress and persistent psychopathology (Taylor & Bagby, 2004). Personality traits are 
defined in such a way as to be pervasive and entrenched aspects of a person’s behaviour, 
affect, and cognition (Allemand, Steiger, & Hill, 2013). In this context, alexithymia may 
create a persistent problem for patients receiving psychiatric treatment. Moreover, the stable 
nature of personality traits mean that they are more resistant to change or change at a slower 
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rate over time compared to clinical states, such as negative affect (Allemand et al., 2013). 
Nevertheless, stability does not imply that meaningful changes to personality do not occur 
(Widiger, 2003). Thus, what is of interest to clinicians is whether alexithymia is a stable 
personality trait and the therapeutic approaches most effective at reducing alexithymia. 
Researchers have argued that assessment of change in personality is best done by 
assessing multiple forms of stability because assessing mean-level stability alone for 
example, cannot account for individual differences in personality in response to treatment 
effects nor can it provide strong support for the stable nature of personality traits (Allemand 
et al., 2013; Santor, Bagby, & Joffe, 1997). Change in personality, and alexithymia, has 
typically been approached by assessing mean-level stability and relative stability. 
Mean-level stability refers to the extent to which the average alexithymia score for a 
group of patients remains consistent over time (Allemand et al., 2013). It is typically 
measured using t-tests or analysis of variance, where a significant difference in the average 
scores measured across time equates to mean-level change. Mean-level stability provides a 
general indication of change in alexithymia scores on average: at a group level. However, 
while this form of assessment can produce a constant standard deviation with a varying mean, 
there is no guarantee that patients’ scores are not changing by roughly the same amount for 
each patient in the group. That is, alexithymia scores in a group can maintain the same 
distribution from the mean even though some patients’ scores may increase and other 
patients’ scores may decrease over time. Relative stability, on the other hand, is a stronger 
indicator that patients’ scores are roughly changing by the same amount. 
Relative stability is implied by a high test-retest correlation, where a perfect positive 
correlation indicates that patients’ alexithymia scores have changed by exactly the same 
amount over time (Allemand et al., 2013). Furthermore, high test-retest correlations can be 
interpreted as, for an arbitrary score the distances to nearby scores before treatment are 
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roughly maintained after treatment. This would amount to an approximation of a movement 
or translation of scores. 
It is noteworthy that relative stability and mean-level stability are conceptually and 
statistically distinct as they provide different interpretations of change in a set of scores over 
time (Allemand et al., 2013). Therefore, observing average change in scores at a group level 
does not rule out the possibility of observing relative stability among scores at an individual 
level (Santor et al., 1997). For example, high degrees of relative stability have been observed 
in the personality traits neuroticism and extraversion over a five-week treatment period in 
addition to significant mean-level declines in these traits and in depression severity (Santor et 
al., 1997). Similarly, relative stability and mean-level change in alexithymia has been 
observed in previous studies (e.g., Luminet et al., 2001). 
Some have argued that, in addition to examining numerous forms of stability, change 
in alexithymia must be examined in the context of acute change in clinical symptoms before 
judgments are made concerning the degree to which alexithymia can change following 
treatment (Luminet et al., 2001). Significant reductions in alexithymia scores alongside 
reductions in clinical symptoms is one of the primary observations that led critics to conclude 
that alexithymia is not a stable trait construct, and rather that alexithymia is dependent on 
change in clinical symptoms and thus does not constitute a personality vulnerability to 
psychopathology (Honkalampi, Hintikka, Saarinen, et al., 2000). Few studies have examined 
different forms of stability in the context of change in clinical symptoms. Therefore, 
premature conclusions are likely to have been reached regarding the stability of alexithymia, 
whether it is dependent on clinical symptoms, and whether it influences the onset and course 
of psychopathology (Luminet et al., 2001; Santor et al., 1997). 
Many studies examining change in alexithymia have found significant mean-level 
reductions in alexithymia over time in response to various therapeutic interventions, 
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including pharmacotherapy (Luminet et al., 2001), CBT (Rufer et al., 2010), and 
psychotherapy (Ogrodniczuk, Sochting, Piper, & Joyce, 2012). Given the responsivity of 
alexithymia to various interventions, many researchers have speculated about the most 
effective interventions to treat alexithymia. Taylor (1992) and Lumley et al. (2007) have 
suggested the potential value of autogenic training and biofeedback for the treatment of 
alexithymia, yet no empirical studies have examined these approaches. In addition, some 
authors have also described targeted treatments for alexithymia including: a three-step 
integrative therapy that helps patients to develop accounts of their own affective experiences 
and make use of communication with others in order to manage stress (Vanheule, Verhaeghe, 
& Desmet, 2011), a skills-based training intervention that helps patients to attend to and 
express their feelings more effectively (Kennedy & Franklin, 2002), and a hypnotic imagery 
intervention that helps patients process emotions and activate mental images (Gay, Hanin, & 
Luminet, 2008). However, the majority of studies that have investigated change in 
alexithymia have done so incidentally to investigating change in clinical symptoms following 
treatment for a psychiatric disorder of interest. Therefore, researchers have speculated about 
which prevailing approaches to treatment would be the most effective in reducing levels of 
alexithymia. Treatments conducted in a group format have been considered beneficial for 
alexithymic patients as groups provide a safe and supportive environment for patients to 
experience and learn about emotions through a wide range of interpersonal situations (Apfel-
Savitz, Silverman, & Bennett, 1977; Swiller, 1988). Supportive therapy, which has a more 
directive and external focus, has been considered more effective at reducing alexithymia in 
patients compared to traditional interpretive or analytic psychotherapies (Ogrodniczuk, Joyce, 
& Piper, 2013; Sifneos, 1975), which demand a level of introspection that may be 
challenging for these patients (Ogrodniczuk et al., 2013). Behavioural interventions like CBT 
also provide a directive and external focus and have been suggested to be less anxiety 
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provoking for alexithymic patients as they focus on coping with unpleasant emotions and 
bodily sensations due to physiological reactivity (Rufer et al., 2010) rather than an inward 
examination of the self. Lastly, some have proposed that emotion-focused interventions that 
target the identification and expression of emotion are the most effective type of treatment to 
mitigate alexithymia features (Becker-Stoll & Gerlinghoff, 2004; Hyer, Woods, & 
Boudewyns, 1991; Vanheule et al., 2011), since these interventions aim to enhance the way 
patients process and experience emotions. 
Overall, questions remain in the literature regarding the impact of alexithymia on 
therapeutic outcome, the stability of alexithymia following therapeutic intervention, and the 
most effective treatment approaches for reducing alexithymia levels. Vast differences 
between studies, including psychiatric diagnosis, treatment approaches, and outcome 
measures, have made it difficult to discern a clear picture of alexithymia’s role in the 
therapeutic process. Understanding this role is essential if therapeutic interventions designed 
to treat psychiatric disorders are to be improved, particularly since alexithymia is considered 
to be a predisposing factor for psychological distress and persistent psychopathology (Taylor 
et al., 1997). 
The purpose of the present literature review was to evaluate the role of alexithymia in 
the therapeutic process, while taking factors such as therapeutic approach and outcome 
measure into consideration. This review also evaluated the stability of alexithymia following 
therapeutic intervention and the effectiveness of several therapeutic interventions in reducing 
alexithymia levels. A comprehensive and systematic review of the literature will help to 
clarify the most effective therapeutic interventions that are currently available as well as 
provide more compelling recommendations for clinicians and future researchers working in 
psychiatric settings about how to improve alexithymic features in psychiatric patients. 
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It should be noted that Kojima (2012) conducted a recent review of the prognostic 
value of alexithymia among clinical populations. However, it was judged that the focus and 
inclusion criteria of the present review differed significantly enough to be carried out. For 
example, the present review focused on the role of alexithymia in therapeutic intervention 
rather than the influence of alexithymia on prognosis of psychopathology. In addition, the 
present search criteria included psychiatric samples exclusively rather than clinical samples 
in general (i.e., medical and psychiatric). Therefore, the present review offers a broader 
insight into the role of alexithymia in the therapeutic process and is more specific to the 
psychiatric population. 
Method 
Search 
A systematic search was conducted through Medline, ProQuest Psychology Journals, 
and Web of Science databases to obtain potentially relevant articles. The database searches 
were supplemented by searching Google Scholar for relevant articles and by crosschecking 
the articles that were included in the previous systematic review (Chapter 2). All databases 
were searched using combinations of the following keywords: alexithymia, treatment 
outcome, stability, and TAS-20. The title and abstract of the identified articles were then 
screened for relevance against the inclusion and exclusion criteria. If abstracts were not 
available or unable to provide sufficient information, the full-text article was retrieved and 
screened in the same manner. 
Inclusion and Exclusion Criteria 
For inclusion, studies were required to: (1) include adults (≥ 18 years old), (2) 
measure alexithymia using the total TAS-20 score, (3) include psychiatric participants, and 
(4) be published in the English language. Studies involving participants diagnosed with 
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organic mental disorders (e.g., dementia), mental retardation, developmental disorders, or 
physiological conditions as the primary diagnosis were excluded. Also excluded, were studies 
examining change in categories of alexithymia exclusively without examining change in 
alexithymia scores because categorical changes in alexithymia can give a misleading 
impression of instability since alexithymia scores bordering a category would only need to 
change slightly to move into another category (Luminet et al., 2001). The census data for 
inclusion ranged from 1994 to 2014. 
Data Extraction 
Data from the selected studies were independently extracted onto a standardised form 
developed for this review. The following data were extracted: author(s) and date, country of 
the study, characteristics of participants (sample size and psychiatric diagnosis), treatment 
approach, format (individual or group), method (whether the study used comparative or 
control groups), outcome measure(s), and study findings (which included information about 
the form of stability examined and whether the study accounted for change in clinical 
symptoms). This information is summarised in two tables: Table 3 presents the data from 
studies that examined the impact of alexithymia on therapeutic outcome and Table 4 presents 
the data from studies that examined the stability or change in alexithymia following 
treatment. In addition, the recruitment setting and treatment specifications (duration of 
treatment and individual sessions) for each study were extracted (recruitment setting data not 
shown in tables). 
Results 
The search effort resulted in 177 citations. Twelve duplicate citations were removed 
and 118 citations were excluded as irrelevant after they were screened for potential relevance 
as based on the inclusion and exclusion criteria. The remaining 47 full-text articles were 
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assessed for eligibility. Sixteen studies were excluded for the following reasons: five studies 
were follow-up studies that shared a participant sample with a study that was already 
included in the present review (Honkalampi, Hintikka, Antikainen, Lehtonen, & Viinamäki, 
2001; Honkalampi et al., 2007; Honkalampi, Hintikka, Laukkanen, et al., 2001; Rufer et al., 
2006; Saarijärvi, Salminen, & Toikka, 2006), four studies examined TAS-20 factors only 
rather than total TAS-20 score (De Gucht, Fischler, & Heiser, 2004; McCallum, Piper, 
Ogrodniczuk, & Joyce, 2003; Ogrodniczuk et al., 2004, 2005), three studies were not 
prospective (Carton et al., 2010; Chen et al., 2011; Coriale et al., 2012), two studies examined 
alexithymia at baseline only (Joyce, O'Kelly, Ogrodniczuk, Piper, & Rosie, 2012; Viinamäki 
et al., 2003), one study examined change in TAS-20 categories exclusively (Honkalampi, 
Hintikka, Saarinen, et al., 2000), and one study examined change in TAS-20 scores in 
remitted patients only rather than the whole patient sample (Marchesi et al., 2005). Cleland, 
Magura, Foote, Rosenblum, and Kosanke (2005) published a second study (Rosenblum et al., 
2005) that involved the same sample but they examined and reported on different aspects of 
alexithymia and therapeutic outcome, and thus these studies were counted as two separate 
studies in the present review. In addition, Speranza, Loas, Guilbaud, and Corcos (2011) 
extended their earlier study (Speranza et al., 2007) by examining whether treatment approach 
influenced alexithymia stability. Their latter study was not counted as a separate study in the 
present review, but the findings were noted in the results column of the 2007 study. After this 
process of eligibility, 31 relevant studies were retained for review. Of these 31 studies, 16 
studies examined the role of alexithymia in therapeutic outcome (the impact of alexithymia 
on treatment outcome), 24 studies examined the stability or change in alexithymia following 
therapeutic intervention (the impact of treatment on change in alexithymia), and 9 studies 
examined both the role of alexithymia in therapeutic outcome and change in alexithymia 
following therapeutic intervention. 
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Characteristics of the Studies Examining Alexithymia and Therapeutic Outcome 
Most of the 16 studies that examined the influence of alexithymia on therapeutic 
outcome were undertaken in Europe (n = 9) and involved sample sizes smaller than 100 
participants (n = 10). The size of the samples ranged from 32 to 297 (median = 77.5). The 
studies involved psychiatric samples with the following diagnoses: addictive disorders (n = 
6), anxiety disorders (n = 3), varied diagnoses (i.e., general psychiatric samples, n = 4), 
depressive disorders (n = 2), and somatoform disorders (n = 1). The study samples were 
recruited from outpatient settings (n = 9), inpatient settings (n = 4), and hospitals and/or 
clinics (n = 2). One study did not specify a recruitment setting. All of the studies reported that 
the therapeutic interventions employed were effective at reducing clinical symptomatology in 
patient samples. 
The formats of treatment employed in the present studies were group therapy (n = 8), 
individual therapy (n = 2), and a combination of group and individual therapy (n = 3). Three 
studies did not specify a treatment format. Approaches to treatment included CBT (n = 6), 
psychodynamic psychotherapy (n = 3), CBT or a motivational intervention (n = 2), 
unspecified psychotherapy (n = 2), pharmacotherapy (n = 1), pharmacotherapy with exposure 
techniques (n = 1), and psychoeducation with assertiveness training (n = 1). Half of the 
studies conducted treatments that ran for less than 12 weeks, ranging between 5 to 10 weeks 
and half of the studies conducted treatments that ran for 12 weeks or more, ranging between 
12 to 18 weeks. Two studies did not specify the duration of treatment. Ten studies specified 
the number of days per week sessions were conducted (ranging between 1 to 7 days per 
week) and seven studies specified session duration (ranging between 1 to 9 hours per 
session). Eight studies used specific measures of therapeutic outcome relevant to psychiatric 
diagnosis (e.g., Beck Depression Inventory, Beck, Steer, & Brown, 1996), four studies used 
general outcome measures such as those assessing psychological distress (e.g., Global 
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Severity Index, Derogatis, 1983), and four studies used a combination of specific and general 
measures of therapeutic outcome. 
All of the studies that examined the influence of alexithymia on therapeutic outcome 
employed a prospective research design. Four studies involved longitudinal follow-up periods 
of 3 months (Ogrodniczuk et al., 2012), 6 months (Rufer et al., 2010), and 12 months (de 
Haan, Schellekens, et al., 2012; Spek et al., 2008). One study employed an experimental 
research design with a control group (Reese, 2008). Two studies employed a comparative 
research design, yet only one of these studies examined the influence of alexithymia on 
therapeutic outcome between the treatment conditions (Rosenblum et al., 2005). 
The Influence of Alexithymia on Therapeutic Outcome 
It is important to note that the studies that found alexithymia to have a negative 
influence on therapeutic outcome(s) refer to findings that higher alexithymia scores 
correlated with lower outcome scores or that alexithymic patients produced less improvement 
in outcomes compared to non-alexithymic patients. This is different to finding that 
alexithymic patients, or patients with higher alexithymia scores, made no therapeutic gains or 
that they reported greater clinical symptomatology after treatment than at the beginning of 
treatment. Moreover, no study in the present review found that higher alexithymia scores 
were associated with better therapeutic outcome. 
Of the 16 studies that examined the influence of alexithymia on therapeutic outcome, 
2 studies found that higher levels of alexithymia before treatment had a negative influence on 
therapeutic outcome. Six of the remaining studies that were reviewed found that higher levels 
of alexithymia had a negative influence on some therapeutic outcomes (i.e., these studies 
reported mixed findings) and eight studies found that alexithymia had no influence on 
therapeutic outcome. 
 77 
 
The two studies that found higher alexithymia levels before treatment to have a 
negative influence on therapeutic outcome examined categorical levels of alexithymia (TAS-
20 scores ≥ 61) on therapeutic outcome. Grabe et al. (2008) conducted a study on 297 general 
psychiatric inpatients who were treated with 8 to 12 weeks of psychodynamic group 
psychotherapy. In this study, patients identified as alexithymic had significantly higher 
psychological distress scores before, during, and after treatment compared to the non-
alexithymic patients. Özsahin et al. (2003) conducted a study on 65 patients diagnosed with 
depression who were treated with 10 weeks of pharmacotherapy and found that although 
alexithymic patients and non-alexithymic patients had similar levels of depression before 
treatment, the alexithymic patients reported significantly smaller reductions in depression 
severity after treatment compared to the non-alexithymic patients. In addition, higher 
alexithymia scores before treatment were found to significantly predict higher depression 
scores after treatment. 
The six studies that reported mixed findings regarding the influence of alexithymia on 
therapeutic outcome employed a variety of therapeutic approaches that most commonly 
involved CBT (n = 3). The average duration of treatment across the studies that reported 
mixed findings was 10 weeks (ranging between 10 and 12 weeks). In addition, all of these 
studies were primarily conducted in North America and involved patients diagnosed with 
addictive disorders. One of these studies conducted a 3 month follow-up assessment of 68 
general psychiatric patients treated with intensive integrated therapy (Ogrodniczuk et al., 
2012). Ogrodniczuk et al. (2012) found that, after controlling for change in depression 
severity, less improvement in alexithymia over the course of treatment was associated with 
less improvement in interpersonal problems after treatment and with higher levels of 
aggression at the 3 month follow-up. However, alexithymia during the treatment period 
(measured at pre, post, and change score from pre to post treatment) was not associated with 
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interpersonal problems at the 3 month follow-up. One study in the present review examined 
the impact of alexithymia after treatment on therapeutic outcome (Fukunishi, Kikuchi, et al., 
1997). In this study, patients who were identified as alexithymia after treatment reported 
significantly greater anxiety severity compared to patients who were non-alexithymic after 
treatment. 
The eight studies that found alexithymia to have no influence on therapeutic outcome 
involved CBT (n = 5), psychodynamic psychotherapy (n = 2), and intensive psychotherapy (n 
= 1). The average duration of treatment in these studies was 10 weeks (ranging between 5 and 
18 weeks). These studies were conducted primarily in Europe and involved various 
diagnostic samples. Four of the five studies that employed CBT conducted follow-up 
assessments. These studies found alexithymia to have no impact on therapeutic outcome at 6 
month (Rufer et al., 2010) and 12 month follow ups (de Haan, Schellekens, et al., 2012; 
Reese, 2008; Spek et al., 2008). 
There were two studies in the present review that examined the influence of 
alexithymia on therapeutic outcome using a control or comparative condition (Reese, 2008; 
Rosenblum et al., 2005). Reese (2008) conducted a study involving 84 patients diagnosed 
with somatoform disorders who were treated with either 10 weeks of CBT or a control 
condition that involved regular visits to their primary care physician. Alexithymia was not 
found to be a mediator in the association between treatment type and therapeutic outcome 
(somatisation symptoms, physical functioning, and mental health). Reese concluded that 
alexithymia could not account for the difference in effectiveness of CBT, compared to the 
control condition, in modifying therapeutic outcomes. Rosenblum et al. (2005) conducted a 
study involving 186 patients diagnosed with substance misuse disorders who were treated 
with either 10 weeks of CBT or motivational intervention. Alexithymia was not shown to 
moderate the differences in addiction severity after treatment between the treatment 
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conditions. However, patients with higher levels of alexithymia before treatment abstained 
from alcohol for shorter periods following motivational intervention compared to CBT.
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Table 3 
Influence of Alexithymia on Therapeutic Outcome 
Reference Country Sample Treatment Outcome measure Results 
Balestrieri, Isola, 
Baiano, and Ciano 
(2013) 
Italy 98 binge eating 
disorder and eating 
disorders not 
otherwise specified 
outpatients 
Psychoeducation and 
assertiveness training (10 
weeks, 1x p/week for 1.5 
hours) 
Eating disorder symptoms - 
subscales body 
dissatisfaction and bulimia 
(EDI-BD and EDI-BU); 
mean body mass index 
(BMI); median weekly 
frequency of binges; 
recovery (proportion of 
patients without diagnosis) 
Pre TAS-20 ≠ Δ MI, ΔEDI-BD, 
ΔEDI-BU, frequency of binges; 
lower pre TAS-20 scores ~ 
recovery 
Becker-Stoll and 
Gerlinghoff (2004) 
Germany 47 eating disorder 
outpatients (female) 
Intensive group 
psychotherapy (16 weeks, 7x 
p/week, from 08:00 to 17:00 
hours) 
Eating disorder symptoms 
(EDI); recovery score
a
 
(higher = better recovery); 
prognosis score
a
 (higher = 
better prognosis)  
Pre TAS-20 ≠ any outcome 
variable 
Cleland et al. (2005ᵇ) USA 186 substance misuse 
outpatients 
(1) group CBT or (2) group 
motivational intervention 
(10 weeks, 2x p/week); data 
collected at pre and post 
treatment 9-21 weeks 
(average 15 weeks) 
Addiction Severity Index for 
alcohol and drug use (ASI); 
therapeutic alliance (HAQ) 
Higher pre TAS-20 predicted 
higher ASI alcohol, ≠ ASI drugs; 
higher pre TAS-20 ~ lower HAQ 
scores 
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Table 3 (continued) 
Reference Country Sample Treatment Outcome measure Results 
de Haan, 
Schellekens, et al. 
(2012) 
Netherlands 100 alcohol 
dependent 
inpatients (male) 
One month detox before 
inpatient group therapy: 
cognitive behavioural 
approach; data collected at 
12 month follow up 
Abstinence one month 
before follow up; ≤ 5 units 
of alcohol use p/day over 
12 months before follow 
up; time in treatment; 
improvement on 
EuropASI domains 
Alcohol, Psychiatry, and 
Drugs 
Pre TAS-20 ≠ any outcome measures at 12 
month follow up 
Fukunishi, Kikuchi, 
et al. (1997) 
Japan 50 anxiety disorder 
patients 
Pharmacotherapy and 
repeated hyperventilation 
provocations and 
respiratory training 
combined with exposure 
in vivo (12 weeks, 1x 
p/week) 
Severity of anxiety 
(HAM-A); severity of 
depression (HAM-D) 
Higher pre TAS-20 ~ higher post HAM-A, 
≠ HAM-D; alexithymic patients post 
treatment ~ higher post HAM-A 
Grabe et al. (2008) Germany 297 general 
psychiatric 
inpatients 
Psychodynamic group 
therapy (8-12 weeks, 3x 
p/week for 1.5hrs); data 
collected at pre, during (4 
weeks), and post 
treatment; individual 
therapy (1hr p/week) 
General psychological 
distress (GSI) 
Alexithymics (TAS-20 ≥ 61) had higher 
GSI pre, during, and post treatment 
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Table 3 (continued) 
Reference Country Sample Treatment Outcome measure Results 
Joyce et al. (2013) Canada 32 general 
psychiatric 
outpatients 
(1) psychodynamic group 
psychotherapy (18 weeks); 
(2) 73% patients had 
concomitant 
pharmacotherapy 
Symptom distress, 
interpersonal 
relationships, social role 
performance and global 
functioning (OQ-45); 
interpersonal distress 
(IIP); quality of life 
(QOLI) 
Controlling for trait anxiety, pre TAS-20 ≠ 
any outcome measures 
Ogrodniczuk et al. 
(2012) 
Canada 68 general 
psychiatric 
outpatients 
Intensive integrated group 
therapy (12 weeks, 5x 
p/week, for 3hrs); data 
collected at pre and post 
treatment, and 3 month 
follow up 
Interpersonal problems 
(IIP-28) total score and 
subscales: Interpersonal 
Sensitivity, Interpersonal 
Ambivalence, and 
Aggression 
Controlling for Δ depression, pre to post 
ΔTAS-20 ~ pre to post ΔIIP-28 scores and 
lower Aggression (IIP-28 subscale) at 
follow up; post to follow-up ΔTAS-20 ~ 
post to follow-up ΔIIP-28 scores; pre, post, 
or ΔTAS-20 ≠ IIP-28 scores at follow-up 
Özsahin et al. 
(2003) 
Turkey 65 depressive 
outpatients 
Pharmacotherapy (SSRI 
20mg/day for 10 weeks)  
Severity of depression 
(HAM-D) 
Higher pre TAS-20 ~ higher post HAM-D 
Reese (2008) USA 84 somatoform 
disorder patients 
(1) individual CBT or (2) 
control: primary care 
physician medical 
treatment as usual (10 
weeks, 1x p/week, for1hr); 
data collected at pre and 
post treatment, and 6 and 
12 month follow up 
Somatisation symptoms 
(CGI); physical 
functioning & mental 
health (SF-36) 
Pre TAS-20 not mediator of ~ between 
treatment and outcomes 
 83 
 
Table 3 (continued) 
Reference Country Sample Treatment Outcome measure Results 
Rosenblum et al. 
(2005ᵇ) 
USA 186 substance 
misuse outpatients 
(1) group CBT or (2) 
group motivational 
intervention (10 weeks, 2x 
p/week); data collected at 
pre and post treatment 9-
21 weeks  (average 15 
weeks) 
Addiction Severity Index 
for alcohol and drug use 
(ASI); days abstinent 
(TLFB method) 
Pre TAS-20 moderated abstinence but not 
ASI in type of therapy: higher pre TAS-20 
~ higher abstinence after group CBT vs. 
group motivational intervention 
Rufer et al. (2004) Germany 42 obsessive-
compulsive 
disorder inpatients 
(1) individual and group 
CBT (mean 10 weeks, 
individual 3-4x p/week + 
group unspecified; (2) 
60% patients had 
concomitant 
pharmacotherapy (SSRI)  
OCD symptoms (Y-BOCS 
change scores) 
Pre TAS-20 ≠ ΔY-BOCS 
Rufer et al. (2010) Germany 55 panic disorder 
outpatients 
(1) short-term group CBT 
(5 weeks, 1x p/week, for 
2.5 hrs); (2) 35% patients 
had concomitant 
pharmacotherapy; data 
collected at pre and post 
treatment, and 6 month 
follow up 
Panic and agoraphobia 
symptoms (PAS); global 
improvement (CGI) 
Pre TAS-20 ≠ post or follow up PAS or 
CGI 
Spek et al. (2008) Netherlands 119 sub-threshold 
depressive patients 
CBT; data collected at pre 
and post treatment, and 1 
year follow up 
Depression severity (BDI) Pre TAS-20 ≠  DI post or follow up 
C. Spitzer et al. 
(2005) 
Germany 100 general 
psychiatric 
inpatients 
Psychodynamic group 
therapy (mean 6 weeks, 3x 
p/week, for 1hr) 
Interpersonal functioning 
(IIP-C); post scores and 
change scores 
Pre TAS-20 category ≠ post IIP-C or ΔIIP-
C 
 84 
 
Table 3 (continued) 
Reference Country Sample Treatment Outcome measure Results 
Stasiewicz et al. 
(2012) 
USA 71 alcohol 
dependent 
outpatients 
(1) group CBT plus one of 
two treatment enhancers: 
(a) affect regulation 
training, or (b) health and 
lifestyle (12 weeks, 1x 
p/week) 
Alcohol dependence 
severity (SADD); 
drinking-related negative 
consequences (DrInC); 
drinks per drinking day; 
percent days heavy 
drinking 
Controlling for anxiety, depression, pre-
treatment scores, and number of sessions 
attended, higher pre TAS-20 ~ higher post 
SADD, but no other outcome measure 
Note. ≠ = no association; ~ = association; Δ = change score from pre to post treatment; ASI = Addiction Severity Index (McLellan et al., 1992); BDI = Beck Depression 
Inventory (Beck et al., 1996); CGI = Clinical Global Impression Scale (Guy, 1976); DrInC = The Drinker Inventory of Consequences (W. R. Miller, Tonigan, & 
Longabaugh, 1995); EDI = Eating Disorder Inventory (Garner, Olmstead, & Polivy, 1983); EuropASI = European Addiction Severity Index (Hendriks, Kaplan, van Limbeek, 
& Geerlings, 1989); GSI = Global Severity Scale (Derogatis, 1983); HAM-A = Hamilton Anxiety Rating Scale (Hamilton, 1959); HAM-D = Hamilton Depression Rating 
Scale (Hamilton, 1960); HAQ = Helping Alliance Questionnaire (Luborsky et al., 1996); IIP = The Inventory of Interpersonal Problems (L. M. Horowitz, Rosenberg, Baer, 
Ureño, & Villaseñor, 1988); IIP-C = The Inventory of Interpersonal Problems-Circumplex Scales (L.M. Horowitz, Alden, Wiggins, & Pincus, 2000); IIP-28 = Inventory of 
Interpersonal Problems-28 (Stern, Kim, Trull, Scarpa, & Pilkonis, 2000); OQ-45 = The Outcome Questionnaire-45 (Asay, Lambert, Gregersen, & Goates, 2002); PAS = The 
Panic and Agoraphobia Scale (Bandelow, 1995); QOLI = The Quality of Life Inventory (Lehman, 1996); SADD = The Short Alcohol Dependence Data Questionnaire 
(Davidson & Raistrick, 1986); SF-36 = Short-Form Health Survey (Ware & Sherbourne, 1992); TLFB = Time-Line Follow-Back (Sobell & Sobell, 1992); Y-BOCS = Yale-
Brown Obsessive Compulsive Scale (Goodman et al., 1989). 
a
Recovery scores based on improvement in body mass index and/or frequency of bingeing and/or vomiting p/week; prognosis scores based on danger of relapse. 
b
These studies shared data, but were counted as two separate studies as they assessed different therapeutic outcomes. 
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Characteristics of the Studies Examining Change in Alexithymia 
The majority of the 24 studies that examined change in alexithymia following 
therapeutic intervention were undertaken in Europe (n = 13) and involved sample sizes 
smaller than 100 patients. The sample sizes ranged from 3 to 297 (median = 61.5). The 
studies involved psychiatric samples with the following primary diagnoses: addictive 
disorders (n = 10), varied diagnoses (i.e., general psychiatric samples, n = 5), anxiety 
disorders (n = 4), depressive disorders (n = 2), somatoform disorders (n = 2), and 
schizophrenia (n = 1). The study samples were recruited from outpatient settings (n = 10), 
inpatient settings (n = 7), hospitals and/or clinics (n =6), and community advertisement (n = 
1). 
Most studies did not specify a treatment format. However, the studies that did specify 
a treatment format employed group therapy (n = 5), individual therapy (n = 3), and a 
combination of group and individual therapy (n = 3). Approaches to treatment included CBT 
(n = 6), naturalistic and non-active approaches (e.g., detoxification, n = 4), psychoeducation 
with assertiveness training or behavioural management skills (n = 2), pharmacotherapy (n = 
2), and eight studies used a variety of other therapeutic approaches (including a 12-step 
program, psychodynamic psychotherapy, unspecified psychotherapy, pharmacotherapy with 
exposure techniques, a targeted treatment for alexithymia, affect school therapy, and an 
interpretive or supportive psychotherapy condition). Two of the studies reviewed did not 
specify a treatment approach. Most of the studies conducted treatments that ran for less than 
12 weeks (n = 11), ranging from 2 to 12 weeks. Five studies did not specify the duration of 
treatment. Eleven studies specified the number of days per week that sessions were conducted 
(ranging between 1 to 7 days per week) and seven studies specified session duration (ranging 
between 50 minutes to 9 hours per session). 
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All of the studies that examined change in alexithymia employed a prospective 
research design. Eight studies were longitudinal and involved follow-up periods of 2 to 3 
months (Clyne & Blampied, 2004), 3 months (Ogrodniczuk et al., 2012), 6 months 
(Ogrodniczuk et al., 2013; Rufer et al., 2010), 12 months (Kennedy & Franklin, 2002; Reese, 
2008), or numerous follow up periods of 3 to 12 months (Todarello et al., 2005) and 6 to 24 
months (Honkalampi et al., 2004). One study employed an experimental research design with 
a control group (Reese, 2008) and one study employed a comparative research design 
(Ogrodniczuk et al., 2013). One study employed a case-series design that involved three 
patients (Kennedy & Franklin, 2002). 
Stability and Treatment of Alexithymia 
All of the 24 studies that examined change in alexithymia following therapeutic 
intervention assessed mean-level stability. Relative stability was assessed in 12 of these 
studies in addition to mean-level stability. In addition, 14 of the studies that examined change 
in alexithymia following therapeutic intervention took into account change in clinical 
symptoms. All together, 20 studies found mean-level instability or change in alexithymia 
scores following treatment. The remaining four studies found mean-level stability, or no 
change, in alexithymia scores following treatment. 
Of the 20 studies that reported mean-level change in alexithymia over time, 9 studies 
examined whether this change was dependent of the severity of clinical symptoms. Two 
studies found significant moderate to large positive correlations (according to Cohen, 1988) 
between alexithymia change scores and clinical severity change scores (Baker et al., 2012; 
Fukunishi, Kikuchi, et al., 1997). However, the other seven studies found that mean-level 
change in alexithymia was independent of baseline clinical severity (Rufer et al., 2010) or 
change in clinical severity (Ogrodniczuk et al., 2013), and that change in clinical severity 
accounted for a non-significant amount of variance in alexithymia change (de Timary et al., 
 87 
 
2008; Luminet et al., 2001; Melin et al., 2010; Ogrodniczuk et al., 2012) or a small amount of 
variance in alexithymia change (16%, Grabe et al., 2008). 
Three of the four studies that found mean-level stability in alexithymia showed that 
alexithymia scores remained stable despite significant decreases in clinical symptomatology 
during the same period (Picardi et al., 2012; Rufer et al., 2004; Todarello et al., 2005). The 
other study that found mean-level stability in alexithymia showed that, while depression 
severity decreased over time, alexithymia and general psychopathology severity remained 
stable (Pinard et al., 1996). These studies involved small sample sizes (≤ 42), which were 
below the median sample size of the studies in the present review. Sample size was the only 
factor to differentiate the studies that found change in alexithymia scores across time from 
those that did not; factors such as the country of the study, sample diagnosis, recruitment 
setting, or duration of treatment were similarly varied across all of the studies that examined 
change in alexithymia. 
Relative stability in alexithymia was reported by 100% of the 12 studies that assessed 
it. Three studies confirmed the relative stability of alexithymia during follow up periods of 6 
months (Rufer et al., 2010), 12 months (Todarello et al., 2005), and 3 years (Speranza et al., 
2007). 
Seven of the 12 studies also examined factors that could impact on the relative 
stability of alexithymia. Using regression analyses, all of these studies showed that 
alexithymia before treatment was the best predictor of alexithymia after treatment compared 
to various measures of clinical severity assessed before and after treatment, such as 
depression severity (de Haan, Joosten, et al., 2012; de Haan et al., 2014; de Timary et al., 
2008; Grabe et al., 2008; Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005). 
There were two studies in the present review that examined change in alexithymia 
using a control or comparative condition (Ogrodniczuk et al., 2013; Reese, 2008). These 
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studies showed significant declines in alexithymia scores across all treatment conditions. 
However, even greater declines in alexithymia scores were observed following particular 
treatment conditions. Reese (2008) found a significant decline in alexithymia scores in both a 
CBT and control condition during treatment and at 12 month follow up. While significantly 
greater declines in alexithymia scores were found in the CBT condition during treatment 
compared to the control condition, from post treatment to 12 month follow up there was no 
difference in the amount of change in alexithymia between the treatment conditions. 
Ogrodniczuk et al. (2013) obtained similar findings in 112 general psychiatric patients when 
comparing supportive and interpretive psychotherapy conditions. While alexithymia scores 
declined significantly from before to after 20 weeks of treatment in both conditions, there 
was a significantly greater decline in alexithymia scores from before to after treatment in the 
supportive psychotherapy condition. However, despite further decreases in alexithymia 
scores at 6 month follow up, there was no difference between the treatment conditions in the 
amount of change in alexithymia scores during this time.
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Table 4 
Change in Alexithymia Following Treatment 
Reference Country Sample Treatment Results 
Akkerman (1996) USA 139 substance 
misuse inpatients
a
 
12-step program with AA components (7-
10 days of detox then 26-30 day treatment) 
Mean instability 
Baker et al. 
(2012) 
United Kingdom 55 general 
psychiatric patients 
Individual CBT; unspecified duration Mean instability; ΔTAS-20 ~ Δ SI 
Balestrieri et al. 
(2013) 
Italy 98 binge eating 
disorder and eating 
disorders not 
otherwise specified 
outpatients 
Psychoeducation and assertiveness 
training (10 weeks, 1x p/week for 1.5 
hours) 
Mean instability 
Becker-Stoll and 
Gerlinghoff 
(2004) 
Germany 47 eating disorder 
outpatients (female) 
Intensive group psychotherapy (16 weeks, 
7x p/week from 08:00 to 17:00 hours) 
Mean instability; relative stability 
Clyne and 
Blampied (2004) 
New Zealand 11 binge eating 
disorder participants
b
 
(female) 
Group psychoeducation and behavioural 
management (11 weeks, 1x p/week for 
2hrs); data collected at pre and post, and 2-
3 month follow up 
Mean instability at each study phase 
de Haan, Joosten, 
et al. (2012) 
Netherlands 140 substance use 
disorder inpatients 
Individual and group CBT for 3 months; 
some patients received additional 5 
sessions of CBT with motivational 
interviewing, relapse prevention, and 
social skills training 
Mean instability and relative stability; pre TAS-20 
score predicted post TAS-20 score over and above 
clinical symptoms of anxiety and depression; 
intervention type did not account for change in 
TAS-20 
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Table 4 (continued) 
Reference Country Sample Treatment Results 
de Haan et al. 
(2014) 
Netherlands 101 substance use 
disorder inpatients 
Detoxification (2-3 weeks, average 14 
days); pharmacotherapy in first few 
days (benzodiazepines and/or 
methadone) 
Mean instability and relative stability; pre TAS-20 score 
predicted post TAS-20 score over and above post 
depression severity 
Fukunishi, 
Kikuchi, et al. 
(1997) 
Japan 50 anxiety disorder 
patients 
Pharmacotherapy, repeated 
hyperventilation provocations, 
respiratory training and exposure in 
vivo (12 weeks, 1x p/week) 
Mean instability; ΔTAS-20 ~ ΔHAM-A; ΔTAS-20 ≠ 
ΔHAM-D 
Grabe et al. 
(2008) 
Germany 297 general 
psychiatric 
inpatients 
Psychodynamic group therapy (8-12 
weeks, 3x p/week for 1.5hrs); data 
collected at pre, during (4 weeks), and 
post treatment; individual therapy (1hr 
p/week) 
Mean instability from pre to post, and pre to discharge; 
ΔTAS-20 ~ ΔGSI; relative stability from pre to discharge; 
pre TAS-20 best predictor of post TAS-20 
Honkalampi et 
al. (2004) 
Finland 106 depressive 
outpatients 
≥ 50% of time patients received 
pharmacotherapy, psychotherapy, and 
inpatient care; data collected at pre 
treatment and 6 month, 12 month, and 
24 month follow ups 
Mean instability at each study phase 
Kennedy and 
Franklin (2002) 
Australia Case series: 3 
anxiety disorder 
patients 
Skills-based intervention for 
alexithymia specifically (16-24 weeks, 
1x p/week); data collected at pre 
(average of 4 weeks prior to treatment 
and pre treatment), post, and 4 weeks 
post treatment, and 12 month follow up 
Mean instability from pre to post; 2/3 cases mean 
instability at 4 week post and 12 month follow up 
Luminet et al. 
(2001) 
Canada 46 depressive 
outpatients 
Pharmacotherapy (antidepressants); 
data collected at pre treatment and 14 
week follow up 
Mean instability; ΔTAS-20 ≠ ΔHAM-D; relative stability; 
pre TAS-20 best predictor of post TAS-20 
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Table 4 (continued) 
Reference Country Sample Treatment Results 
Melin et al. 
(2010) 
Sweden 46 somatoform 
disorder outpatients 
(chronic benign 
pain) 
(1) Affect School group therapy (8 
weeks, 1x p/week); (2) 22% had 
concomitant pharmacotherapy 
(antidepressants) 
Mean instability; ΔTAS-20 ≠ ΔHAD-D 
Ogrodniczuk et 
al. (2013) 
Canada 112 general 
psychiatric 
outpatients 
(1) interpretive individual 
psychotherapy or (2) supportive 
individual psychotherapy (20 weeks, 1x 
p/week, for 50mins); data collected at 
pre and post treatment, and 6 month 
follow up 
Mean instability during each study phase and therapy type, 
after controlling for pre to 6 month follow up Δ DI; pre to 
post TAS-20 > decline in supportive vs. interpretive 
therapy; post to follow up TAS-20 ≠ between therapy 
types 
Ogrodniczuk et 
al. (2012) 
Canada 68 general 
psychiatric 
outpatients 
Intensive integrated group therapy (12 
weeks, 5x p/week for 3hrs); data 
collected at pre and post treatment, and 
3 month follow up 
Mean instability from pre to post; pre to post ΔTAS-20 ≠ 
pre to post Δ DI; stability from post to 3 month follow up 
Picardi et al. 
(2012) 
Italy 41 general 
psychiatric 
inpatients 
Unspecified treatment (average 8 
weeks, ± 32.6 days) 
Mean and relative stability for both groups; pre TAS-20 
best predictor of post TAS-20 
Pinard et al. 
(1996) 
Canada 21 substance 
dependent patients 
Detoxification (4-6 weeks, average 36.6 
days) 
Mean stability; ΔTAS-20 ~ Δ DI and ΔGSI 
Reese (2008) USA 84 somatoform 
disorder patients 
(1) individual CBT or (2) control: 
primary care physician medical 
treatment as usual (10 weeks, 1x 
p/week, for1hr); data collected at pre 
and post treatment, and 6 and 12 month 
follow up 
Mean instability from pre to post: pre to post TAS-20 > 
decline in treatment vs control; relative stability from pre 
to post in both groups; post to follow up TAS-20 ≠ 
between groups 
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Table 4 (continued) 
Reference Country Sample Treatment Results 
Rufer et al. 
(2010) 
Germany 55 panic disorder 
outpatients 
(1) short-term group CBT (5 weeks, 1x 
p/week, for 2.5 hrs); (2) 35% patients 
had concomitant pharmacotherapy; data 
collected at pre and post treatment, and 
6 month follow up 
Mean instability from pre to post and pre to follow up, 
after controlling for BDI; relative stability from pre to post 
and post to follow up 
Rufer et al. 
(2004) 
Germany 42 obsessive-
compulsive 
disorder inpatients 
(1) individual and group CBT (mean 10 
weeks, individual 3-4x p/week + group 
unspecified; (2) 60% patients had 
concomitant pharmacotherapy (SSRI) 
Mean stability and relative stability  
Speranza et al. 
(2007ᶜ) 
France 102 eating 
disorders patients 
(female) 
Unspecified treatment: 57% 
psychotherapy, 40% pharmacotherapy, 
and/or combination of these; data 
collected at pre treatment and 3 year 
follow-up 
Mean instability and relative stability; independent of 
treatment type (Speranza et al., 2011) 
Stasiewicz et al. 
(2012) 
USA 71 alcohol 
dependent 
outpatients 
(1) group CBT plus one of two 
treatment enhancers: (a) affect 
regulation training, or (b) health and 
lifestyle (12 weeks, 1x p/week) 
Mean instability in both samples 
de Timary et al. 
(2008) 
Belgium 70 alcohol 
dependent 
inpatients 
Detoxification (14-18 days); 
pharmacotherapy in first 48hrs 
(benzodiazepines) 
Mean instability; ΔTAS-20 ≠ Δ DI or ΔSTAI-S; relative 
stability; pre TAS-20 best predictor of post TAS-20 
Todarello et al. 
(2005) 
Italy 29 schizophrenic 
outpatients 
Pharmacotherapy (antipsychotics, 
antidepressants, and/or mood 
stabilisers); data collected at pre 
treatment and 3, 6, and 12 month follow 
ups 
Mean stability at 3, 6, and 12 month follow ups; relative 
stability from pre to 12 month follow up; pre TAS-20 best 
predictor of post TAS-20 
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Table 4 (continued) 
Reference Country Sample Treatment Results 
Note. AA = alcoholics anonymous; ≠ = no association; ~ = association; Δ = change score from pre to post treatment; BDI = Beck Depression Inventory (Beck et al., 1996); 
HAD-D = Hospital Anxiety and Depression Scale – depression subscale (Zigmond & Snaith, 1983); HAM-A = Hamilton Anxiety Rating Scale (Hamilton, 1959); HAM-D = 
Hamilton Depression Rating Scale (Hamilton, 1960); GSI = Global Severity Index (Derogatis, 1983); STAI-S = State-Trait Anxiety Inventory – state portion (Spielberger, 
1983). 
a
68 patients completed post-tests.
 
b
Participants were recruited via community advertisement and then diagnosed using The Binge Eating Scale (Gormally, Black, Daston, & Rardin, 1982) and The 
Questionnaire on Eating and Weight Patterns (R. L. Spitzer et al., 1993). 
c
This study published follow up data, which is presented in the corresponding results column. 
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Discussion 
Assumptions about the role of alexithymia in the therapeutic process have been 
widely debated in the literature and infrequently investigated. A systematic literature review 
was carried out to evaluate the influence of alexithymia on therapeutic outcome, to 
investigate the stability of alexithymia during therapeutic intervention, to evaluate the 
efficacy of different therapeutic approaches that are currently available to improve 
alexithymic features in psychiatric patients, and to provide more compelling 
recommendations for clinicians and future researchers working with alexithymic patients. 
The studies in the present review were evenly divided between those that found 
higher levels of alexithymia to have a negative influence on all or some therapeutic outcomes 
and those that found alexithymia to have no influence on therapeutic outcomes. The studies 
that conducted follow-up assessments also presented conflicting findings, with one study 
finding that change in alexithymia scores during treatment had a negative influence on 
patients’ aggression levels 3 months after treatment  (Ogrodniczuk et al., 2012) and other 
studies finding that alexithymia scores before treatment had no influence on therapeutic 
outcome 6 to 12 months after treatment (e.g., de Haan, Schellekens, et al., 2012; Rufer et al., 
2010). No major differences were found between these groups of studies concerning the 
therapeutic approach or outcome measures that were employed. 
However, the studies that found alexithymia to have a negative influence on all or 
some therapeutic outcomes differed to the studies that found alexithymia to have no impact 
on therapeutic outcomes in terms of the psychiatric diagnosis of the study samples and the 
location where the studies were undertaken. The studies that reported alexithymia to have a 
negative influence on all or some therapeutic outcomes involved samples that were mainly 
diagnosed with addictive disorders and that were predominately undertaken in North America 
whereas the studies that found alexithymia to have no influence on therapeutic outcomes 
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involved various diagnostic samples and were predominately undertaken in European 
countries. This finding indicates that alexithymia is more problematic for patients with 
addictive disorders and for patients residing in North America in terms of the benefit they 
may receive from treatment. A probable explanation for this finding is that the greater 
proportions of alexithymic patients reported in the studies that involved patients diagnosed 
with addictive disorders and the studies that were undertaken in North America (see Chapter 
2) provided more statistical power to detect a relationship between alexithymia and 
therapeutic outcome. 
One study in the present review provided a stronger level of evidence than the other 
studies on this issue by employing a control group. Reese (2008) found that the effectiveness 
of CBT compared to a control condition in modifying therapeutic outcome was independent 
of alexithymia score. However, as the study sample was small and involved patients 
diagnosed with somatoform disorders, the generalisablity of the finding to other psychiatric 
populations may be limited. 
It was difficult to observe trends regarding whether alexithymia has more or less 
influence on therapeutic outcome following certain interventions because there was a scarcity 
of studies employing comparative conditions. The overrepresentation of CBT compared to 
other therapeutic interventions across the studies in the present review added to the 
ambiguity. Given that most of the present studies employed CBT and reported that 
alexithymia had no impact on therapeutic outcome, it is reasonable to suggest that 
alexithymia interferes less with CBT compared to other interventions. One study in the 
present review provided some evidence to support the idea that alexithymia may interfere less 
with behavioural-based treatments, such as CBT (Rufer et al., 2010). Rosenblum et al. (2005) 
found that patients with higher alexithymia scores before treatment achieved better a 
therapeutic outcome (abstaining from alcohol) following CBT compared to motivational 
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intervention. However, the lack of influence of alexithymia on therapeutic outcome does not 
appear to be specific to CBT as studies that employed numerous other interventions also 
found alexithymia to have no influence on therapeutic outcomes. Moreover, alexithymia was 
shown to have no influence on outcomes following treatments that demanded insight and 
emotional awareness from patients (psychodynamic psychotherapy, Joyce et al., 2013; C. 
Spitzer et al., 2005), and which are considered more problematic for alexithymic patients 
compare to CBT (Lumley et al., 2007; Sifneos, 1973). 
The vast majority of studies that examined change in alexithymia following 
therapeutic intervention observed mean-level change in alexithymia scores. Numerous 
treatment approaches were shown to be effective at reducing alexithymia scores, including 
CBT (e.g., Reese, 2008; Stasiewicz et al., 2012), pharmacotherapy (Luminet et al., 2001), and 
more traditional psychodynamic psychotherapies (Grabe et al., 2008). Therefore, in general, 
alexithymic patients appear to be able to improve their abilities to recognise, communicate, 
and examine their feelings following most therapeutic interventions. However, given that the 
majority of these studies involved quasi-experimental designs that did not involve control 
groups, it is not clear whether reductions in alexithymia were a result of treatment effects or 
other factors. The only study in the present review that did employ a control condition found 
that alexithymia scores declined during both CBT and the control condition (Reese, 2008). 
This finding raises the question about whether alexithymia levels are likely to decline over 
time regardless of therapeutic intervention, perhaps as a response to declines in clinical 
symptomatology. Moreover, studies that found declines in alexithymia following non-active 
therapeutic interventions, such as detoxification (de Haan et al., 2014; de Timary et al., 
2008), support the idea that change in alexithymia may be dependent on change in clinical 
symptoms. 
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Many of the studies that did investigate whether mean-level change in alexithymia 
was dependent on change in clinical symptoms showed that change in alexithymia after 
treatment was largely independent of baseline clinical severity or change in clinical 
symptoms from before to after treatment (de Timary et al., 2008; Grabe et al., 2008; Luminet 
et al., 2001; Melin et al., 2010; Ogrodniczuk et al., 2013; Ogrodniczuk et al., 2012; Rufer et 
al., 2010). The findings from these studies do not support the idea that alexithymia is merely 
a state-dependent construct (see Honkalampi, Hintikka, Saarinen, et al., 2000) that fluctuates 
alongside fluctuations in clinical states. Rather these findings indicate that reductions in 
alexithymia are more likely to result from other influences, such as treatment effects. 
The present review of the literature found that there is not enough evidence to clarify 
speculation about which treatment approaches may be more effective at reducing alexithymia 
because only one study compared the influence of different therapeutic interventions. 
Ogrodniczuk et al. (2013) found a greater decline in alexithymia following supportive 
psychotherapy compared to interpretive psychotherapy. This finding strengthens the 
proposition that supportive psychotherapy is more suited to alexithymic patients compared to 
traditional interpretive or analytic psychotherapies because supportive approaches provide 
more reassurance and less anxiety provocation, which alexithymic patients require (Sifneos, 
1975). On the other hand, in the same study Ogrodniczuk et al. (2013) also found no 
differences in the amount of change in alexithymia between supportive psychotherapy and 
interpretive psychotherapy at 6 month follow-up despite further decreases in alexithymia 
scores. Reese (2008) observed a similar finding where alexithymia scores declined more 
during CBT compared to a control condition. However, there was no difference in the amount 
of change in alexithymia between the treatment conditions from post treatment to 12 month 
follow up. The findings from these studies indicate that although alexithymia scores may be 
reduced to a greater extent during certain interventions and compared to no treatment at all, 
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once an intervention has finished so does the added benefit of that intervention for 
alexithymic patients and that the superiority of one treatment over another does not appear to 
be long lasting. 
All of the studies in the present review that examined relative stability in alexithymia 
confirmed that alexithymia was relatively stable. Several studies in the present review also 
observed relative stability in alexithymia during follow-up periods of 6 months (Rufer et al., 
2010), 12 months (Todarello et al., 2005), and 3 years (Speranza et al., 2007). In addition, all 
of the studies that went on to examine the relative stability of alexithymia in the context of 
change in clinical symptoms provided stronger evidence to support alexithymia as a stable 
personality trait by showing that the relative stability of alexithymia was independent of 
individual differences in clinical severity (de Haan, Joosten, et al., 2012; de Haan et al., 2014; 
de Timary et al., 2008; Grabe et al., 2008; Luminet et al., 2001; Picardi et al., 2012; Todarello 
et al., 2005). 
Some studies in the present review indicated that while alexithymia scores may 
decline on average for a group of patients following treatment, moderate to high levels of 
alexithymia can persist for some patients (Grabe et al., 2008) and may increase their risk of 
experiencing ongoing psychiatric symptomatology (Fukunishi, Kikuchi, et al., 1997). 
Fukunishi, Kikuchi, et al. (1997) found that although alexithymia scores declined during 
treatment, patients that remained alexithymic after treatment reported significantly greater 
anxiety severity compared to patients that were non-alexithymic after treatment. In addition, 
Ogrodniczuk et al. (2012) found that less change in alexithymia during treatment (i.e., more 
stable alexithymia) was associated with poorer therapeutic outcomes after treatment. Patients 
with persistent levels of alexithymia that remain after treatment are more likely to experience 
residual symptoms (symptoms that persist despite evident response to treatment or remission 
of mental illness) that may prolong their recovery from a psychiatric illness. 
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Limitations and Recommendations 
A delimitation of the present systematic review was a focus on the consistency of 
reported associations rather than an assessment of the strength of these associations. Thus, the 
results of studies that found large effect sizes could be masked by the results of many studies 
that found small effect sizes. In addition, the samples sizes of individual studies identified for 
this review varied from 3 to 297 and the findings from these studies were treated equally with 
this method. Further empirical examination of these data will help to substantiate the present 
findings (i.e., by conducting a meta-analysis) where issues such as sample size are accounted 
for in determining the size of effects. 
A number of limitations were observed across the majority of studies in the present 
review. In general, small sample sizes were included, which reduced the statistical power and 
generalisability of findings. The studies were predominately conducted in Europe and North 
America, and most studies involved patients diagnosed with addictive disorders. Thus, 
conclusions from the present review would be most applicable to psychiatric populations 
similar in nature to those with eating and substance use disorders and those receiving 
psychiatric treatment in Europe and North America. 
Little was known about the degree of treatment integrity involved in the present 
studies that were reviewed, as few studies assessed the extent to which interventions were 
delivered as intended, or provided detailed information about the interventions that were 
employed, including how they differed from other interventions. A lack of treatment integrity 
poses a threat to inferences drawn about the relationship between treatment and outcome as 
well as the comparative efficacy of different treatments (Bhar & Beck, 2009). The mixed 
findings in literature regarding the relationship between alexithymia and therapeutic 
intervention raise questions about treatment integrity. For example, it is not known whether 
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the present studies that employed CBT adhered to a similar CBT protocol or how many of the 
interventions delivered were unique to CBT. 
An important factor that has received little attention in the reviewed literature is the 
influence of persistent or stable levels of alexithymia after treatment on therapeutic outcome. 
Preliminary evidence suggests that patients are at greater risk of experiencing residual 
symptoms when their level of alexithymia is high after treatment (Fukunishi, Kikuchi, et al., 
1997) or changes little during treatment (Ogrodniczuk et al., 2012). Replication of these 
studies is needed to confirm whether stable levels of alexithymia influence therapeutic 
outcome. From a practical perspective, acknowledgement that alexithymic patients may be 
vulnerable to residual symptomatology following treatment may encourage clinicians to 
closely monitor their patient’s progress and help alexithymic patients to prepare and 
accommodate for such difficulties. 
Only one study in the present review employed a control condition when examining 
the influence of therapeutic intervention on change in alexithymia (Reese, 2008). 
Unfortunately, this study did not report whether there were significant reductions in clinical 
symptoms for the control group nor was there an investigation into whether the change in 
alexithymia scores was dependent on change in clinical symptoms. Therefore, there is a lack 
of experimental research to examine whether alexithymia levels are likely to decline 
regardless of therapeutic intervention or in response to a decline in clinical symptomatology. 
In addition, only three studies (Cleland et al., 2005; Ogrodniczuk et al., 2013; Rosenblum et 
al., 2005) employed different therapeutic interventions for comparison and consequently a 
detailed understanding of alexithymia’s role across different therapeutic interventions could 
not be acquired. It will be necessary for future researchers to compare different therapeutic 
approaches in order to understand whether alexithymia interferes more with particular 
approaches or whether particular approaches are more effective at reducing alexithymia. 
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Study 2 (Chapter 5) in the present thesis will contribute to this body of research by examining 
the relationship between alexithymia and two types of group therapy. 
Conclusion 
The purpose of the present literature review was to evaluate the role of alexithymia in 
the therapeutic process. It can be confidently stated that the role of alexithymia in the 
therapeutic process remains contentious. Findings from the studies that examined the 
influence of alexithymia on therapeutic outcome were divided, including findings from 
studies that employed control or comparative conditions. Half of the literature in the present 
review indicated that higher levels of alexithymia before treatment may lead to poorer 
therapeutic outcomes, particularly in patients diagnosed with addictive disorders and in 
patients receiving treatment in North America. However, robust studies with experimental 
designs are needed to corroborate these findings. In addition, speculation about whether 
alexithymia may interfere more with certain interventions remains unresolved as very few 
studies in the present review compared different therapeutic interventions. 
The literature also indicates that numerous therapeutic approaches are likely to be 
effective at improving alexithymia at a group level. However, questions remain regarding the 
most effective therapeutic approach to improve alexithymia as very few studies in the present 
review employed comparative treatment conditions. There was strong evidence in the 
literature to support the idea that alexithymia is a relative stable personality trait. Therefore, 
although alexithymia can be reduced following therapeutic intervention, some degree of 
alexithymia is likely to remain as a stable aspect of a patient’s psychology. Future studies will 
need to examine the extent of change in alexithymia compared to clinical states (e.g., effect 
sizes) in order to substantiate that alexithymia is more resistant to change following 
intervention compared to clinical states. 
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CHAPTER 4 
STUDY 1 
Alexithymia is typically more prevalent in the psychiatric population compared to the 
general community population (see Chapter 2). It has been proposed that individuals who 
experience greater difficulties identifying, communicating, and examining their inner 
thoughts and feelings are at greater risk of developing psychiatric illness (Taylor et al., 1997). 
However, even simple estimates of an alexithymic individual’s risk of developing psychiatric 
illness are problematic because rates of alexithymia in the psychiatric literature have been 
shown to vary substantially (see Chapter 2). For instance, rates of alexithymia have ranged 
from 17.6% (Müller et al., 2003) to 51.0% (Joyce et al., 2013) in studies that have involved 
general psychiatric samples. 
The majority of studies reporting on prevalence rates of alexithymia have been 
undertaken in Europe and North America. The literature review conducted in Chapter 2 noted 
that psychiatric rates of alexithymia reported in studies undertaken outside of Europe (mainly 
in North America) tended to be greater than the psychiatric rates of alexithymia reported in 
studies undertaken in Europe. There are few studies on alexithymia in the Australian 
population, and no information about the prevalence rate of alexithymia in the Australian 
general psychiatric population. Australian research evaluating the occurrence of alexithymia 
in psychiatric samples would contribute to the literature by examining where these rates fall 
in comparison to the range of alexithymia rates that have been reported globally. Research in 
this area would also provide normative information for clinicians working with psychiatric 
populations in Australia (as compared to norms derived from the original Canadian outpatient 
sample, Bagby, Parker, et al., 1994). 
Comparisons of prevalence rates of alexithymia in psychiatric and community 
populations have generally been made across international studies that have examined these 
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populations separately. Studies that compare prevalence rates of alexithymia between 
psychiatric and community samples from a common population are ideal as they reduce the 
amount of variation that is incurred between international samples, whereby the main 
difference between the samples is the presence of a psychiatric diagnosis and not numerous 
cultural differences, including social, political, historical, and economic circumstances. 
However, few researchers have compared prevalence rates of alexithymia between general 
psychiatric and community samples from one common population. 
Another way to obtain accurate estimates of prevalence rates of alexithymia is to 
consider the influence of potential confounding factors on alexithymia, such as demographic 
differences in study samples. Previous researchers have suggested that higher rates of 
alexithymia are found in certain demographic groups, such as males (e.g., Levant, 1992). 
However, the literature review reported on in Chapter 2 revealed many inconsistencies in the 
literature regarding the relation between alexithymia and demographic factors, particularly 
gender, education level, and economic status. In addition, this review found that alexithymia 
was related to demographic factors more often in studies that involved community samples 
and less often in studies that involved psychiatric samples. Examining the extent to which 
these demographic factors may impact on high levels of alexithymia in general psychiatric 
and community samples from one common population may lead to a more accurate 
understanding of this issue. Moreover, research in this area could help to identify 
demographic groups of people who experience higher levels of alexithymia as well as 
encourage researchers to control for the potential confounding influence of these factors in 
future alexithymia research. 
Differences in psychological distress severity may also help to explain variability in 
the prevalence rates of alexithymia in general psychiatric and community populations. There 
is growing evidence of a link between alexithymia and psychological distress, with the 
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outcomes of several studies showing that alexithymic individuals report significantly greater 
levels of psychological distress than non-alexithymic individuals in psychiatric (Evren et al., 
2008; Leweke et al., 2009; C. Spitzer et al., 2005) and community samples (Bouchard, 2009; 
Liang & West, 2011). While the direction of causality is unclear, a prominent theory 
proposes that alexithymia poses a vulnerability to the development and maintenance of 
psychiatric illness because it reflects a broad deficit in the cognitive processing of emotion  
that leads to elevated psychological distress (Taylor et al., 1997). 
Some evidence for the theory that alexithymia is a risk factor for psychiatric illness 
has been provided by studies that have found high alexithymia scores to be associated with 
the new incidence of psychiatric symptomatology in non-clinical samples (Heinrichs et al., 
2005; McCaslin et al., 2006; Tolmunen et al., 2011) and with the persistence of psychiatric 
symptomatology in psychiatric samples over time (Bach & Bach, 1995; Loas et al., 1997; 
Reese, 2008; Viinamäki et al., 2002). Another way to examine the link between alexithymia 
and psychological distress is to compare the strength of this association in different 
populations, such as in general psychiatric and community samples. If the strengths of the 
relationship between alexithymia and psychological distress were similar in a psychiatric and 
community sample, it would indicate that sample group is not a contributing factor to the 
relationship and that psychological distress is a probable consequence for most individuals 
with alexithymia. Findings about the relationship between alexithymia and psychological 
distress may reinforce our understanding of alexithymia as a risk factor in the development of 
psychopathology. 
The overall aim of Study 1 was to examine differences in alexithymia between a 
sample of Australian psychiatric patients and a sample of Australian community participants. 
There were three specific aims: 1) to compare differences in alexithymia between the sample 
groups; 2) to examine the potential influence of gender, education level, and employment 
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status on alexithymia scores in the sample groups; and 3) to compare the association between 
alexithymia and psychological distress in the sample groups. Alexithymia was expected to be 
more prevalent in the psychiatric sample compared to the community sample, in line with 
overall findings in the literature. Differences in alexithymia scores were expected to be 
dependent on demographic variables of gender, education level, and employment status in the 
community sample but not in the psychiatric sample, in line with the general trend in the 
literature. Also, given the theory that alexithymia is a risk factor for psychiatric illness 
(Taylor et al., 1997), the relationship between alexithymia and psychological distress was 
expected to be a similar strength in both sample groups. 
Method 
Participants 
The present study drew data from an outpatient mental health facility, which was 
linked with a tertiary hospital in the southern suburbs of Perth Western Australia. The 
psychiatric sample comprised 151 patients
1
 who attended the outpatient facility at some time 
in 2008 to 2011, inclusive. The overall sample ranged in age from 18 to 66 years (M = 41.89 
years, SD = 12.23 years) and comprised 109 (72.2%) females patients. Hospital psychiatrists 
had diagnosed patients based on the International Classification of Mental and Behavioural 
Disorders (ICD-10, World Health Organization, 2010). When a patient had been diagnosed 
with more than one psychiatric condition, only the primary diagnosis was noted in the present 
research. Patients had been diagnosed with a variety of psychiatric conditions (see Table 6) 
                                                          
1
 Note: Data was initially collected from 284 psychiatric patients. Since many of the patients attended more than 
one therapy group and completed additional tests data were retained from patients’ earliest therapy group to try 
to control for possible cumulative treatment effects. In addition, some patients were removed from the dataset if 
they had not completed corresponding sets of pre and post alexithymia and psychological distress tests. These 
conditions resulted in the final sample size of 151. 
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and many had been prescribed psychotropic medication as part of their ongoing treatment. 
They had also experienced a diverse treatment history, ranging from one inpatient 
hospitalisation to numerous hospitalisations and/or ongoing private treatment. All patients 
required a written referral from their case-manager to attend the facility, who was either a 
general practitioner or an allied health professional from an external agency. Only patients 
who did not require inpatient care or major adjustments to their medication and who were 
free of alcohol or substance misuse were eligible for the outpatient program. 
The community sample consisted of 216 participants living in Perth, Western 
Australia. This sample ranged in age from 18 to 75 years (M = 33.48 years, SD = 14.37 years) 
and comprised 157 (72.7%) females participants. 
Measures 
Psychiatric patients completed the 20-item Toronto Alexithymia Scale (TAS-20), the 
42-item Depression Anxiety Stress Scale (DASS, Lovibond & Lovibond, 1995), and a 
demographic questionnaire and consent form for the data to be used in research (see 
Appendices A and B for a copy of these documents; the TAS-20 is not provided for copyright 
reasons). Community participants completed the TAS-20, 21-item DASS, a demographic 
questionnaire, and a consent form for the data to be used in research (see Appendices C, D, 
and E for a copy of these documents). 
Alexithymia. 
The TAS-20 (Bagby, Parker, et al., 1994) is a self-report questionnaire designed to 
measure alexithymia as a personality trait. Participants respond on a 5-point Likert type rating 
scale for each of the 20 items, from 1 (strongly disagree) to 5 (strongly agree). Each item 
corresponds to one of three factors associated with the TAS-20: difficulties identifying 
feelings and distinguishing feelings from bodily sensations of emotional arousal (DIF, factor 
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one), difficulties describing feelings to others (DDF, factor two), and externally oriented 
thinking (EOT, factor three). Three factor scores and a total score can be calculated. Cut-off 
scores for the TAS-20 have been recommended: individuals scoring below 51 are considered 
non-alexithymic and those scoring above 61 are considered alexithymic (Taylor et al., 1997). 
A recent study by Parry (2012) determined that the cut-off scores developed by Taylor et al. 
(1997) were appropriate for use in Western Australian samples. The TAS-20 is the most well-
established and widely used instrument to measure alexithymia, with evidence of high 
internal consistency in community and psychiatric samples (α > .79,  agby, Parker, et al., 
1994; α > .77, Meganck et al., 2008), as well as adequate test-retest reliability, construct 
validity, and criterion validity in community and psychiatric samples (Bagby, Parker, et al., 
1994). 
Psychological distress. 
The DASS is a self-report questionnaire designed to measure symptoms of 
depression, anxiety and stress. There are two versions of the DASS: the short 21-item version 
and the original 42-item version. It has been suggested that the DASS-21 is preferable for 
research purposes because it reduces administration time (The University of New South 
Wales, 2013). Participants respond on a 4-point Likert type rating scale, where response 
options range from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the 
time). The DASS-21 and DASS-42 yield three scale scores for depression, anxiety, and 
stress, as well as a total composite score (ranging from 0 to 63 and 0 to 126, respectively). 
The total score measures negative emotional symptoms (Sinclair et al., 2012; The University 
of New South Wales, 2013) and can be interpreted as reflecting negative affectivity or 
psychological distress (Gregorio, 2010; Page, Hooke, & Morrison, 2007; Willemsen, Markey, 
Declercq, & Vanheule, 2011). The DASS-21 is found to have good reliability for the separate 
scales of depression (α = .91), anxiety (α = .84), and stress (α = .90) (Lovibond & Lovibond, 
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1995). Similarly the DASS-42 is found to have good reliability for depression (α = .94), 
anxiety (α = .88), and stress (α = .93) (Nieuwenhuijsen, de Boer, Verbeek, Blonk, & van 
Dijk, 2003). Both versions of the DASS have been found to be valid and reliable measures 
for psychiatric populations (Ng et al., 2007; Page et al., 2007) and community populations 
(Crawford & Henry, 2003; Gregorio, 2010). The total score of the DASS-21 for the 
community sample was doubled so that it could be compared to the norms of the original 
DASS-42 (The University of New South Wales, 2013). 
Procedure 
Both the Faculty of Computing Health and Science Ethics Committee at Edith Cowan 
University and the ethics committee of the tertiary hospital granted approval for the present 
research. The psychiatric patients completed the TAS-20 and DASS-42 assessments at the 
beginning and at the completion of group therapy. These assessments were then filed at the 
outpatient mental health facility, collected by the researcher, and organised into an electronic 
database. 
The participants from the community sample were recruited using snowball sampling. 
A study flyer was placed at various community-oriented locations around Perth (Appendix 
F). Participants were offered a chance to win one of two $100 department store gift vouchers 
for participating in the present research. Participants who responded to the study flyer 
accessed the package of assessments via a web link (URL) to Qualtrics (a password protected 
survey software program). The package included an information sheet for potential 
participants (Appendix G), a consent form, the TAS-20, DASS-21, a demographic 
questionnaire, and a list of counselling and support organisations (Appendix H). 
Participant anonymity was maintained as names and contact details were not 
necessary in completing the package of assessments. However, participants were given the 
choice to enter a draw to win one of two $100 Department store gift vouchers by emailing an 
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address created specifically for this purpose. This email address was provided following 
completion of the assessments and the personal details were not linked to any assessment 
information. Participants were informed that winners would be required to nominate a postal 
address in order to obtain their prize. Data were obtained from the Qualtrics database 
approximately six months after collection began. This data were then organised and exported 
into Statistical Package for the Social Sciences version 19.0 (SPSS, IBM Corp., 2010) for 
analysis. 
Statistical Analysis 
While a large body of research has supported the TAS-20 as a good measure of 
alexithymia, several studies have challenged this view, arguing that there is unacceptably low 
internal reliability in the externally oriented thinking factor in particular (Besharat, 2008; 
Gignac et al., 2007; Meganck et al., 2008; Vorst & Bermond, 2001). In addition, while 
previous studies have evaluated the reliability of the TAS-20 for use in Australian community 
populations (see Gignac et al., 2007; Parry, 2012), no study could be located that has 
evaluated the reliability of the TAS-20 for use in Australian psychiatric populations. 
Therefore, the present study examined the internal reliability of the overall TAS-20 scale and 
three factors for use with the psychiatric and community samples before further analyses 
were conducted. Bivariate correlations between the separate TAS-20 factors were also 
examined. Internal reliabilities of the overall TAS-20 and three factors were estimated using 
Chronbach’s alpha (α), where coefficient values of .50, .60, and .70 correspond to 
unacceptable, acceptable, and good levels of internal reliability, respectively (see George & 
Mallery, 2003). 
Chi-Square analysis was used to examine differences in demographic factors between 
the psychiatric and community samples. Three, two-way analysis of variance (ANOVA) tests 
were conducted to examine whether differences in alexithymia scores (dependent variable) 
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between the psychiatric and community samples (independent variable) were dependent on 
the gender of the participants, their educational background, or current employment status 
(independent variables). Chi-Square analysis was used to examine differences in categorical 
levels of alexithymia between the psychiatric and community samples. An ANOVA was 
conducted to examine differences in psychological distress scores between the psychiatric 
and community samples. Pearson’s correlations and Fisher’s Z transformation were used to 
examine correlations between alexithymia and psychological distress and to standardise these 
distributions, respectively. Pearson’s correlation coefficient (r) values of .10, .30, .50, and 
.70, correspond to small, medium, large, and very large effect sizes, respectively (see Cohen, 
1988). Effect sizes for ANOVA’s were estimated using partial eta-squared (partial η2), where 
values of .01, .09, and .25, correspond to small, medium, and large effect sizes, respectively 
(see Cohen, 1988). All data were analysed using SPSS version 19.0 (IBM Corp., 2010). 
Results 
Data Preparation 
No data was missing from the community sample. There were a small number of 
missing items remaining in the psychiatric dataset (0.23%). These missing items were 
assumed to be missing at random (see Fichman & Cummings, 2003). The expectation 
maximisation (EM, IBM Corp., 2010) method was chosen over listwise deletion in order to 
maximise the size of the dataset. The EM method involved replacing missing test items with 
imputed values (by estimating the means, correlations, and covariances). No univariate 
outliers were detected as each test variable was equivalent to standardised test scores, or z-
scores, below 3.29 (as recommended by Field, 2005), with 95% of the data having standard 
scores below 1.96 (p < .05, two-tailed test). The assumption of normality was assessed by 
way of the Shapiro-Wilks statistics. Normality was found to be violated for the DASS in the 
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community sample only. However, this sample was sufficiently large and the DASS data was 
used in a one-way ANOVA, which is robust against deviations from normality (Keppel & 
Wickens, 2004; Tabachnick & Fidell, 2007). 
Internal reliability of the TAS-20. 
Cronbach alpha (α) coefficients for the overall TAS-20 scale in the psychiatric sample 
was .80 and .76 in the community sample. Alpha coefficients for the three TAS-20 factors 
differed greatly. In the psychiatric sample, the DIF, DDF, and EOT factors obtained α 
coefficients of .86, .51, and .29, respectively. The α coefficient of the DDF factor would have 
increased to .76 if item 4 (“I am able to describe my feelings easily”) was deleted. The α 
coefficient of the EOT factor could not be improved by deleting any item. In the community 
sample, the DIF, DDF, and EOT factors obtained α coefficients of .89, .36, and .20, 
respectively. The α coefficients of the DDF or EOT factors could not be improved by 
deleting any item. Due to the unacceptable internal reliability of the EOT factor in the 
psychiatric and community samples for the present study, it was unlikely that any meaningful 
interpretation of the separate factor scores could be possible, except taken together in total 
TAS-20 score as a general indication of alexithymia (Gignac et al., 2007; Vorst & Bermond, 
2001). Consequently, all further analyses of alexithymia in the present psychiatric and 
community samples used the total TAS-20 score only. 
Bivariate correlations between the separate TAS-20 factors for the psychiatric and 
community samples are displayed in Table 5. All Pearson’s correlations between the separate 
TAS-20 factors were positive and significant in both group samples, p < .01. There was a 
moderate (r = .30 to .69) and strong (r >.70) association between the DIF and DDF factors 
for the psychiatric and community samples, respectively (based on criteria established by 
Cohen, 1988). In both group samples, the DDF and EOT factors were moderately associated 
whereas the DIF and EOT factors were weakly associated (r < .30). 
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Table 5 
Bivariate Correlations Between TAS-20 Factors for the Psychiatric and Community Samples 
Factors DIF DDF EOT 
  Psychiatric  
DIF 1.0   
DDF .66** 1.0  
EOT .27** .45** 1.0 
  Community  
DIF 1.0   
DDF .71** 1.0  
EOT .29** .41** 1.0 
** p < .01. 
Demographic Characteristics 
Demographic details of the psychiatric and community samples are presented in Table 
6. This table includes frequency counts and percentages for gender, education level, 
employment status, and ICD-10 diagnosis (diagnosis for the psychiatric sample only). 
Females were overrepresented in the psychiatric sample, with a similar high 
proportion of females observed in the community sample, χ2 (1) = 0.01, p = .916. The 
proportion of psychiatric patients who had completed primary/secondary education and who 
had completed some form of post-secondary education (including technical college and 
university) was relatively balanced. The community sample, on the other hand, included a 
higher percentage of post-secondary educated participants compared to the psychiatric 
sample, χ2 (1) = 58.21, p < .001. There were also a higher percentage of employed 
participants in the community sample compared to the psychiatric sample, χ2 (1) = 147.79, p 
< .001. 
Over half of the psychiatric patients had been diagnosed with a mood (affective) 
disorder that included bipolar affective disorder, depressive episodes, recurrent depressive 
disorders, and persistent mood disorders such as cyclothymia and dysthymia. Approximately 
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one quarter of the patients had been diagnosed with a neurotic, stress-related, and 
somatoform disorder; including social phobia, panic disorder, generalized anxiety disorder, 
obsessive-compulsive disorder, and adjustment disorders (i.e., post-traumatic stress disorder). 
The remaining patients had been diagnosed with schizophrenia, schizotypal, and delusional 
disorders (i.e., paranoid and simple schizophrenia, delusional disorder, schizoaffective 
disorder, and unspecified non-organic psychosis); behavioural syndromes associated with 
physiological disturbances and physiological factors (i.e., anorexia nervosa); and disorders of 
adult personality and behaviour (i.e., borderline personality disorder, avoidant personality 
disorder, and mixed personality disorder.
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Table 6 
Demographic Characteristics of the Psychiatric and Community Samples 
 Psychiatric  
(N = 151) 
 Community 
 (N = 216) 
Characteristic Frequency (%)  Frequency (%) 
Gender      
Female 
Male 
Total 
109 
42 
151 
72.2 
27.8 
100 
 
 
157 
59 
216 
72.7 
27.3 
100 
Education      
Primary/Secondary 
Post-Secondary 
a
 
Total 
Missing 
Total 
80 
62 
142 
9 
151 
53 
41 
94 
6 
100 
 
 
38 
178 
216 
17.6 
82.4 
100 
Employment      
Paid 
Unpaid/Unemployed 
Total 
33 
118 
151 
21.9 
78.1 
100 
 
 
184 
32 
216 
85.2 
14.8 
100 
Diagnosis 
b
      
F20-F29 
F30-F39 
F40-F48 
F50-F59 
F60-F69 
Total 
13 
79 
38 
1 
20 
151 
8.6 
52.3 
25.2 
0.7 
13.2 
100 
  
 
 
a
Post-Secondary includes technical and university education.  
b
Diagnosis by ICD-10 Category: F20-F29 schizophrenia, schizotypal, and delusional disorders; F30-F39 
mood (affective) disorders; F40-F48 neurotic, stress-related, and somatoform disorders; F50-F59 behavioural 
syndromes associated with physiological disturbances and physiological factors; and F60-F69 disorders of 
adult personality and behaviour. 
Alexithymia in the Psychiatric and Community Samples 
Means and standard deviations of alexithymia scores by gender, education level, and 
employment status as well as overall scores for the psychiatric and community samples are 
presented in Table 7. Overall, the psychiatric patients reported significantly greater 
alexithymia scores compared to the community participants, F(1, 365) = 103.38, p < .001. 
Even when accounting for demographic variables the size of the group differences in 
alexithymia was still significant, partial η2 = .22 (medium to large effect).
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Table 7 
Descriptive Statistics of Alexithymia Scores by Gender, Education, and Employment 
 Psychiatric  Community 
Demographic Variable M SD  M SD 
Gender      
Male 
Female 
59.74 
59.89 
12.09 
12.30 
 48.52 
45.55 
13.01 
12.54 
Education      
Secondary/ High school 
Tertiary/ TAFE 
60.92 
57.93 
12.03 
12.52 
 46.42 
46.35 
12.87 
12.71 
Employment      
Employed 
Unemployed 
58.97 
60.09 
13.29 
11.93 
 46.10 
47.84 
12.87 
11.82 
Overall 59.85 12.20  46.36 12.71 
Results of the two-way ANOVA tests examining the influence of gender, education 
level, and employment status on differences in alexithymia scores between the psychiatric 
and community samples are presented in Table 8. The difference in alexithymia scores 
between the samples did not depend on the gender, education level, or employment status of 
the participants as the interactions between sample group and demographic variables were not 
significant.
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Table 8 
Results of Two-Way ANOVAs by Sample Group and Demographic Variables 
Variables F p Partial η2 
Gender x Sample
a
 1.11 .292  
Gender
a
 0.91 .341  
Sample
a
 74.27 < .001 .17 
Education x Sample
b
 0.89 .345  
Education
b
 0.98 .322  
Sample
b
 71.40 < .001 .17 
Employment x Sample
a
 0.03 .858  
Employment
a
 0.69 .406  
Sample
a
 53.27 < .001 .13 
Note. Sample = psychiatric and community; gender = male and female; education = secondary/ high school; and 
employment = employed and unemployed. 
a
df = 1(363).  
b
df = 1(354). 
According to TAS-20 cut-off scores, 87 patients (57.6%) in the psychiatric sample 
were identified as alexithymic (TAS-20 scores of ≥ 61) and 35 patients (23.2%) were 
identified as non-alexithymic (TAS-20 scores ≤ 51). In the community sample, 33 
participants (15.3%) were identified as alexithymic and 148 participants (68.5%) were 
identified as non-alexithymic. Pearson’s Chi-Square indicated that there was a significant 
difference between the psychiatric and community samples in the proportion of participants 
that were identified as alexithymic and non-alexithymic, χ2 (1) = 85.84, p < .001. Cramer’s V 
indicated a large and significant association (.53, p < .001) between categorical level of 
alexithymia and group sample (see Cohen, 1988). Alexithymia was 3.8 times more prevalent 
in the psychiatric sample than in the community sample. 
Alexithymia and Psychological Distress in the Psychiatric and Community Samples 
Results of the ANOVA showed that the psychiatric patients reported significantly 
greater psychological distress scores (M = 58.22, SD = 29.94) compared to the community 
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participants (M = 26.03, SD = 21.78), F(1, 365) = 142.16, p < .001, partial η2 = .28 (large 
effect). Results from Pearson’s correlations showed a medium positive and significant 
association (see Cohen, 1988) between DASS and TAS-20 scores for both the psychiatric, 
r(166) = .46, p < .001, and community, r(216) = .46, p < .001, samples. A Fisher’s Z 
transformation showed that the difference in the correlation sizes between DASS and TAS-20 
scores for the two sample groups was not significant, z-obs =  .06, p = .951. 
Discussion 
The purpose of Study 1 was to examine differences in alexithymia between a sample 
of Australian psychiatric patients and a sample of Australian community participants. This 
study also examined the influence of the gender, education level, and/or employment status 
of the participants on differences in alexithymia between the sample groups. Lastly, the 
present study examined the relation between alexithymia and psychological distress in the 
psychiatric and community samples. 
Prior to the analyses, the internal reliability of the TAS-20 and the three separate 
factors were evaluated for use in the present research. The overall TAS-20 scale 
demonstrated good internal reliability (α ≥ .70, George & Mallery, 2003) in both the 
psychiatric and community samples. This finding was consistent with previous studies where 
good internal reliability for the overall scale has been found for both psychiatric samples 
(Loas et al., 2001; Müller et al., 2004; Stasiewicz et al., 2012) and community samples 
(Martίnez-Sanchez, Ato-Gárcίa, & Ortiz-Soria, 2003; Scott, 2009; Tsaousis et al., 2010), 
including Australian community samples (Gignac et al., 2007; Parry, 2012). In addition, 
correlations between the TAS-20 factors for the psychiatric and community samples 
indicated the existence of discriminant validity as the correlation coefficients were all less 
than .80 (see Anderson & Gerbing, 1988). Correlation coefficients less than .80 between the 
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TAS-20 factors indicate that each factor is likely to be measuring a theoretically unique facet 
of alexithymia (see Groth-Marnat, 2009). 
Although the overall TAS-20 scale has been found to have good internal reliability, 
there were inconsistencies in the internal reliability of the separate TAS-20 factors in the 
present study. The DIF factor demonstrated good internal reliability in the psychiatric and 
community samples, yet the DDF and EOT factors demonstrated poor to unacceptable 
internal reliability, respectively. Alpha coefficients for the EOT factor in the present samples 
were much lower than α coefficients for the DIF and DDF factors, which has also been found 
in many previous studies (Kooiman et al., 2002; Leising et al., 2009; Loas et al., 2001; 
Loiselle & Cossette, 2001; Meganck et al., 2008; Thorberg et al., 2010). It has been 
suggested that the low internal reliability of the EOT factor may result from a response bias 
to the large number of reverse-scored items that load onto the EOT factor (Meganck et al., 
2008; Vorst & Bermond, 2001). Revision of the EOT factor and the use of reverse-scored 
items has been suggested (Besharat, 2008; Gignac et al., 2007; Meganck et al., 2008). The 
unacceptable internal reliability of the EOT factor in the present study indicates that revision 
of this factor is needed before meaningful interpretation of the separate factor scores can be 
made in Australian samples. 
The mean TAS-20 score for the psychiatric sample was consistent with previous 
research (Clyne & Blampied, 2004; de Haan, Schellekens, et al., 2012; Frewen, Lanius, et al., 
2008; Meganck et al., 2009) and was similar to findings reported from a study of 404 general 
psychiatric outpatients in Belgium (Vanheule et al., 2007). The mean TAS-20 score for the 
community sample was also consistent with previous research (Bouchard, 2009; Kreitler, 
2002; Lundh & Simonsson-Sarnecki, 2001; Parker et al., 2001; Scott, 2009) and was similar 
to the mean TAS-20 scores reported by Gignac et al. (2007) and Parry (2012) in their 
Australian community studies. 
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There was a medium to large difference in alexithymia scores between the psychiatric 
and community sample. As expected, the psychiatric patients reported significantly greater 
alexithymia scores than the community participants. These findings were consistent with 
previous international studies that have demonstrated greater alexithymia scores in 
psychiatric samples compared to community or student samples (Müller et al., 2003; 
Vanheule et al., 2007). Comparing differences in categories of alexithymia (alexithymic and 
non-alexithymic) between the sample groups also produced expected results, as the 
proportion of participants identified as alexithymic was significantly greater in the psychiatric 
sample than in the community sample. The prevalence rate of alexithymia was almost four 
times higher in the psychiatric sample compared to the community sample. This finding 
highlights the pervasiveness of alexithymia amongst general psychiatric patients and supports 
the idea that dysfunctional emotional states, characterised by alexithymia, are a central 
feature to most psychopathology (Krystal, 1988; Lane & Schwartz, 1987; Taylor, 1987). 
The prevalence rates of alexithymia in the present psychiatric and community samples 
fell within the range of alexithymia rates that have been reported globally (see Chapter 2). 
Furthermore, the prevalence rate of alexithymia in the psychiatric sample was greater than the 
prevalence rates of alexithymia reported in previous European studies involving  general 
psychiatric outpatients (Joukamaa et al., 2008; Leweke et al., 2012; Porcelli et al., 2004; 
Todarello et al., 1995; Tutkun et al., 2004; Vanheule et al., 2007), but was comparable to the 
prevalence rate reported in a Canadian study that involved general psychiatric outpatients 
(Joyce et al., 2013). This finding supports a trend reported on in Chapter 2 where, on average, 
prevalence rates of alexithymia in psychiatric samples tended to be higher across studies 
undertaken outside of Europe. 
Differences in alexithymia scores between the psychiatric and community samples in 
the present study were not explained by the demographic factors of gender, education level, 
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and employment status. This finding indicates that demographic factors are unlikely to play a 
role in the alexithymia construct. This finding is in contrast to the expectation that differences 
in alexithymia scores would be dependent on demographic factors in the community sample, 
but not in the psychiatric sample, as most of the studies reviewed in the literature (see 
Chapter 2) that involved community samples found a significant influence of demographic 
factors on alexithymia scores. However, this finding is partially consistent with the overall 
trend reported on in the Chapter 2, which showed that the majority of the reviewed studies 
(59.2%) reported no significant differences in alexithymia scores between males and females 
(e.g., Bouchard, 2009; Speranza et al., 2004) or between employed and unemployed 
participants (e.g., de Haan, Schellekens, et al., 2012; El Rasheed, 2001). The present finding 
that education level did not account for differences in alexithymia scores between the sample 
groups was in contrast to most of the studies in the same review that reported significantly 
higher alexithymia scores in participants with fewer years of education (e.g., Franz et al., 
2008; Leweke et al., 2012). Ultimately, the findings from Study 1 indicate that males, lower 
educated individuals, or unemployed individuals are no more at risk of experiencing 
alexithymia than females, higher educated individuals, or employed individuals. 
In line with previous research (e.g., Antony, Bieling, Cox, Enns, & Swinson, 1998), 
the psychiatric patients reported significantly greater psychological distress severity than the 
community participants did. The mean DASS score in the psychiatric sample was consistent 
with previous studies involving Australian (e.g., Ng et al., 2007; Page et al., 2007) and 
Canadian (Clara, Cox, & Enns, 2001) psychiatric patients. The mean DASS score for the 
community participants in the present study was also consistent with various studies 
involving community and student populations (e.g., Lozano, 2010; Osman et al., 2012; 
Sinclair et al., 2012; Tully, Zajac, & Venning, 2009). 
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While the psychiatric patients reported greater psychological distress severity than the 
community participants, the strength of the association between alexithymia and 
psychological distress was similar for both sample groups. Moderate associations were found 
in the present study between alexithymia and psychological distress in both the psychiatric 
and community samples. This finding was consistent with a number of previous studies 
linking alexithymia to various measures of psychological distress in both psychiatric (Evren 
et al., 2008; Leweke et al., 2009; C. Spitzer et al., 2005) and community (Bouchard, 2009; 
Liang & West, 2011) samples. In addition, this finding supports the hypothesis that inabilities 
in recognising and expressing feelings results in a failure to regulate distressing emotions, 
leading to elevated psychological distress (Taylor et al., 1997). A similar strength of the 
association between alexithymia and psychological distress between the sample groups 
indicates that the relationship between alexithymia and psychological distress is not 
influenced by, or an outcome of, psychiatric illness. That is, alexithymic individuals in the 
community are not exempt from experiencing a similar degree of psychological distress to 
alexithymic patients in the general psychiatric population. Essentially, alexithymic 
individuals may be vulnerable to developing or maintaining a greater level of psychological 
distress regardless of whether they are seeking treatment for a psychiatric disorder or are a 
member of the general community. 
Limitations and Recommendations 
The findings from Study 1 were limited by a cross-sectional design, where no causal 
inferences about the relationship between alexithymia and clinical severity could be made. In 
addition, a high proportion of community participants were educated to a technical college or 
university level. This proportion is much higher than would be expected in a representative 
sample of the Australian population (see Australian Bureau of Statistics, 2011). While a high 
level of education in the community sample may suggest an increased willingness for highly 
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educated individuals to participate in psychological research, it is also possible that the 
sampling process was limited by placing recruitment posters at locations in close proximity to 
local universities. Some of the present findings may have been biased because there was an 
under representation of males in the psychiatric and community samples as well as an 
underrepresentation of individuals with a lower level of education in the community sample. 
Another potential limitation worth mentioning is that the community participants 
completed study materials online whereas the psychiatric patients completed study materials 
using a more traditional paper and pencil format. While most studies have shown that 
psychometric properties of data do not significantly change when questionnaires are 
completed online rather than on paper (e.g., Herrero & Meneses, 2006; E. T. Miller et al., 
2002; Vallejo, Jordán, Díaz, Comeche, & Ortega, 2007), differences in the assessment format 
between the present study samples may have had a small impact on participants’ responses 
(for a description of the potential problems associated with comparing online and paper 
assessments, see Fouladi, McCarthy, & Moller, 2002). 
The present findings have implications for clinicians and researchers working in 
psychiatric settings. Early recognition of alexithymia in psychiatric patients may be important 
to clinicians in managing the psychological distress that is associated with alexithymia. This 
is especially important as a large proportion of the psychiatric population (possibly the 
majority of them) experiences increased difficulties recognising, communicating and 
examining their feelings in treatment. Early recognition of alexithymia in psychiatric patients 
may also influence the therapeutic approach chosen by clinicians to treat these patients. 
Determining effective interventions to reduce alexithymia levels may be crucial for the 
management of psychological distress and potential prognosis in a large percentage of 
psychiatric patients. Chapter 5 of the present research will examine the efficacy of different 
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group therapy approaches in reducing alexithymia in psychiatric patients and will provide 
recommendations to clinicians working with these populations. 
Conclusion 
The overall aim of Study 1 was to examine differences in alexithymia between 
Australian psychiatric and community samples. To the researcher’s knowledge, this is the 
first study to have evaluated the reliability of the overall TAS-20 score and separate factors in 
an Australian psychiatric sample. It is also one of the few studies to have examined the effect 
of demographic variables on differences in alexithymia scores between psychiatric and 
community samples from a similar location. The added inclusion of a community sample in 
Study 1 meant that any correlates of alexithymia (i.e., demographic variables and 
psychological distress) could be attributed to associations with the alexithymia construct, 
rather than a mere association with the presence of a psychiatric disorder. In line with 
previous research, higher alexithymia scores and a greater prevalence rate of alexithymia 
were observed in the psychiatric sample compared to the community sample, which 
highlights the predominance of emotion processing difficulties in the Australian psychiatric 
outpatient population. More than half of the psychiatric patients were identified as 
alexithymic, which was several times the rate of alexithymia identified in the community 
sample. Differences in alexithymia scores between the psychiatric and community samples 
were not dependent on gender, level of education, or employment status. Thus, identifying 
individuals who may be vulnerable to experiencing alexithymia remains a complicated task, 
as alexithymia scores are likely to be similar within various demographic groups. Likewise, 
the severity of psychological distress is likely to be similar for all individuals with high levels 
of alexithymia, regardless of whether they are psychiatric patients or individuals in the 
community. This finding supports the theory that alexithymic individuals have a vulnerability 
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to developing and/or maintaining psychological distress and psychiatric illness (see Taylor et 
al., 1997).
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CHAPTER 5 
STUDY 2 
Alexithymic patients are thought to respond poorly to many standard therapeutic 
interventions (Krystal, 1979; McCallum et al., 2003; Sifneos, 1975; Taylor et al., 1997). 
Specifically, core features of alexithymia, such as a reduced capacity for introspection, to 
attend to emotional cues, and to communicate feelings to others, are believed to undermine 
the therapeutic process and be difficult to treat (McCallum et al., 2003; Sifneos, 1972/1973; 
Taylor et al., 1997). 
The empirical evidence to support the idea that alexithymia undermines therapeutic 
intervention is not consistent. The findings from a systematic review of the literature (see 
Chapter 3) indicated that alexithymia scores before treatment did not influence therapeutic 
outcome in some studies (e.g., de Haan, Schellekens, et al., 2012; Joyce et al., 2013; Rufer et 
al., 2004). On the other hand, some studies reviewed had found a link between high 
alexithymia scores before treatment and poor therapeutic outcomes, such as greater alcohol 
dependence severity (Stasiewicz et al., 2012) and poor therapeutic alliance (Cleland et al., 
2005). Previous studies have also found that elevated or more stable levels of alexithymia 
that persist after treatment are related to poor therapeutic outcomes, such as greater anxiety 
severity (Fukunishi, Kikuchi, et al., 1997) and less improvement in interpersonal problems 
during treatment (Ogrodniczuk et al., 2012). 
It is unclear if the approach or focus of therapy is a factor that influences the 
relationship between alexithymia and poor therapeutic outcome. Some researchers have 
proposed that alexithymia may have less of a negative impact on behavioural-based 
treatments, including CBT (Rufer et al., 2010), because the external focus of alexithymic 
patients undergoing CBT may improve their adherence to structured exercises and 
behavioural recommendations (Lumley et al., 2007). In contrast, it has been suggested that 
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alexithymia may interfere with traditional psychotherapies that demand a greater degree of 
insight or emotional awareness, such as psychodynamic psychotherapy, as alexithymic 
patients have difficulties examining their problems from a psychological perspective (Lumley 
et al., 2007; Sifneos, 1973). Some support has been provided for the idea that alexithymia has 
less of a negative impact on CBT compared to other therapeutic approaches, such as 
motivational intervention (Rosenblum et al., 2005). 
In addition to examining the impact of alexithymia on therapeutic outcome, 
researchers have examined how alexithymia might change as a result of undergoing therapy. 
Assessing change in alexithymia has typically been approached in two ways: by assessing 
mean-level stability, where the average alexithymia score of a whole group is examined over 
time; and relative stability, where relative differences among individuals’ alexithymia scores 
are examined over time. Analysis of mean-level stability provides a general indication of 
change in alexithymia at a group level. However, analysis of mean-level stability does not 
provide detailed information of change in alexithymia at an individual level, such as whether 
patients’ scores are roughly changing by the same amount. Personality researchers have 
argued that mean-level change is commonly observed in personality traits in addition to 
relative stability (Allemand et al., 2013). 
Previous studies have supported the idea that alexithymia is a personality trait by 
finding high degrees of relative stability in alexithymia scores following therapeutic 
intervention in spite of significant mean-level declines (e.g., Grabe et al., 2008; Luminet et 
al., 2001; Rufer et al., 2010; Speranza et al., 2007). These studies are consistent with findings 
of relative stability and mean-level change in other personality traits, such as neuroticism and 
extraversion (Santor et al., 1997). It has been suggested that both mean-level and relative 
stability of alexithymia should be considered when examining the influence of therapeutic 
intervention on alexithymia so that accurate conclusions can be reached concerning the extent 
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to which alexithymia can change over time (Mikolajczak & Luminet, 2006). Luminet et al. 
(2001) have argued that, in addition to examining different forms of stability, only by 
demonstrating the relative stability of alexithymia in the context of acute change in clinical 
symptoms is strong evidence provided to support alexithymia as a personality trait. A 
systematic review of the literature (see Chapter 3) found that relative stability in alexithymia 
scores has been observed alongside acute change in clinical symptoms (e.g., de Timary et al., 
2008; Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005). 
Studies that have examined change in alexithymia following therapeutic intervention 
have employed interventions that are available to treat various psychiatric disorders rather 
than interventions designed specifically to treat alexithymia. Some researchers have 
speculated about the efficacy of available therapeutic interventions to reduce alexithymia 
levels in psychiatric patients. Behavioural-based interventions such as CBT are thought to be 
less anxiety provoking for alexithymic patients as they are more directive and focus 
externally on coping with unpleasant emotions and bodily sensations (Rufer et al., 2010) 
rather than focusing on examining inner thoughts and feelings. In contrast, some researchers 
have proposed that emotion-focused interventions with skills-training components that 
address emotion awareness and modulation would be effective at reducing alexithymia levels 
since these interventions aim to enhance the way patients process and experience emotions 
(Hyer et al., 1991; Sifneos, 1973). A number of emotion-focused interventions, which 
typically place emphasis on identifying emotions, promoting verbal and non-verbal 
expression of emotions, and understanding emotional states and associated bodily sensations, 
have been found to be effective at reducing alexithymia (e.g., Beresnevaite, 2000; Kennedy 
& Franklin, 2002; Melin et al., 2010). 
In addition to differences in therapeutic approach, some researchers have considered a 
group therapy format to be effective for alexithymic patients because groups provide a 
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supportive environment for patients that maximises their opportunity to learn about emotions 
through a wide range of interpersonal situations (Apfel-Savitz et al., 1977; Swiller, 1988). 
Furthermore, alexithymic patients have been shown to prefer group therapy compared to  
individual therapy (Ogrodniczuk, Piper, Joyce, & Abbass, 2009), which may enhance their 
engagement in treatment and improve therapeutic outcomes. 
Studies that have examined the effects of therapeutic intervention on alexithymia 
while employing comparative treatment conditions are rare and consequently information 
about the superiority of a particular therapeutic approach for reducing alexithymia remains 
unclear. Studies that have examined the influence of alexithymia on therapeutic outcome 
have also produced inconsistent findings. The idea that alexithymia undermines the 
therapeutic process requires further examination because the relevance of alexithymia as a 
risk factor in the maintenance of psychiatric illness relies on the value of alexithymia as a 
predictor of therapeutic outcome. 
The overarching aim of Study 2 was to examine the relationship between alexithymia 
and therapeutic intervention. There were four specific aims: 1) to investigate the influence of 
alexithymia before treatment on change in psychological distress during treatment, and 
examine whether this influence was different for group therapy type (emotion focused 
therapy and cognitive-behavioural focused therapy); 2) to examine the mean-level and 
relative stability of alexithymia while accounting for group therapy type and change in 
psychological distress over time; and 3) to investigate the influence of change in alexithymia 
during treatment on psychological distress after treatment, and examine whether this 
influence was dependent on group therapy type. 
Higher alexithymia scores before treatment were expected to be associated with less 
change in psychological distress severity following emotion focused (EF) group therapy but 
not following cognitive-behavioural focused (CBF) group therapy, similar to findings by 
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Rosenblum et al. (2005). Mean-level change in alexithymia was expected over time, 
independent of group therapy type, in line with the literature. Changes in alexithymia were 
also expected to be largely independent of changes in psychological distress, as this finding 
would be consistent with previous research. In addition, and in line with previous research, it 
was anticipated that alexithymia would show a high degree of relative stability, even after 
controlling for the influence of psychological distress severity before and after treatment. 
Finally, less change in alexithymia severity during treatment was expected to predict higher 
psychological distress scores after treatment, independent of group therapy type, similar to 
findings by Ogrodniczuk et al. (2012). 
Method 
Participants and Procedure 
The sample for Study 2 consisted of 61 psychiatric outpatients who were selected 
from the original psychiatric sample used in study one (N = 151). The 61 patients were 
selected because they had completed corresponding measures of alexithymia and 
psychological distress before and after treatment. The sample included 47 (77.0%) females, 
with age in the total sample ranging from 19 to 66 years (M = 42.40 years, SD = 12.45 years). 
Twenty-seven of the patients had completed some form of post-secondary education 
(including technical college and university) and 14 were employed. ANOVA and Chi-Square 
tests showed no significant differences in demographic factors and in pre-treatment TAS-20 
or DASS-42 scores between the original sample and the subset involved in the present study. 
All patients completed TAS-20 and DASS-42 tests before (time 1) and after (time 2) 
the completion of a therapy group. Some patients had attended more than one therapy group 
and completed additional tests. Therefore, in order to control for the possible confound of a 
cumulative treatment effect, only the first alexithymia and psychological distress tests that 
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were from a patient’s earliest therapy group were retained for use in the present study. 
Recruitment methods, eligibility for service, and details about the present sample can be 
found in Chapter 4. Each patient had attended one of the two different types of group therapy 
conducted at the outpatient facility: emotion focused group therapy (n = 30) or cognitive-
behavioural focused group therapy (n = 31). 
Measures 
Psychiatric patients completed the 20-item Toronto Alexithymia Scale (TAS-20), the 
42-item Depression Anxiety Stress Scale (DASS), and a demographic questionnaire and 
consent form for the data to be used in research. The psychometric characteristics of the 
measures were reported on in Chapter 4. 
Therapy. 
The outpatient mental health facility offers a broad range of therapeutic group 
interventions to assist patients to recover from a variety of mental health problems. The 
facility aims to reduce psychiatric symptomatology and to develop patients’ personal, social, 
and emotional skills required for effective self-management of their mental illness. The group 
interventions encourage progress towards developing self-respect, balanced thinking, a 
healthy lifestyle with meaning, and enhance more effective functioning and a greater sense of 
belonging in the wider community. 
As part of the induction process, staff at the facility conducted interviews with new 
patients to help determine their suitability to group therapy and allocation to a specific 
therapy group. Group therapy suitability and allocation was based on a patient’s level of 
functioning, current needs and expectations, diagnoses or their most pressing difficulty, and 
availability. The groups were therefore diagnostically heterogeneous. All eligible patients 
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were required to complete an introductory 4-week therapy group before re-enrolling into 
other therapy groups. 
Two clinical staff from various disciplines, including clinical psychology, social 
work, occupational therapy, and psychiatric nursing facilitated the groups. Each group 
included approximately 5 to 12 patients and were run during standard business hours with the 
occasional after-hours group for those with daytime commitments. All groups were structured 
and time limited: sessions ran for 2 hours over an average of eight weeks (min = 4, max = 
10). The theoretical approach to group therapy at the facility was predominately guided by 
cognitive-behavioural theory. 
Categorising the types of therapy groups for use in this research was based on the 
most prominent difference between the groups, which was the therapeutic focus. Two types 
of group therapy were designated: emotion focused (EF) group therapy and cognitive-
behavioural focused (C F) group therapy. EF group therapy addressed patients’ 
dysfunctional emotions through various goal-oriented interventions, such as psychoeducation 
(in identifying and differentiating emotions, understanding the role of emotions, and the 
physiological impact of emotions on the body), emotion awareness and mindfulness training, 
assertive communication, relaxation, and homework (e.g., mindfulness techniques). Emotion 
expression was encouraged during the sessions. C F group therapy addressed patients’ 
maladaptive thoughts, behaviours, and emotions through various goal-oriented interventions, 
such as psychoeducation (in identifying and challenging maladaptive thoughts and 
behaviours, and understanding the interaction between cognition, behaviour, and emotion), 
cognitive restructuring, development of adaptive coping strategies, role-play, goal setting, 
relaxation, and homework (e.g., thought records). There were no differences in the length of 
the sessions or duration of the interventions between the two group types as both group types 
ran for 2 hours over an average of 8 weeks. 
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Statistical Analysis 
Bivariate correlations were calculated to examine relationships between all variables 
under consideration at time 1 and time 2. Three bivariate correlations were conducted to 
examine the relation between alexithymia at time 1 and change in psychological distress 
during treatment (i.e., DASS scores at time 2 minus DASS scores at time 1) for the overall 
group, and for each group therapy type. In order to examine mean-level change in 
alexithymia over time, a mixed model ANOVA was performed, with alexithymia scores at 
time 1 and time 2 as the within-subjects variable and group type as the between-subjects 
variable. Pearson’s correlation was used to examine the relative stability of alexithymia 
scores from time 1 to time 2. In order to estimate the relative stability of alexithymia while 
controlling for psychological distress severity, hierarchical regression analyses were 
conducted. Alexithymia scores at time 2 served as the criterion variable. In the first model, 
group type was entered as the dummy-coded predictor variable. In the second model, 
psychological distress scores at time 1 and time 2 were the predictor variables, and in the 
third model alexithymia score at time 1 was added as an additional predictor variable (as was 
done by Grabe et al., 2008; Luminet et al., 2001; Picardi et al., 2012). In a separate regression 
analysis, change scores in alexithymia (i.e., TAS-20 scores at time 2 minus TAS-20 scores at 
time 1) were regressed on change scores in psychological distress to examine the extent to 
which expected change in alexithymia might be accounted for by change in psychological 
distress. Finally, a multiple regression analysis was conducted to predict psychological 
distress at time 2 based on change scores in alexithymia, while controlling for psychological 
distress at time 1 and group therapy type. 
Cohen’s (1998) guidelines were used to interpret effect sizes. Accordingly, correlation 
coefficient (r) values of .10, .30, .50, and .70, correspond to small, medium, large, and very 
large effect sizes, respectively. Effect sizes for ANOVA were estimated using partial eta-
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squared (partial η2), where values of .01, .09, and .25, correspond to small, medium, and 
large effect sizes, respectively. Effect sizes for simple and multiple regression analyses were 
estimated using Cohen’s f (f2), where f2 values of .02, .15, and .35, correspond to small, 
medium, and large effect sizes, respectively. Lastly, effect sizes for hierarchical regression 
analyses were estimated using ΔR2, where values of .10, .30, .50, and .70, correspond to 
small, medium, large, and very large effect sizes, respectively. All data were analysed using 
SPSS version 19.0 (IBM Corp., 2010). The TAS-20 and DASS-42 test scores were subject to 
a number of data preparation procedures, which were detailed in Chapter 4. 
Results 
Bivariate Correlations Among Variables 
Bivariate correlations between alexithymia and psychological distress at time 1 and 
time 2 are reported in Table 9. Alexithymia at time 1 was related to psychological distress at 
time 1, and alexithymia at time 2 was related to psychological distress across time. 
Table 9 
Bivariate Correlations for Variables Under Consideration at Time 1 and Time 2 
 1 2 3 4 
1. Alexithymia t1 1.0    
2. Alexithymia t2 .74*** 1.0   
3. Psychological Distress t1 .48*** .32* 1.0  
4. Psychological Distress t2 .25 .39** .47*** 1.0 
Note. Boldface coefficients are test-retest correlations. 
* p < 0.05. 
** p < .01. 
*** p < .001. 
Influence of Alexithymia at Time 1 on Change in Psychological Distress 
Results from Pearson’s correlations showed a medium negative and significant 
correlation between alexithymia at time 1 and change in psychological distress, r(61) = -.32, 
p = .013 in the overall group. Correlations were not significant between alexithymia and 
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change in psychological distress for the EF group, r(30) = -.35, p = .056, or for the CBF 
group, r(31) = -.28, p = .125, when examined separately. 
Mean-Level Change and Relative Stability of Alexithymia 
Results of a mixed model ANOVA showed no significant interaction effect between 
change in alexithymia and group therapy type, F(1, 59) = 1.99, p = .163. There was a 
significant main effect for change in alexithymia, with a decrease in alexithymia scores from 
before (M = 58.98, SD = 13.37) to after group therapy (M = 56.51, SD = 12.35), F(1, 59) = 
4.52, p = .038, partial η2 = .07 (small effect size). The main effect for group type was not 
significant, F(1, 59) = 0.28, p = .596. 
Results of Pearson’s test-retest correlations (see Table 9) showed a high degree of 
relative stability in alexithymia evidenced by a very large positive and significant correlation 
between alexithymia at time 1 and time 2. A medium positive and significant correlation was 
observed between psychological distress at time 1 and time 2. 
Explaining the Relative Stability of Alexithymia 
Results of the hierarchical regression analyses are presented in Table 10. Group 
therapy type did not explain a significant amount of variance in alexithymia at time 2 in the 
first model. In the second model, group therapy type and psychological distress at time 1 and 
time 2 explained a statistically significant 13.5% of the variance in alexithymia at time 2, 
Fchg(2, 57) = 6.18, p = .004, ΔR
2
 = .18 (small effect size). Psychological distress at time 2 was 
a positive predictor of alexithymia at time 2. The addition of alexithymia at time 1 in the third 
model explained a statistically significant 59.5% of the variance in alexithymia at time 2, Fchg 
(1, 56) = 65.78, p < .001, ΔR2 = .44 (medium effect size), which was beyond that explained 
by group therapy type and psychological distress at time 1 and time 2. Alexithymia at time 1 
was a positive predictor of alexithymia at time 2. Inspection of the standardised coefficients 
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revealed that alexithymia at time 1 explained approximately 8 times the variance in 
alexithymia at time 2 compared to psychological distress at time 2. 
Table 10 
Hierarchical Regression Summary Explaining the Relative Stability of Alexithymia 
Model  
Unstandardised 
Coefficient 
Std. Error β t p 
1 Group Type -0.02 3.19 -.001 -0.005 .996 
2 Group Type 0.47 2.95 .02 0.16 .874 
 Psychological 
Distress t1 
0.08 0.06 .18 1.31 .194 
 Psychological 
Distress t2 
0.18 0.08 .31 2.27 .027 
3 Group Type -1.89 2.04 -.08 -0.93 .359 
 Psychological 
Distress t1 
-0.79 0.04 -.18 -1.74 .087 
 Psychological 
Distress t2 
0.16 0.05 .27 2.95 .005 
 Alexithymia t1 0.71 0.09 .77 8.11 .000 
Note. β = Standardised Coefficient; outcome variable was Alexithymia t2; Group Type dummy coding 0 = C F 
group therapy and 1 = EF group therapy; multicollinearity was not considered a problem (tolerance level for 
each predictor was > 0.60). 
Influence of Change in Alexithymia on Change in Psychological Distress 
Change scores in alexithymia were regressed on change scores in psychological 
distress. Results showed that change in psychological distress explained 17.5% of the 
variance in change in alexithymia, β = .42, F(1,59) = 12.51, p = .001, f2 = .21 (medium effect 
size). That is, as alexithymia change score increased by 1 standard deviation, psychological 
distress change score increased by .42 of a standard deviation. 
Influence of Change in Alexithymia on Psychological Distress at Time 2 
Results of the multiple regression analysis are presented in Table 11. The model 
explained a statistically significant 30.4% of the variance in psychological distress at time 2, 
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F(3, 57) = 8.31, p < .001, f
2
 = .44 (large effect size). After controlling for psychological 
distress at time 1 and group type, alexithymia change score made a significant contribution to 
the model: as alexithymia change score increased by 1 standard deviation, psychological 
distress at time 2 increased by .30 of a standard deviation. 
Table 11 
Multiple Regression Summary Examining the Influence of Change in Alexithymia on Psychological 
Distress at Time 2 
 
Unstandardised 
Coefficient 
Std. Error β t p 
      
Psychological Distress t1 0.41 0.09 .55 4.77 .000 
Alexithymia Change Score 0.69 0.27 .30 2.59 .012 
Group Type -0.69 4.72 -.02 -0.15 .884 
Note. β = Standardised Coefficient; outcome variable was Psychological Distress t2; Assumption of independent 
errors was met (Durbin-Watson = 1.79); and multicollinearity was not considered a problem (tolerance level for 
each predictor was > 0.89). 
Discussion 
The purpose of Study 2 was to investigate the relationship between alexithymia and 
therapeutic intervention for psychiatric patients by examining the influence of alexithymia 
before treatment on psychological distress severity (as a measure of therapeutic outcome) for 
all of the participants as well as each group therapy type. In addition, this study examined the 
extent of stability in alexithymia scores following group therapy in terms of mean-level and 
relative stability. The potential influences of different group therapy approaches as well as 
change in psychological distress severity on alexithymia stability were accounted for. Lastly, 
this study examined the influence of stability in alexithymia on psychological distress after 
treatment, while controlling for group therapy type and psychological distress before 
treatment. 
Alexithymia before treatment was found to influence therapeutic outcome, as higher 
alexithymia scores correlated significantly with less reduction in psychological distress in the 
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overall group. That is, patients with higher alexithymia scores made less improvement in 
psychological distress from before to after group therapy compared to patients with lower 
alexithymia scores. This finding supports previous studies that have shown alexithymia 
scores before treatment to negatively influence therapeutic outcomes (e.g., Fukunishi, 
Kikuchi, et al., 1997; Özsahin et al., 2003; Stasiewicz et al., 2012). This finding is also 
consistent with the idea that alexithymia poses a particular problem for psychiatric patients 
by contributing to the maintenance of their disorder and interfering with their recovery 
(Taylor et al., 1997). 
There are a number of possible reasons why alexithymia was found to negatively 
influence therapeutic outcome in the present study. It has been suggested that alexithymic 
patients’ difficulties with empathy and perspective-taking may partly explain the association 
between alexithymia and psychological distress as these difficulties lead to the contagion of 
others distress (Moriguchi et al., 2007; Moriguchi et al., 2006). Psychological distress 
severity may have been exaggerated for alexithymic patients during treatment in the present 
study since, by the nature of group therapy, alexithymic patients would have interacted and/or 
been in close contact with several other highly distressed patients during each therapy 
session. In addition, difficulties communicating feelings to others may have made it difficult 
for alexithymic patients in the present study to elicit support and comfort from others during 
group therapy by limiting their chances of developing social relationships with their peers 
(see C. Spitzer et al., 2005). 
The influence of alexithymia before treatment on change in psychological distress in 
the present study was not moderated by group therapy type as this relationship dropped below 
significance levels when each type of group therapy was examined separately. The effect of 
the relationship between alexithymia and change in psychological distress may not have been 
large enough to replicate this outcome in smaller groups, such as in the present emotion 
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focused (EF) and cognitive-behavioural focused (CBF) therapy groups. Suggestions that 
alexithymia may interfere less with certain therapeutic approaches, such as behavioural –
based treatments (Rufer et al., 2010), could not be addressed in the present study and remains 
inconclusive in the literature. 
Although alexithymia before treatment was found to influence group therapy outcome 
in the present study, the moderate relationship between alexithymia and change in 
psychological distress indicates that patients are not strongly disadvantaged during treatment 
by lacking emotion awareness, introspection, and the ability to communication their feelings. 
In combination with inconsistent findings in the literature, the present finding indicates that 
the influence of alexithymia on therapeutic outcome may not be direct. A study of emotion 
regulation skills by Berking et al. (2008) showed that emotion modification and acceptance of 
negative emotions contributed significantly to the prediction of mental health and treatment 
gains, over and above awareness of emotion-related sensations, awareness of emotions, and 
emotional clarity. The authors hypothesised that awareness and understanding of emotion are 
important but only to the extent that they facilitate the modification and acceptance of 
emotions. Therefore, an awareness and understanding of emotional states may be the basic or 
primary skills needed to utilise successive and adaptive emotion regulation skills (Berking et 
al., 2008; Lumley et al., 2005). Information about the influence of alexithymia on therapeutic 
outcome would be enhanced if alexithymia were examined in conjunction with other related 
constructs, such as emotion regulation, because researchers could observe the complex 
connections and interactions alexithymia may have with other constructs that influence the 
therapeutic process. 
Group therapy was effective at reducing alexithymia scores for the psychiatric sample 
as a whole. This finding was in line with numerous studies that have found significant mean-
level reductions in alexithymia scores following group therapy for various psychiatric 
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disorders (e.g., Grabe et al., 2008; Ogrodniczuk et al., 2012; Stasiewicz et al., 2012). In 
addition, the approach to group therapy in the present study did not account for the reduction 
in patients’ alexithymia scores following treatment as mean-level change in alexithymia was 
found to be independent of group therapy type (EF or CBF group therapy). In other words, 
the cognitive-behavioural focused and emotion-focused group therapy approaches were 
equally effective at reducing alexithymia levels in the psychiatric patients. 
Although group therapy was effective at reducing alexithymia scores for the 
psychiatric sample as a whole, the effect was small. In addition, the small reduction in 
alexithymia could not be directly accounted for by the reduction in psychological distress as 
less than one fifth of the variance in the change of alexithymia scores was explained by the 
change of psychological distress scores from before to after treatment. The finding of a small 
mean-level change in alexithymia scores following group intervention is consistent with the 
idea that alexithymia is a personality trait (Taylor et al., 1997) that hence is unlikely to show 
change over time that is large in magnitude (Allemand et al., 2013). Moreover, the finding 
that mean-level change in alexithymia was largely independent of change in clinical severity 
indicates that alexithymia is not exclusively dependent on the severity of clinical states. 
In addition to the present finding of a small mean-level reduction in alexithymia, a 
high degree of relative stability in alexithymia was observed from before to after treatment. 
Stronger evidence for the relative stability of alexithymia was provided by hierarchical 
regression analyses where alexithymia scores before treatment were found to make a 
significant contribution to the prediction of alexithymia scores after treatment over the effects 
contributed by group therapy type and psychological distress severity before and after 
treatment. This finding is in line with several previous studies (de Timary et al., 2008; 
Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005) where alexithymia scores 
before treatment have been found to be the best predictor of alexithymia scores after 
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treatment. In this respect, alexithymia can be compared to other personality traits such as 
neuroticism and extraversion, which have shown a high degree of relative stability and a lack 
of mean-level stability over short periods in the presence of change in clinical symptoms 
(Santor et al., 1997). 
The present findings of a small mean-level reduction in alexithymia as well as relative 
stability in alexithymia in the context of change in psychological distress indicate that 
patients who enter treatment with pronounced difficulties in recognising, examining, and 
communicating their feelings are likely to find that these difficulties persist after treatment 
despite experiencing a marked decline in psychological distress. In fact, reduction in 
alexithymia severity during treatment explained a significant amount of variance in 
therapeutic outcome. Patients who reported less reduction in alexithymia during treatment 
were more likely to report higher psychological distress scores after treatment compared to 
patients who reported greater reduction in alexithymia during treatment. This finding 
indicates that continued difficulties in recognising, verbalising, and examining ones feelings 
once treatment has ended may interfere with patients’ abilities to use psychotherapy 
effectively. Similar findings were made by Ogrodniczuk et al. (2012) where less change in 
alexithymia during treatment (i.e., more stable alexithymia) was associated with less 
improvement in interpersonal problems. Patients with resistant or more stable levels of 
alexithymia are likely to be at greater risk of experiencing persistent clinical symptomatology 
after treatment, which as a result may contribute to the maintenance of their psychiatric 
illness. 
Limitations and Recommendations 
The findings of the present study were limited by the method of data collection. Since 
the data were archival, the researcher could not control for a number of variables that may 
have influenced outcomes of the present study, including the number or types of concomitant 
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treatments patients received and the psychometric scale used to assess therapeutic outcome. 
Since many patients had attended more than one therapy group at the outpatient facility, an 
attempt was made to manage this by only retaining a patient’s earliest set of completed tests 
(i.e., the first group a patient attended where they completed pre and post TAS-20 and DASS 
tests). In addition, the varied lengths of therapy across the different groups at the facility may 
have confounded treatment effects, yet the sample size was not large enough to control for 
treatment duration. Findings concerning the relationship between alexithymia and therapeutic 
outcome were limited to the data provided by using one general measure of psychological 
distress to assess therapeutic outcome, rather than using multiple measures to assess general 
symptomatic improvement or other aspects of outcome, such as therapeutic alliance. 
Based on outcomes and restrictions from the present study, it is recommend that 
future studies employ comparative treatment formats (e.g., group therapy compared to 
individual therapy) as well as distinctive approaches to treatment (e.g., CBT compared to 
psychodynamic psychotherapy) when examining the role of alexithymia in therapeutic 
intervention. In addition, it will be important for future researchers to consider different 
forms of stability in the assessment of alexithymia as growing evidence shows that 
alexithymia is relatively stable and can change in response to therapeutic intervention. 
The present evidence of alexithymia as a personality trait underscores how difficult it 
will be to enact large or acute changes in alexithymia. On the other hand, if alexithymia is a 
stable trait, then any real changes that result from therapeutic intervention will likely have 
long lasting effects. Longitudinal studies involving longer follow up periods would help to 
establish if changes in alexithymia were stable over time following intervention and if 
elevated levels of alexithymia that persisted after treatment had an impact on longstanding 
therapeutic outcome. Clinicians are encouraged to monitor the progress of patients who score 
high in alexithymia throughout treatment to prepare these patients for a potentially slower 
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recovery and/or the use of ongoing specialised care as alexithymia may offer a more stable 
prediction of therapeutic efficacy in the presence of marked improvement in clinical 
symptoms. 
Conclusion 
The overall aim of Study 2 was to investigate the influence of alexithymia on 
therapeutic outcome across comparative treatment approaches as well as the effects of 
comparative treatment approaches on the stability of alexithymia over time. To the 
researcher’s knowledge, this is the first study to have examined the impact of alexithymia on 
group therapy outcome in a general psychiatric outpatient sample. It is also one of the few 
studies to compare different approaches to treatment in relation to alexithymia and to 
examine the stability of alexithymia in the context of change in clinical symptoms. Overall, 
alexithymic patients are therapeutically disadvantaged, to some extent, compared to non-
alexithymic patients as higher alexithymia scores at the beginning of treatment were 
moderately associated with poor therapeutic outcome. Present findings provided evidence to 
suggest that alexithymia is a personality trait that is somewhat responsive to therapeutic 
intervention as the small mean-level reduction and high degree of relative stability in 
alexithymia during treatment were largely independent of the reduction in psychological 
distress during treatment. Patients who reported more stable alexithymia scores over the 
course of treatment were more likely to experience greater psychological distress after 
treatment compared to patients who reported greater reductions in alexithymia over the 
course of treatment. Therefore, despite observing noticeable improvement to patients’ general 
wellbeing, many alexithymic patients are likely to experience ongoing difficulties identifying, 
communicating, and examining their feelings after treatment, as well as ongoing psychiatric 
problems and a need for ongoing therapeutic intervention. 
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CHAPTER 6 
GENERAL DISCUSSION 
The central purpose of this thesis was to advance the understanding of alexithymia by 
addressing a number of gaps in the literature relating to the prevalence of alexithymia in the 
psychiatric and community populations, the role alexithymia plays in explaining the 
perpetuation of psychiatric symptomatology, and the extent to which alexithymia can be 
mitigated by different therapeutic interventions. This research was conducted in four stages, 
which involved two systematic literature reviews and two empirical studies. Although this 
research essentially has a clinical focus, this research also investigated the prevalence of 
alexithymia in the community population to provide a comparative perspective. Accordingly, 
the first literature review (Chapter 2) evaluated the prevalence of alexithymia in psychiatric 
and community samples and Study 1 (Chapter 4) examined the prevalence of alexithymia in 
Australian psychiatric and community samples. The second literature review (Chapter 3) 
examined the role of alexithymia in the therapeutic process across the psychiatric literature. 
Study 2 (Chapter 5) extended the clinical focus of the present research by examining the role 
of alexithymia in different group therapy interventions for psychiatric outpatients. 
The main findings were detailed and summarised within the respective chapters: 
Chapter 2 through 5. The overall purpose of this chapter is to synthesise the findings of the 
systematic literature reviews and the empirical studies to address the goals of the present 
research. 
The Prevalence of Alexithymia in the Psychiatric and Community Populations 
The systematic review in Chapter 2 found that prevalence rates of alexithymia 
reported across the psychiatric literature were typically far greater than the rates reported 
across the community literature. In addition, there was a very high range in prevalence rates 
of alexithymia in psychiatric samples. Following a more detailed evaluation of this literature, 
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it was found that certain populations may have a higher prevalence rate of alexithymia (e.g., 
patients diagnosed with depressive, somatoform, and addictive disorders; and psychiatric 
populations receiving treatment outside of Europe), but this cannot be concluded on the basis 
of the available data. It is unclear why the prevalence of alexithymia should be higher in non-
European samples of psychiatric patients. Given that rates of alexithymia were found to be 
similar in European and non-European studies involving community samples, it is possible 
that differences in psychopathology (e.g., diagnostic severity) between European and non-
European samples will have contributed to the variation in prevalence rates of alexithymia in 
the psychiatric population. Direct comparisons between different psychiatric populations are 
required to accurately assess the relative prevalence of alexithymia in different cultures and 
countries. 
The results from Study 1 were consistent with the overall trend in the literature as 
there was a significantly greater prevalence rate of alexithymia, and higher alexithymia 
scores, in the psychiatric sample compared to the community sample. In addition, the 
particularly high prevalence rate of alexithymia that was found in the Australian psychiatric 
sample in Study 1 was consistent with the trend in the literature where high rates of 
alexithymia were reported in non-European psychiatric samples compared to European 
psychiatric samples. If the findings of the present study were generalised to other tertiary 
hospitals in Australia, then more than half of all outpatients receiving treatment for a 
psychiatric disorder in Australia experience difficulties recognising, communicating, and 
examining their feelings. 
There were a large number of inconsistencies across the literature regarding the 
influence of demographic factors on alexithymia, including the influence of gender, age, 
education, employment, socioeconomic status, income, and marital status. This trend 
suggests that certain demographic factors may influence alexithymia scores but are unlikely 
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to be leading contributors to variance in the prevalence rate of alexithymia in the psychiatric 
or community populations. The findings from Study 1 supported the trend in the literature as 
no differences were found in alexithymia scores between males and females and between 
employed and unemployed psychiatric and community participants. In contrast to most of the 
studies in the literature however, no differences were found in alexithymia scores between 
lower educated (secondary and high school) and higher educated (technical and tertiary) 
psychiatric and community participants.  Together, the overall trend from the literature 
review and findings from Study 1 suggest that no particular demographic group is likely to be 
more vulnerable to experiencing alexithymia. Instead, difficulties recognising, 
communicating, and examining ones feelings are widespread; particularly in populations that 
are receiving treatment for a psychiatric disorder. 
The Role of Alexithymia in Explaining the Perpetuation of Psychiatric Symptomatology 
The systematic review in Chapter 3 found inconsistent findings across the studies that 
examined the influence of alexithymia scores before treatment on therapeutic outcome, with 
some studies finding higher alexithymia scores to have a negative influence on some 
therapeutic outcomes and other studies finding alexithymia to have no influence on 
therapeutic outcomes. Studies that examined the impact of change in alexithymia on 
therapeutic outcome found that elevated or more stable levels of alexithymia that persist after 
treatment were related to poor therapeutic outcome on some measures (Fukunishi, Kikuchi, et 
al., 1997; Ogrodniczuk et al., 2012). The overall finding from this review was that 
alexithymia was more likely to interfere with therapeutic outcome in certain contexts, such as 
in treatments conducted for patients diagnosed with addictive disorders as well as treatments 
conducted in North America. 
The findings in Study 2 were consistent with some studies in the literature, as higher 
alexithymia score before treatment was associated with poorer therapeutic outcome (less 
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reduction in psychological distress severity during treatment). However, this finding did not 
resolve speculation about the influence of alexithymia being treatment specific (i.e., that 
alexithymia interferes less with behavioural-based interventions such as CBT, Rufer et al., 
2010) because the association between alexithymia and therapeutic outcome was not found in 
either treatment approach (cognitive-behavioural focused and emotion-focused group 
therapy) when examined separately. In addition, Study 2 found that less reduction in 
alexithymia over the course of treatment (more stable levels of alexithymia) was associated 
with higher psychological distress after treatment. Overall, findings from Study 2 indicate 
that psychiatric patients are vulnerable to experiencing ongoing clinical symptomatology 
after treatment when their level of alexithymia is high before treatment or changes little 
during treatment. 
The Extent to Which Alexithymia can be Mitigated by Therapeutic Intervention 
The majority of studies in the literature review that was conducted in Chapter 3 
reported a reduction in alexithymia scores following various therapeutic interventions. 
Results of Study 2 were in line with this literature as alexithymia scores reduced following 
group therapy, independent of the two group therapy approaches. In general, it remains 
unclear whether alexithymia is more responsive to specific treatments as few studies have 
compared the efficacy of different therapeutic interventions for treating alexithymia in 
psychiatric patients.  Further investigation is needed to determine the most effective 
therapeutic context for treating alexithymia. 
What was observed in Study 2 was that the reduction in alexithymia scores were small 
and largely independent of the reduction in psychological distress scores. Alexithymia was 
also found to be relatively stable even after controlling for psychological distress severity 
before and after treatment and type of group therapy. This finding is in line with the literature 
where alexithymia has been consistently found to be relatively stable. Evidence in the 
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literature, and from Study 2, support the proposition (Taylor et al., 1997) that alexithymia is a 
personality trait as evidenced by a high degree of relative stability, independent of change in 
clinical symptoms. Overall findings indicate that while alexithymia can improve with 
therapeutic intervention to a certain degree, clinically problematic levels of alexithymia are 
likely to persist after treatment in spite of apparent reductions in clinical symptomatology. 
Implications of the Research 
The present studies have provided support for the theoretical framework underlying 
this research, wherein the alexithymia construct was considered a potential predisposing 
factor that interacts with stressors to increase general susceptibility to psychopathology. The 
high rates of alexithymia amongst psychiatric samples and the therapeutic challenge that 
alexithymia represents, indicates that alexithymia is an important construct to consider within 
the psychiatric domain. 
The present findings have a number of implications for future research. Increased 
recognition of the prevalence of alexithymia amongst psychiatric patients should encourage 
researchers to consider alexithymia as a confounding factor when evaluating the efficacy of 
existing and novel therapeutic interventions. That is, a large proportion of alexithymic 
patients in a sample group are likely to impact on the efficacy of therapeutic interventions by 
increasing the severity of clinical symptomatology both during and after treatment for the 
overall sample. 
Strong empirical evidence of relative stability in alexithymia in the context of change 
in clinical symptoms will contribute to the acknowledgment of alexithymia as a personality 
trait. Increased recognition of alexithymia as a personality trait may in turn influence research 
methods by encouraging researchers to consider more complex models that differentiate 
relative stability from mean-level change when assessing how alexithymia and clinical states 
relate during therapeutic intervention. For instance, change in alexithymia may be a direct 
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outcome of therapeutic effects on alexithymia or an indirect outcome of change in clinical 
states influencing other important variables, which moderate or mediate the relationship 
between alexithymia and clinical states.  
The present research has raised doubt as to whether alexithymia would be considered 
a major obstacle to therapeutic success. Although the present research indicates that there is 
an increased risk imposed by alexithymia on therapeutic outcome for psychiatric patients, 
evidence in the literature about the influence of alexithymia on therapeutic outcome has been 
inconsistent, with many studies finding that alexithymia scores before treatment had no 
impact on therapeutic outcomes (e.g., Rufer et al., 2010; Spek et al., 2008). The effects of 
alexithymia, both before and during treatment, on therapeutic outcome in the present study 
were significant, yet they were small to moderate. The present findings should encourage 
researchers to consider broader elements of the therapeutic context in an attempt to expand 
the theoretical understanding of alexithymia in the therapeutic process. For instance, other 
factors related to alexithymia that have a more direct influence on or that are more essential 
to the success or failure of therapeutic intervention need to be investigated. The direct role of 
alexithymia in the therapeutic process may need to be reconsidered to involve examinations 
of variables that may moderate or mediate the relationship between alexithymia and 
therapeutic outcome. For example, given that emotion regulation is gaining popularity in the 
transdiagnostic understanding of therapeutic outcome, and that alexithymia has been found to 
be negatively correlated with several measures of emotion regulation (e.g., Pandey, Saxena, 
& Dubey, 2011; Stasiewicz et al., 2012), examination of the relation between alexithymia and 
emotion regulation skills may help to explain the mechanism through which alexithymia 
influences therapeutic outcome (for an overview of the potential mediating mechanisms that 
link alexithymia with physical and mental health related problems, see Dubey, Pandey, & 
Mishra, 2010). 
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Additionally, increased recognition of alexithymia as a personality trait that affects a 
considerable number of psychiatric patients in many countries is important for the psychiatric 
care of alexithymic patients. The present findings that higher alexithymia scores before 
treatment and greater stability of alexithymia during the course of treatment were related to 
poorer therapeutic outcome show that alexithymic patients are more vulnerable to 
experiencing greater clinical severity after treatment than non-alexithymic patients are. It is 
likely that alexithymic patients will require longer periods of treatment over the course of 
their illness in order to achieve a similar rate of recovery to non-alexithymic patients. 
Subsequently, alexithymic patients are likely to be engaged with mental health services for 
considerably longer periods compared to non-alexithymic patients. Assessing alexithymia at 
intake will be important for clinicians and mental health services as alexithymic patients have 
different treatment responses and may require different service delivery responses, such as 
parallel treatment where patients are treated for alexithymia at the same time as receiving 
treatment for a primary psychiatric disorder. Early detection and successful treatment of 
alexithymia is likely to impact on future service usage and costs in mental health settings. 
Findings from the present research indicate that successful treatment of alexithymia 
has the potential to result in improved therapeutic outcomes, as non-alexithymic patients and 
patients who made greater reductions in alexithymia during treatment reported lower levels of 
psychological distress following treatment. Successful treatment of alexithymia could be 
defined as at least moderate to large mean-level reductions in scores, which would be in line 
with the average effects of psychotherapy that are widely shown to be significant and large 
(for a review of psychotherapy efficacy and effectiveness research, see Lambert & Ogles, 
2004). However, the enduring nature of alexithymia as a personality trait combined with 
small reductions in alexithymia scores following group therapy found in the present research 
indicate that successful treatment of alexithymia by this comparison may prove difficult. 
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Moreover, attempts to uncover the most effective therapeutic intervention to treat 
alexithymia may be unproductive because comparisons of different therapeutic interventions 
for treating psychiatric disorders, including personality disorders, have been shown to result 
in similar treatment outcomes (see Livesley, 2007; Wampold, 2001). Wampold (2001) has 
provided evidence to indicate that interventions developed for particular deficits (e.g., 
cognitive-behavioural therapy for patients with maladaptive cognitions) are no more effective 
than interventions not developed for the deficit (interpersonal therapy for patients with 
maladaptive cognitions). The present finding that the reduction in alexithymia during 
treatment was not differentiated by the approach to group therapy supports the argument that 
different therapeutic approaches result in similar treatment outcomes and thus clarity about 
the treatment of alexithymia is unlikely to be achieved by comparing the effectiveness of 
interventions based on theoretical orientation. Rather, to improve the treatment of 
alexithymia it is suggested that researchers and clinicians examine common factors of 
treatment, such as therapeutic alliance, therapist competence, and therapist allegiance to 
theoretical orientation, that have been found to account for more variance in therapeutic 
outcome than specific approach to treatment (see Messer & Wampold, 2002). 
Strengths and Limitations of the Research 
There were a number of strengths in the present research. The present research was 
carefully designed and empirically rigorous. This included evaluating the reliability of the 
total TAS-20 and three factors for use in the present empirical studies. Two extensive 
literature bases were complied, upon which further empirical examination can develop. A 
systematic review of prevalence data on alexithymia was undertaken for the first time, which 
helped to clarify the global prevalence rate of alexithymia in both psychiatric and community 
populations. The addition of community samples in the literature review and in the first 
empirical study also provided a comparative perspective on the prevalence of alexithymia. 
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The second empirical study expanded previous research on the role of alexithymia in 
therapeutic outcome by comparing cognitive-behavioural focused and emotion focused 
approaches not previously examined. The potential therapeutic efficacy of these different 
approaches in treating alexithymia was examined through robust statistical methods, which 
considered different forms of stability in alexithymia. In addition, issues of dependence 
between change in alexithymia and change in clinical states were addressed. 
In contrast to the strengths of the present research, there were also a number of 
limitations. The conceptualisation of the alexithymia construct was restricted to how it is 
defined by the TAS-20 as the present research focused solely on the TAS-20 as a measure of 
alexithymia. However, the TAS-20 was judged the most psychometrically sound and 
applicable measure to use when comparing international studies and for use in the present 
samples of the empirical studies. Furthermore, the use of archival data for the psychiatric 
sample in the empirical stages of this research limited the design and direction of the research 
as the variables under consideration were predetermined. This limitation included a lack of 
follow-up data to confirm whether alexithymia scores before or after treatment had long-
standing influence on therapeutic outcome. This limitation also included the use of one 
measure to assess therapeutic outcome. Measuring different aspects of outcome would have 
been ideal to determine the influence of alexithymia on multiple aspects of therapeutic 
outcome, including general domains of well-being and functioning as well as specific 
changes in clinical symptoms. 
Directions for Future Research 
There are several directions for alexithymia research based on the findings of the 
present research. While the systematic literature reviews provided comprehensive summaries 
of relevant studies on the prevalence of alexithymia and role of alexithymia in the therapeutic 
process, respectively, clinicians and future researchers would benefit from further empirical 
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examination of these data. Specifically, meta-analyses will yield a more precise (narrower 
confidence intervals) overall estimate of the prevalence rate of alexithymia in the psychiatric 
and community populations and a more precise effect of alexithymia on therapeutic outcome. 
Future research examining the role of alexithymia in the therapeutic process would 
benefit from replicating the findings of the present research with a larger sample size while 
addressing the methodological limitations mentioned above. It is also important for future 
researchers to conduct longitudinal studies to provide a more comprehensive understanding 
of the role of alexithymia in the therapeutic process over time. Studies involving longer 
periods of follow-up would help to confirm expectations of the long-standing influence of 
alexithymia on therapeutic outcome as well as long-term stability of alexithymia following 
therapeutic intervention. 
Findings from the present research indicate that alexithymia is a complex construct 
that requires equally complex methods for assessing its role in the therapeutic process. In this, 
future researchers could examine potential mediating or moderating factors that may be 
related to alexithymia and the therapeutic context. In particular, investigation into the 
interaction of common treatment factors with alexithymia (e.g., therapeutic alliance and 
therapist characteristics) will expand the understanding of alexithymia and provide valuable 
information for the treatment of alexithymic patients. 
Conclusion 
The present research examined the prevalence of alexithymia in the psychiatric and 
community populations, the role alexithymia plays in explaining the perpetuation of 
psychiatric symptomatology, and the extent to which alexithymia can be mitigated by 
different therapeutic interventions. Findings from this research substantiated the strong 
presence of alexithymia in the psychiatric population and contributed to improving the 
understanding of the role of alexithymia in the therapeutic process. There is evidence to 
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suggest that the influence of alexithymia on therapeutic outcome is indirect and to challenge 
the notion that specific therapeutic interventions may have superior treatment effects on 
reducing alexithymia in psychiatric patients. The present findings will incite future 
researchers to advance sophisticated inquiry into the influence of alexithymia on therapeutic 
outcome. Strong evidence of the persistent nature of alexithymia as a personality trait 
supports the need for future researchers to understand the exact mechanisms underlying the 
relationship between alexithymia and therapeutic intervention. Although alexithymia cannot 
provide a single explanation for patient response to therapeutic intervention, the principal 
conclusion of the present research is that alexithymia should be considered a connected part 
of an overall strategy for the prevention and treatment of psychopathology. 
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Appendix A 
Depression Anxiety Stress Scale Version 42 
 
DAS S Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you over 
the past week.  There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found myself getting upset by quite trivial things 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I just couldn't seem to get going 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I had a feeling of shakiness (eg, legs going to give way) 0      1      2      3 
8 I found it difficult to relax 0      1      2      3 
9 I found myself in situations that made me so anxious I was most 
relieved when they ended 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting upset rather easily 0      1      2      3 
12 I felt that I was using a lot of nervous energy 0      1      2      3 
13 I felt sad and depressed 0      1      2      3 
14 I found myself getting impatient when I was delayed in any way 
(eg, elevators, traffic lights, being kept waiting) 
0      1      2      3 
15 I had a feeling of faintness 0      1      2      3 
16 I felt that I had lost interest in just about everything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I perspired noticeably (eg, hands sweaty) in the absence of high 
temperatures or physical exertion 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life wasn't worthwhile 0      1      2      3 
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Reminder of rating scale: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
                22 I found it hard to wind down 0      1      2      3 
23 I had difficulty in swallowing 0      1      2      3 
24 I couldn't seem to get any enjoyment out of the things I did 0      1      2      3 
25 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
26 I felt down-hearted and blue 0      1      2      3 
27 I found that I was very irritable 0      1      2      3 
28 I felt I was close to panic 0      1      2      3 
29 I found it hard to calm down after something upset me 0      1      2      3 
30 I feared that I would be "thrown" by some trivial but 
unfamiliar task 
0      1      2      3 
31 I was unable to become enthusiastic about anything 0      1      2      3 
32 I found it difficult to tolerate interruptions to what I was doing 0      1      2      3 
33 I was in a state of nervous tension 0      1      2      3 
34 I felt I was pretty worthless 0      1      2      3 
35 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
36 I felt terrified 0      1      2      3 
37 I could see nothing in the future to be hopeful about 0      1      2      3 
38 I felt that life was meaningless 0      1      2      3 
39 I found myself getting agitated 0      1      2      3 
40 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
41 I experienced trembling (eg, in the hands) 0      1      2      3 
42 I found it difficult to work up the initiative to do things 0      1      2      3 
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Appendix B 
Demographic Questionnaire and Consent Form for Psychiatric Patients 
 
Group Therapy Program, Ellen Street 
 
Surname: URMN: Sex: 
Forenames: Birth date: 
Address: Phone: 
 
GP details: ___________________________________________________________________ 
Who referred you? ____________________________________________________________ 
To help us assist you with planning suitable groups, and so that we can monitor if the groups 
have helped you, please complete the following questions as openly and honestly as possible: 
Do you have any physical health concerns? □No □Yes 
If yes, please describe: ______________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
Other factors (those factors apart from the physical problems just described) that might interfere 
with your attendance at the group program (e.g. work, transport, sleep pattern, reading, and 
writing) 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
What are your reasons for attending the Group Therapy Program at Ellen Street? 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
What are you hoping to get out of groups? 
_________________________________________________________________________________ 
 
Introductory 
Planning Session 
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_________________________________________________________________________________ 
Tell us about your hobbies and/or interests? 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
General Information: 
What country were you born in? ___________________________ 
What language do you speak at home? _________________________ 
Do you live: □Alone □With family □Shared accommodation 
Do you have supportive: □Family □Friends □Neither 
Current employment type 
□ No current employment 
□ Casual paid work 
□ Part-time paid work 
□ Full time paid work 
□ Voluntary work 
□ Other, please specify: ____________________________ 
 
Work – Have you been employed in the last 2 years: 
□ No current employment 
□ Casual paid work 
□ Part-time paid work 
□ Full time paid work 
□ Voluntary work 
□ Other, please specify: ____________________________ 
 
What education have you completed: 
□ Primary school 
□ High school 
□ University 
□ Technical Education 
 
How many years of education have you completed in total? __________________________ 
Do you identify any communication or learning difficulties? □No □Yes 
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Please specify: ___________________________________________________________________ 
_________________________________________________________________________________ 
Would you like to attend other groups aimed at? 
□ Domestic Violence 
By signing this form you are giving the Group Therapy Program, Ellen Street, permission to 
use the information on this questionnaire, as well as other questionnaires during intake and 
when attending groups, for evaluation and research purposes. Personal information will not be 
released in any form to protect your privacy. 
Signature: _______________________________________Date: ____/____/_______ 
Clinician: (print name) __________________________________________ 
Signature: _________________________________________________ 
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Appendix C 
Depression Anxiety Stress Scale Version 21 
 
DAS S 21 Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you over the 
past week.  There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
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Appendix D 
Demographic Questionnaire for Community Participants 
 
Do you live in Perth, Western Australia? 
Yes  No 
Gender 
Male  Female 
Age at last birthday 
...................... 
Employment    
Full-time Part-time/Casual Unemployed 
Education     
High school Technical/Tafe University  
If you have attended university, are you a current student? 
 Yes  No 
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Appendix E 
Consent Form for Community Participants 
 
Please read the following statements and click ‘Yes, I consent to participate in this 
study’ if you agree. 
 I have read and understand the information sheet and wish to participate in the 
research. 
 I understand that my participation in this study is entirely voluntary, that my name 
and contact details are not required, and that I am free to quit the survey at any time 
before submission without consequence. 
 I understand that if I experience any distress I will be provided with the details of 
support services following this survey. 
 I understand that any identifying information will be erased from the final project, that 
I have the right to view the results of the final project, and that the study may be 
published. 
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Appendix F 
Study Flyer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
You could win one of two $100 Myer gift 
vouchers. 
 
My name is Lauren McGillivray and I am a PhD student in Clinical Psychology at Edith 
Cowan University. I am studying people’s ability to connect with and talk about their 
emotions. People who experience difficulties with emotion may also have problems with 
other aspects of their lives. Emotion is an important area in mental health and this study 
will help inform future therapeutic applications. 
If you are over the age of 18 year, your participation would be greatly appreciated. You 
will need to complete a short online survey, which will take approximately 20 minutes. 
Go to the following website to learn more: 
 
“URL link” 
 
Thank you for your time! 
 
This study has been approved by the Edith Cowan University Human Research Ethics 
Committee. Your participation can be anonymous - your contact details are not 
required, unless you enter the prize draw. All information will remain strictly 
confidential. 
 
 
 
Do you want to be part of a 
psychology study? 
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Appendix G 
Information Sheet for Community Participants 
 
Thank you for your interest. My name is Lauren McGillivray and I am a PhD candidate 
studying Clinical Psychology at Edith Cowan University. My research, titled Alexithymia in a 
psychiatric population: stability and relationship with therapeutic outcome, involves an 
investigation into the relationship between Alexithymia (a deficit in identifying and 
describing emotion) and therapeutic intervention. Although this research is primarily focused 
on the psychiatric population, for one of my studies I require student and community 
participants as a comparison sample, which is where I need your help. 
Please note that this project has received ethical approval from the Faculty of Computing 
Health and Science Ethics Committee at Edith Cowan University. 
This survey includes three sections for you to complete: one demographic questionnaire and 
two assessments. 
If you choose to participate in this project, you may enter into the draw to win one of 
two $100 Myer gift vouchers. 
Please note that your contact details are not required unless you enter the draw to win a $100 
Myer gift voucher. In this case, you will be required to send an email to an address separate 
from this survey, thus your details will not be linked back to any assessment results. Any 
information collected will remain strictly confidential, between my supervisors and me, with 
any identifying information being erased from the final project. 
You may quit the survey at any time before submission without consequence. However, it 
would be beneficial for the research if you could take the time to answer all of the questions: 
there are no right or wrong answers. 
Participants will be able to access results of the final research project. If you have any 
questions or concerns please feel free to email me at lmcgilli@our.ecu.edu.au or call my 
supervisors: Dr. Rodrigo Becerra and Dr. Craig Harms on (08) 6304 2786 and (08) 6304 
5715, respectively. Alternatively, if you wish to contact someone who is not connected with 
this study, please call the ECU ethics research officer, Kim Griftkins on (08) 6304 2170. 
Thank you for reading this information and I hope you can participate in my study. 
  
Kind regards 
Lauren McGillivray 
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Appendix H 
Counselling and Support Organisations for Community Participants 
 
Centrecare 
Confidential counselling service 
Ph:  (08) 9325 6644 
Email: www.centrecare.com.au 
 
Crisis Care 
Confidential counselling service 
Ph: (08) 9223 1111 (24hr) 
Email: www.dcp.wa.gov.au/crisisandemergency/pages/crisiscare.aspx 
 
Lifeline 
Confidential telephone counselling service 
Ph: 13 11 14 (24hr) 
Email: www.lifeline.org.au 
 
Edith Cowan University Psychological Services 
Confidential counselling service 
Joondalup House, 8 Davidson Terrace, Joondalup 
Ph: (08) 9301 0011 
Email: www.ecu.edu.au/schools/psychology-and-social-science/facilities 
 
Edith Cowan University Student Counselling Service 
Confidential counselling service for ECU students on all campuses 
Ph: (08) 9370 6706 
Email: student.ecu.edu.au/support/counselling 
 
